ST JUDE CHILDRENS RESEARCH HOSPITAL INC: Form 990, tax year 2020
View the entire original 990 at ProPublica ↗
- Organization
- ST JUDE CHILDRENS RESEARCH HOSPITAL INC (EIN 62-0646012)
- Tax period
- 2020-07-01 to 2021-06-30
- Filed
- 2022-04-28
- IRS object ID
- 202201189349300740
- Schema version
- 2020v4.2
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule H
- Schedule I
- Schedule J
- Schedule L
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2022-04-28T12:53:38-05:00 | ReturnTs |
| Tax Period End | 2021-06-30 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 861065772 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | DELOITTE TAX LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1033 DEMONBREUN SUITE 400 | AddressLine1Txt |
| City | NASHVILLE | CityNm |
| State Abbreviation | TN | StateAbbreviationCd |
| ZIP | 37203 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2020-07-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 620646012 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ST JUDE CHILDREN'S RESEARCH HOSPITAL | BusinessNameLine1Txt |
| Business Name Line2 | INC | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | STJU | BusinessNameControlTxt |
| Phone | 9015953903 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 262 DANNY THOMAS PLACE | AddressLine1Txt |
| City | MEMPHIS | CityNm |
| State Abbreviation | TN | StateAbbreviationCd |
| ZIP | 381053678 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | PAT KEEL | PersonNm |
| Person Title | EVP, CAO & CFO | PersonTitleTxt |
| Phone | 9015953903 | PhoneNum |
| Signature | 2022-04-28 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | PAT | PersonFirstNm |
| Person Last | KEEL | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | 999009999 | SSN |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | FRANCIS J BEDARD | PreparerPersonNm |
| PTIN | P00752421 | PTIN |
| Phone | 6152591800 | PhoneNum |
Additional Filer Information AdditionalFilerInformation
Trusted Customer TrustedCustomerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trusted Customer | 2 | TrustedCustomerCd |
| Authentication Assurance Level | AAL1 | AuthenticationAssuranceLevelCd |
| Identity Assurance Level | IAL1 | IdentityAssuranceLevelCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2020 | TaxYr |
| Build TS | 2022-09-23 18:48:47Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | JAMES R DOWNING | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 262 DANNY THOMAS PLACE | AddressLine1Txt |
| City | MEMPHIS | CityNm |
| State Abbreviation | TN | StateAbbreviationCd |
| ZIP | 381053678 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $1,273,321,208 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.STJUDE.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1959 | FormationYr |
| Legal Domicile State | TN | LegalDomicileStateCd |
| Activity Or Mission | THE MISSION OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL IS TO ADVANCE CURES, AND MEANS OF PREVENTION, FOR PEDIATRIC CATASTROPHIC DISEASES THROUGH RESEARCH AND TREATMENT. CONSISTENT WITH THE VISION OF OUR FOUNDER DANNY THOMAS, NO CHILD IS DENIED TREATMENT BASED ON RACE, RELIGION OR A FAMILY'S ABILITY TO PAY. | ActivityOrMissionDesc |
| Voting Members Governing Body | 41 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 38 | VotingMembersIndependentCnt |
| Total Employee | 5657 | TotalEmployeeCnt |
| Total Volunteers | 231 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $1,094,131,374 | PYContributionsGrantsAmt |
| CY Contributions Grants | $1,130,870,648 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $125,905,299 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $127,720,587 | CYProgramServiceRevenueAmt |
| PY Investment Income | -$193,341 | PYInvestmentIncomeAmt |
| CY Investment Income | -$493,754 | CYInvestmentIncomeAmt |
| PY Other Revenue | $18,338,842 | PYOtherRevenueAmt |
| CY Other Revenue | $14,099,558 | CYOtherRevenueAmt |
| PY Total Revenue | $1,238,182,174 | PYTotalRevenueAmt |
| CY Total Revenue | $1,272,197,039 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $1,519,684 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $1,618,459 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $597,891,284 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $628,009,566 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $0 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $504,569,569 | PYOtherExpensesAmt |
| CY Other Expenses | $536,928,123 | CYOtherExpensesAmt |
| PY Total Expenses | $1,103,980,537 | PYTotalExpensesAmt |
| CY Total Expenses | $1,166,556,148 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $134,201,637 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $105,640,891 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $6,740,895,238 | TotalAssetsBOYAmt |
| Total Assets EOY | $9,161,722,368 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $176,671,371 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $188,169,580 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $6,564,223,867 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $8,973,552,788 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | THE MISSION OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL IS TO ADVANCE CURES, AND MEANS OF PREVENTION, FOR PEDIATRIC CATASTROPHIC DISEASES THROUGH RESEARCH AND TREATMENT. CONSISTENT WITH THE VISION OF OUR FOUNDER DANNY THOMAS, NO CHILD IS DENIED TREATMENT BASED ON RACE, RELIGION OR A FAMILY'S ABILITY TO PAY. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $524,965,679 | ExpenseAmt |
| Grant | $1,511,609 | GrantAmt |
| Revenue | $131,703,129 | RevenueAmt |
| Desc | PATIENT CARE: THE HOSPITAL PROVIDED 17,234 INPATIENT DAYS OF CARE DURING THE YEAR. OUR BONE MARROW TRANSPLANTATION PROGRAM ACCOUNTED FOR 4,413 OR 26% OF THOSE INPATIENT DAYS. PATIENTS MADE 61,519 CLINIC REGISTRATIONS DURING THE YEAR. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $520,687,169 | ExpenseAmt |
| Grant | $106,850 | GrantAmt |
| Desc | RESEARCH: THE CURRENT BASIC SCIENCE AND CLINICAL RESEARCH AT THE HOSPITAL INCLUDES WORK IN GENE THERAPY, CHEMOTHERAPY, THE BIOCHEMISTRY OF NORMAL AND CANCEROUS CELLS, RADIATION TREATMENT, BLOOD DISEASES, RESISTANCE TO THERAPY, VIRUSES, HEREDITARY DISEASES, INFLUENZA, PEDIATRIC AIDS AND PHYSIOLOGICAL EFFECTS OF CATASTROPHIC ILLNESSES. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $35,248,075 | ExpenseAmt |
| Desc | EDUCATION AND TRAINING: AS PART OF ITS MISSION, THE HOSPITAL HAS DEVELOPED A GLOBAL INITIATIVE (ST. JUDE GLOBAL) TO IMPROVE THE SURVIVAL RATES OF CHILDREN WITH CANCER AND OTHER CATASTROPHIC DISEASES WORLDWIDE. ST. JUDE GLOBAL ACCOMPLISHES THIS BY SHARING KNOWLEDGE, TECHNOLOGY AND ORGANIZATIONAL SKILLS, HELPING TO IMPLEMENT NEW APPROACHES TO TREAT PEDIATRIC CANCER GLOBALLY, AND DEVELOPING REGIONAL NETWORKS COMMITTED TO ERADICATING CANCER IN CHILDREN. THIS MISSION WILL BE ACHIEVED BY FOCUSING ON THREE OVERRIDING GOALS: (1) TO TRAIN THE CLINICAL WORKFORCE THAT WILL BE REQUIRED TO MEET OUR MISSION, (2) TO DEVELOP AND STRENGTHEN HEALTH SYSTEMS AND PATIENT-CENTERED INITIATIVES THAT ENCOMPASS THE ENTIRE CONTINUUM OF CARE REQUIRED FOR CHILDREN WITH CANCER AND NON-MALIGNANT HEMATOLOGICAL DISEASES, AND (3) TO ADVANCE KNOWLEDGE IN GLOBAL PEDIATRIC ONCOLOGY AND HEMATOLOGY THROUGH RESEARCH TO SUSTAIN A CONTINUOUS IMPROVEMENT IN THE LEVEL AND QUALITY OF CARE DELIVERED AROUND THE GLOBE. THESE INITIATIVES ARE SPEARHEADED BY ST. JUDE EXPERTS WHO WORK CLOSELY WITH HEALTHCARE PROFESSIONALS AT OUR PARTNER SITES. IN ADDITION, A GRADUATE PROGRAM AT THE DOCTORAL AND MASTER'S LEVEL IS OFFERED THROUGH A WHOLLY-OWNED SUBSIDIARY, ST. JUDE CHILDREN'S RESEARCH HOSPITAL GRADUATE SCHOOL OF BIOMEDICAL SCIENCES, LLC, TO EDUCATE AND TRAIN FUTURE GENERATIONS OF SCIENTISTS SEEKING TO UNDERSTAND THE MOLECULAR BASIS OF HUMAN DISEASE AND DEVELOP NOVEL THERAPIES BASED ON THAT UNDERSTANDING. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $1,080,900,923 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (1) | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | Yes (1) | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | Yes (1) | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (1) | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | Yes (1) | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | 0 | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | Yes (1) | OperateHospitalInd |
| Audited Financial Stmt Att | Yes (1) | AuditedFinancialStmtAttInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | Yes (1) | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | Yes (1) | DisregardedEntityInd |
| Related Entity | Yes (1) | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 981 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 5657 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | Yes (1) | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 41 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 38 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (1) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | Yes (1) | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | Yes (1) | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | Yes (1) | LocalChaptersInd |
| Policies Reference Chapters | Yes (1) | PoliciesReferenceChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | SHARON HENDRIX | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 9015953903 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 262 DANNY THOMAS PLACE | AddressLine1Txt |
| City | MEMPHIS | CityNm |
| State Abbreviation | TN | StateAbbreviationCd |
| ZIP | 381053678 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (52 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd | Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd |
|---|---|---|---|---|---|---|---|---|---|
| CHARLES M ROBERTS | |||||||||
| EVP/DIRECTOR CANCER CENTER | 55.00 | 0.00 | Yes (X) | $1,410,345 | $0 | $86,116 | |||
| JAMES R DOWNING | |||||||||
| PRESIDENT/CEO | 55.00 | 1.00 | Yes (X) | $1,303,467 | $0 | $255,516 | Yes (X) | ||
| MATTHEW J KRASIN | |||||||||
| FACULTY | 55.00 | 0.00 | $1,207,169 | $0 | $66,297 | Yes (X) | |||
| RICHARD C SHADYAC JR | |||||||||
| EX-OFFICIO DIRECTOR | 1.00 | 55.00 | $0 | $945,764 | $123,064 | Yes (X) | |||
| THOMAS E MERCHANT | |||||||||
| CHAIR | 55.00 | 0.00 | $946,881 | $0 | $66,297 | Yes (X) | |||
| ELLIS NEUFELD | |||||||||
| EVP/CLINICAL DIRECTOR | 55.00 | 0.00 | Yes (X) | $837,550 | $0 | $168,974 | |||
| ANDREW DAVIDOFF | |||||||||
| CHAIR | 55.00 | 0.00 | $928,854 | $0 | $63,737 | Yes (X) | |||
| DOUGLAS R GREEN | |||||||||
| CHAIR | 55.00 | 0.00 | $868,425 | $0 | $58,144 | Yes (X) | |||
| CHING-HON PUI | |||||||||
| CHAIR | 55.00 | 0.00 | $830,384 | $0 | $39,009 | Yes (X) | |||
| JAMES I MORGAN | |||||||||
| EVP/SCIENTIFIC DIRECTOR | 55.00 | 0.00 | Yes (X) | $803,210 | $0 | $59,075 | |||
| PATRICIA A KEEL | |||||||||
| EVP, CAO & CFO | 55.00 | 0.00 | Yes (X) | $771,997 | $0 | $80,541 | |||
| CARLOS RODRIGUEZ-GALINDO | |||||||||
| EVP/CHAIR | 55.00 | 0.00 | Yes (X) | $732,364 | $0 | $77,439 | |||
| MARY ANNA QUINN | |||||||||
| FORMER EVP/CAO | 0.00 | 0.00 | $216,945 | $0 | $5,717 | Yes (X) | |||
| JOYCE ABOUSSIE | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| SUSAN MACK AQUILLARD MD | |||||||||
| VOTING DIRECTOR | 8.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| JOSEPH S AYOUB JR ESQ | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| PAUL J AYOUB ESQ | |||||||||
| VOTING DIRECTOR | 8.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| FREDERICK M AZAR MD | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| JAMES B BARKATE | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| MARTHA PERINE BEARD | |||||||||
| VOTING DIRECTOR | 4.00 | 8.00 | $0 | $0 | $0 | Yes (X) | |||
| SHERYL BOURISK | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| ROBERT A BREIT MD | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| TERRY L BURMAN | |||||||||
| VOTING DIRECTOR | 8.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| ANN M DANNER | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| JOSEPH M DEVIVO | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| FRED P GATTAS III PHARMD | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| RUTH GAVIRIA | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| CHRISTOPHER GEORGE MD | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| JUDY HABIB | |||||||||
| VOTING DIRECTOR | 4.00 | 8.00 | $0 | $0 | $0 | Yes (X) | |||
| GABRIEL HADDAD MD | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| PAUL K HAJAR | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| CHUCK HAJJAR | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| FOUAD HAJJAR MD | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| FREDERICK R HARRIS JR MD | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| BRUCE B HOPKINS | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| J DAVID KARAM II | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| SHARON L MCCOLLAM | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| MICHAEL D MCCOY | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| ROBERT T MOLINET ESQ | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| RAMZI NUWAYHID | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| THOMAS PENN III | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| CHRISTINA M RASHID | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| CAMILLE F SARROUF JR ESQ | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| JOSEPH C SHAKER | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| JOSEPH G SHAKER | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| GEORGE A SIMON II | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| MICHAEL SIMON | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| TONY THOMAS | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| RICHARD M UNES | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| PAUL H WEIN ESQ | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| SUSAN R WINDHAM-BANNISTER | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | $0 | $0 | $0 | Yes (X) | |||
| TAMA ZAYDON | |||||||||
| VOTING DIRECTOR | 4.00 | 8.00 | $0 | $0 | $0 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $10,857,591 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $945,764 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $1,149,926 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 1509 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | Yes (1) | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| FLINTCO LLC | |||||
| 2179 HILLSHIRE CIRCLE | MEMPHIS | TN | 38133 | CONSTRUCTION CONTRACTOR | $139,421,341 |
| G4S SECURE SOLUTIONS USA INC | |||||
| 1395 UNIVERSITY BLVD | JUPITER | FL | 33458 | SECURITY SERVICES | $6,356,100 |
| CERNER CORP | |||||
| 2800 ROCKCREEK PARKWAY | KANSAS CITY | MO | 64117 | SOFTWARE SUPPORT | $6,117,612 |
| METHODIST HEALTHCARE MEMPHIS | |||||
| 1265 UNION AVE | MEMPHIS | TN | 38104 | MEDICAL SERVICES | $6,061,037 |
| DYNAMIX GROUP INC | |||||
| PO BOX 116609 | ATLANTA | GA | 303686609 | SOFTWARE SUPPORT | $5,165,477 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 297 | CntrctRcvdGreaterThan100KCnt |
| Related Organizations | $997,103,326 | RelatedOrganizationsAmt |
| Government Grants | $122,203,967 | GovernmentGrantsAmt |
| All Other Contributions | $11,563,355 | AllOtherContributionsAmt |
| Total Contributions | $1,130,870,648 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | PATIENT CARE | Desc |
| Business | 621110 | BusinessCd |
| Total Revenue Column | $127,720,587 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $127,720,587 | RelatedOrExemptFuncIncomeAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $127,720,587 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $14,236 | TotalRevenueColumnAmt |
| Exclusion | $14,236 | ExclusionAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $7,613,807 | TotalRevenueColumnAmt |
| Exclusion | $7,613,807 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $566,964 | SecuritiesAmt |
| Other | $49,215 | OtherAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $423,748 | SecuritiesAmt |
| Other | $700,421 | OtherAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $143,216 | SecuritiesAmt |
| Other | -$651,206 | OtherAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$507,990 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | -$651,206 | RelatedOrExemptFuncIncomeAmt |
| Exclusion | $143,216 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt | ExclusionExclusionAmt |
|---|---|---|---|---|
| CHGME/CHCA | 900099 | $2,513,042 | $2,513,042 | |
| CAFETERIA/VENDING | 722514 | $1,852,003 | $1,852,003 | |
| HHMI | 900099 | $196,501 | $196,501 |
Miscellaneous Revenue MiscellaneousRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $1,924,205 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $1,924,205 | RelatedOrExemptFuncIncomeAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $6,485,751 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $1,272,197,039 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $131,703,129 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $9,623,262 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,618,459 | TotalAmt |
| Program Services | $1,618,459 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,312,462 | TotalAmt |
| Program Services | $4,015,062 | ProgramServicesAmt |
| Management And General | $2,297,400 | ManagementAndGeneralAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $20,528 | TotalAmt |
| Management And General | $20,528 | ManagementAndGeneralAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $482,277,698 | TotalAmt |
| Program Services | $447,490,515 | ProgramServicesAmt |
| Management And General | $34,787,183 | ManagementAndGeneralAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $30,288,955 | TotalAmt |
| Program Services | $28,104,182 | ProgramServicesAmt |
| Management And General | $2,184,773 | ManagementAndGeneralAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $75,836,475 | TotalAmt |
| Program Services | $70,366,313 | ProgramServicesAmt |
| Management And General | $5,470,162 | ManagementAndGeneralAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $33,273,448 | TotalAmt |
| Program Services | $30,873,400 | ProgramServicesAmt |
| Management And General | $2,400,048 | ManagementAndGeneralAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $41,328,988 | TotalAmt |
| Program Services | $38,230,542 | ProgramServicesAmt |
| Management And General | $3,098,446 | ManagementAndGeneralAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,033,657 | TotalAmt |
| Program Services | $1,881,193 | ProgramServicesAmt |
| Management And General | $152,464 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $246,160 | TotalAmt |
| Program Services | $227,705 | ProgramServicesAmt |
| Management And General | $18,455 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $81,448 | TotalAmt |
| Management And General | $81,448 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $112,335,712 | TotalAmt |
| Program Services | $95,829,585 | ProgramServicesAmt |
| Management And General | $16,506,127 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $815,920 | TotalAmt |
| Program Services | $754,750 | ProgramServicesAmt |
| Management And General | $61,170 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,243,141 | TotalAmt |
| Program Services | $2,188,320 | ProgramServicesAmt |
| Management And General | $54,821 | ManagementAndGeneralAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $54,741,984 | TotalAmt |
| Program Services | $50,637,961 | ProgramServicesAmt |
| Management And General | $4,104,023 | ManagementAndGeneralAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $49,930,171 | TotalAmt |
| Program Services | $37,873,342 | ProgramServicesAmt |
| Management And General | $12,056,829 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,026,245 | TotalAmt |
| Program Services | $2,961,381 | ProgramServicesAmt |
| Management And General | $64,864 | ManagementAndGeneralAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $440,741 | TotalAmt |
| Program Services | $261,960 | ProgramServicesAmt |
| Management And General | $178,781 | ManagementAndGeneralAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $94,939,132 | TotalAmt |
| Program Services | $83,059,508 | ProgramServicesAmt |
| Management And General | $11,879,624 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,898,534 | TotalAmt |
| Program Services | $1,075,342 | ProgramServicesAmt |
| Management And General | $823,192 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| LABORATORY SUPPLIES | $66,374,575 | $64,752,431 | $1,622,144 |
| PHARMACEUTICAL SUPPLIES | $59,894,614 | $58,430,835 | $1,463,779 |
| TELEPHONE | $1,563,028 | $1,354,529 | $208,499 |
| ALLOCATION ADJUSTMENTS | $0 | $21,366,097 | -$21,366,097 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $45,034,073 | TotalAmt |
| Program Services | $37,547,511 | ProgramServicesAmt |
| Management And General | $7,486,562 | ManagementAndGeneralAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,166,556,148 | TotalAmt |
| Program Services | $1,080,900,923 | ProgramServicesAmt |
| Management And General | $85,655,225 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,829,004 | BOYAmt |
| EOY | $3,864,893 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $32,617,969 | BOYAmt |
| EOY | $39,278,772 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $24,494,869 | BOYAmt |
| EOY | $21,105,668 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $16,624,122 | BOYAmt |
| EOY | $17,701,525 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $21,891,614 | BOYAmt |
| EOY | $27,450,531 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $2,090,649,068 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $1,086,552,398 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $901,606,015 | BOYAmt |
| EOY | $1,004,096,670 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,418,680 | BOYAmt |
| EOY | $3,209,430 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,736,412,965 | BOYAmt |
| EOY | $8,045,014,879 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,740,895,238 | BOYAmt |
| EOY | $9,161,722,368 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $158,393,691 | BOYAmt |
| EOY | $160,901,221 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $14,752,839 | BOYAmt |
| EOY | $17,262,757 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,524,841 | BOYAmt |
| EOY | $10,005,602 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $176,671,371 | BOYAmt |
| EOY | $188,169,580 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,495,421,852 | BOYAmt |
| EOY | $7,617,971,425 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,068,802,015 | BOYAmt |
| EOY | $1,355,581,363 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,564,223,867 | BOYAmt |
| EOY | $8,973,552,788 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,740,895,238 | BOYAmt |
| EOY | $9,161,722,368 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | $105,640,891 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $633,298 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $2,303,054,732 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consol And Sep Basis Fincl Stmt | Yes (X) | ConsolAndSepBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (1) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (1) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Hospital | Yes (X) | HospitalInd |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $753,145,680 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $851,803,301 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $974,758,247 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $1,094,131,374 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $1,130,870,648 | CurrentTaxYearAmt |
| Total | $4,804,709,250 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $753,145,680 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $851,803,301 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $974,758,247 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $1,094,131,374 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $1,130,870,648 | CurrentTaxYearAmt |
| Total | $4,804,709,250 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Support Total170 | $4,804,709,250 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $4,641,541 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $11,308,521 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $14,733,405 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $9,206,868 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $7,628,043 | CurrentTaxYearAmt |
| Total | $47,518,378 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $20,138,461 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $7,598,809 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $9,873,680 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $9,142,582 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $6,485,751 | CurrentTaxYearAmt |
| Total | $53,239,283 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $4,905,466,911 | TotalSupportAmt |
| Public Support CY170 | 0.97950 | PublicSupportCY170Pct |
| Public Support PY170 | 0.97750 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Form990 Schedule A Part VI Form990ScheduleAPartVIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART II, SECTION B, LINE 10: | FormAndLineReferenceDesc |
| Explanation | EXPLANATION FOR OTHER INCOME: 2016 $ 8,152,422 - BOND DEFEASANCE GAIN $ 4,086,280 - CAFETERIA/VENDING $ 2,058,124 - CHGME/CHCA $ 5,841,635 - OTHER REVENUE $ 20,136,461 - TOTAL OTHER INCOME 2017 $ 4,288,072 - CAFETERIA/VENDING $ 2,351,842 - CHGME/CHCA $ 327,751 - HHMI $ 631,144 - OTHER REVENUE $ 7,598,809 - TOTAL OTHER INCOME 2018 $ 4,454,476 - CAFETERIA/VENDING $ 2,344,673 - CHGME/CHCA $ 363,869 - HHMI $ 2,710,662 - OTHER REVENUE $ 9,873,680 - TOTAL OTHER INCOME 2019 $ 3,706,979 - CAFETERIA/VENDING $ 2,511,652 - CHGME/CHCA $ 314,924 - HHMI $ 2,609,027 - OTHER REVENUE $ 9,142,582 - TOTAL OTHER INCOME 2020 $ 1,852,003 - CAFETERIA/VENDING $ 2,513,042 - CHGME/CHCA $ 196,501 - HHMI $ 1,924,205 - OTHER REVENUE $ 6,485,751 - TOTAL OTHER INCOME | ExplanationTxt |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Volunteers | 0 | VolunteersInd |
| Paid Staff Or Management | Yes (1) | PaidStaffOrManagementInd |
| Media Advertisements | 0 | MediaAdvertisementsInd |
| Mailings Members | 0 | MailingsMembersInd |
| Publications Or Broadcast | 0 | PublicationsOrBroadcastInd |
| Grants Other Organizations | Yes (1) | GrantsOtherOrganizationsInd |
| Grants Other Organizations | $7,200 | GrantsOtherOrganizationsAmt |
| Direct Contact Legislators | Yes (1) | DirectContactLegislatorsInd |
| Direct Contact Legislators | $19,154 | DirectContactLegislatorsAmt |
| Rallies Demonstrations | 0 | RalliesDemonstrationsInd |
| Other Activities | Yes (1) | OtherActivitiesInd |
| Other Activities | $55,094 | OtherActivitiesAmt |
| Total Lobbying Expenditures | $81,448 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | 0 | NotDescribedSection501c3Ind |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART II-B, LINE 1: | FormAndLineReferenceDesc |
| Explanation | LINE 1B) ST. JUDE EMPLOYS A DIRECTOR OF GOVERNMENT AFFAIRS; LINE 1F) AMOUNT LISTED IS CONTRIBUTION TO THE CHGME ADVOCACY CAMPAIGN; LINE 1G) AMOUNT LISTED IS PRORATED SALARY OF DIRECTOR OF GOVERNMENT AFFAIRS PLUS TRAVEL EXPENSES; LINE 1I) AMOUNT LISTED IS RELATED TO PRORATED RETAINER FEES FOR DIRECT FEDERAL AND STATE LEGISLATIVE CONTACTS AS WELL AS PROFESSIONAL DUES ATTRIBUTABLE TO LOBBYING FOR THE CHGME PROGRAM. | ExplanationTxt |
Schedule D IRS990ScheduleD
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $1,033,682,990 | BeginningYearBalanceAmt |
| Contributions | $7,863,768 | ContributionsAmt |
| Investment Earnings Or Losses | $357,550,674 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $69,170,089 | OtherExpendituresAmt |
| End Year Balance | $1,329,927,343 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $1,055,350,944 | BeginningYearBalanceAmt |
| Contributions | $5,491,426 | ContributionsAmt |
| Investment Earnings Or Losses | $34,726,892 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $61,886,272 | OtherExpendituresAmt |
| End Year Balance | $1,033,682,990 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $1,024,698,330 | BeginningYearBalanceAmt |
| Contributions | $4,864,242 | ContributionsAmt |
| Investment Earnings Or Losses | $64,664,085 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $38,875,713 | OtherExpendituresAmt |
| End Year Balance | $1,055,350,944 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $965,253,422 | BeginningYearBalanceAmt |
| Contributions | $21,281,957 | ContributionsAmt |
| Investment Earnings Or Losses | $92,690,065 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $54,527,114 | OtherExpendituresAmt |
| End Year Balance | $1,024,698,330 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $873,056,599 | BeginningYearBalanceAmt |
| Contributions | $12,552,432 | ContributionsAmt |
| Investment Earnings Or Losses | $103,475,245 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $23,830,854 | OtherExpendituresAmt |
| End Year Balance | $965,253,422 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.09540 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.90460 | PrmnntEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | Yes (1) | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | Yes (1) | EndowmentsHeldRelatedOrgInd |
| Related Org List Sch R | Yes (1) | RelatedOrgListSchRInd |
Buildings BuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $1,518,751,636 | OtherCostOrOtherBasisAmt |
| Depreciation | $693,018,663 | DepreciationAmt |
| Book Value | $825,732,973 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $552,214,161 | OtherCostOrOtherBasisAmt |
| Depreciation | $384,130,968 | DepreciationAmt |
| Book Value | $168,083,193 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $19,683,271 | OtherCostOrOtherBasisAmt |
| Depreciation | $9,402,767 | DepreciationAmt |
| Book Value | $10,280,504 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $1,004,096,670 | TotalBookValueLandBuildingsAmt |
Other Assets Org OtherAssetsOrgGrp (2 entries)
| DescDesc | Book ValueBookValueAmt |
|---|---|
| INTEREST IN NET ASSETS OF AMERICAN LEBANESE SYRIAN ASSOCIATED CHARITIES, INC | $8,039,467,697 |
| OTHER ASSETS | $5,547,182 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Other Assets | $8,045,014,879 | TotalBookValueOtherAssetsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (4 entries)
| DescDesc | AmtAmt |
|---|---|
| NOTE PAYABLE | $6,160,590 |
| SELF INSURANCE LIABILITY | $1,714,420 |
| WORKERS COMPENSATION | $1,353,494 |
| OWNER CONTROLLED INSURANCE PROGRAM | $777,098 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $10,005,602 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $2,292,002,395 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $633,298 | NetUnrealizedGainsInvstAmt |
| Other Revenue | $2,016,275,384 | OtherRevenueAmt |
| Revenue Not Reported | $2,016,908,682 | RevenueNotReportedAmt |
| Revenue Subtotal | $275,093,713 | RevenueSubtotalAmt |
| Other Revenues Not Included | $997,103,326 | OtherRevenuesNotIncludedAmt |
| Revenue Not Reported Fincl Stmt | $997,103,326 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $1,272,197,039 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $1,166,556,148 | TotExpnsEtcAuditedFinclStmtAmt |
| Expenses Not Reported | $0 | ExpensesNotReportedAmt |
| Expenses Subtotal | $1,166,556,148 | ExpensesSubtotalAmt |
| Expenses Not Rpt Fincl Stmt | $0 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $1,166,556,148 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (4 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART V, LINE 4: | THE ENDOWMENT FUNDS ARE HELD BY AMERICAN LEBANESE SYRIAN ASSOCIATED CHARITIES, INC., A RELATED ORGANIZATION, AND ARE USED TO SUPPORT THE FUTURE NEEDS OF ST. JUDE. |
| PART X, LINE 2: | AS OF JUNE 30, 2021, THE ORGANIZATION HAD NOT IDENTIFIED ANY UNCERTAIN TAX POSITIONS UNDER ASC TOPIC 740, INCOME TAXES, REQUIRING ADJUSTMENTS TO ITS COMBINED FINANCIAL STATEMENTS. IN THE EVENT THE ORGANIZATION WERE TO RECOGNIZE INTEREST AND PENALTIES RELATED TO UNCERTAIN TAX POSITIONS, IT WOULD BE RECOGNIZED IN THE COMBINED FINANCIAL STATEMENTS AS A GENERAL EXPENSE. GENERALLY, TAX YEARS ENDING 2018 THROUGH 2021 ARE OPEN TO EXAMINATION BY THE FEDERAL AND STATE TAXING AUTHORITIES, RESPECTIVELY. THERE ARE NO INCOME TAX EXAMINATIONS CURRENTLY IN PROCESS. |
| PART XI, LINE 2D - OTHER ADJUSTMENTS: | CHANGE IN INTEREST IN NET ASSETS OF ALSAC WITHOUT DONOR RESTRICTIONS 2,016,275,384. |
| PART XI, LINE 4B - OTHER ADJUSTMENTS: | CONTRIBUTION - SUPPORT RECEIVED FROM ALSAC 997,103,326. |
Schedule F IRS990ScheduleF
Account Activities Outside US AccountActivitiesOutsideUSGrp (8 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| CENTRAL AMERICA AND THE CARIBBEAN | 0 | 0 | PROGRAM SERVICES | RESEARCH / EDUCATION AND TRAINING | $1,460,355 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | PROGRAM SERVICES | RESEARCH / EDUCATION AND TRAINING | $5,984,609 |
| EUROPE (INCLUDING ICELAND & GREENLAND) | 0 | 5 | PROGRAM SERVICES | RESEARCH / EDUCATION AND TRAINING | $3,893,162 |
| MIDDLE EAST AND NORTH AFRICA | 0 | 0 | PROGRAM SERVICES | RESEARCH / EDUCATION AND TRAINING | $3,180,049 |
| NORTH AMERICA | 0 | 0 | PROGRAM SERVICES | RESEARCH / EDUCATION AND TRAINING | $805,828 |
| RUSSIA AND NEIGHBORING STATES | 0 | 0 | PROGRAM SERVICES | RESEARCH / EDUCATION AND TRAINING | $32,980 |
| SOUTH AMERICA | 0 | 0 | PROGRAM SERVICES | RESEARCH / EDUCATION AND TRAINING | $1,222,167 |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | RESEARCH / EDUCATION AND TRAINING | $40,153 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 5 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 5 | TotalEmployeeCnt |
| Subtotal Spent | $16,619,303 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $16,619,303 | TotalSpentAmt |
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 3: | EXPENDITURES ARE RECORDED ON AN ACCRUAL BASIS. PAYMENTS ARE ISSUED BASED ON CONTRACTUAL OBLIGATIONS UPON RECEIPT OF SUPPORTING DOCUMENTATION. |
| PART III ACCOUNTING METHOD: |
Schedule H IRS990ScheduleH
| Field | Value | IRS element (for citing) |
|---|---|---|
| Financial Assistance Policy | Yes (1) | FinancialAssistancePolicyInd |
| Written Policy | Yes (1) | WrittenPolicyInd |
| FPG Reference Free Care | 0 | FPGReferenceFreeCareInd |
| FPG Reference Discounted Care | 0 | FPGReferenceDiscountedCareInd |
| Free Care Medically Indigent | Yes (1) | FreeCareMedicallyIndigentInd |
| Financial Assistance Budget | Yes (1) | FinancialAssistanceBudgetInd |
| Expenses Exceed Budget | Yes (1) | ExpensesExceedBudgetInd |
| Unable To Provide Care | 0 | UnableToProvideCareInd |
| Annual Community Bnft Report | 0 | AnnualCommunityBnftReportInd |
Financial Assistance At Cost Typ FinancialAssistanceAtCostTyp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $46,396,584 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $202,820 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $46,193,764 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.03960 | TotalExpensePct |
Unreimbursed Medicaid UnreimbursedMedicaidGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $195,920,854 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $38,373,220 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $157,547,634 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.13510 | TotalExpensePct |
Unreimbursed Costs UnreimbursedCostsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $10,945,999 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $1,981,697 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $8,964,302 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00770 | TotalExpensePct |
Total Financial Assistance Typ TotalFinancialAssistanceTyp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $253,263,437 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $40,557,737 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $212,705,700 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.18240 | TotalExpensePct |
Community Health Services CommunityHealthServicesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $26,592,706 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $26,592,706 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.02280 | TotalExpensePct |
Health Professions Education HealthProfessionsEducationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $17,541,600 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $291,034 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $17,250,566 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.01480 | TotalExpensePct |
Subsidized Health Services SubsidizedHealthServicesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $24,967,254 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $24,967,254 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.02140 | TotalExpensePct |
Research ResearchGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $464,451,066 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $91,005,871 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $373,445,195 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.32010 | TotalExpensePct |
Cash And In Kind Contributions CashAndInKindContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $1,949,124 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $1,949,124 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00170 | TotalExpensePct |
Total Other Benefits TotalOtherBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $535,501,750 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $91,296,905 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $444,204,845 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.38080 | TotalExpensePct |
Total Community Benefits TotalCommunityBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $788,765,187 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $131,854,642 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $656,910,545 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.56320 | TotalExpensePct |
Economic Development EconomicDevelopmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $107,706 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $107,706 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00010 | TotalExpensePct |
Health Improvement Advocacy HealthImprovementAdvocacyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $25,072 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $25,072 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00000 | TotalExpensePct |
Total Communtity Building Acty TotalCommuntityBuildingActyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $132,778 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $132,778 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00010 | TotalExpensePct |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bad Debt Expense Reported | 0 | BadDebtExpenseReportedInd |
| Bad Debt Expense | $0 | BadDebtExpenseAmt |
| Bad Debt Expense Attributable | $0 | BadDebtExpenseAttributableAmt |
| Reimbursed By Medicare | $0 | ReimbursedByMedicareAmt |
| Cost Of Care Reimbursed By Medcr | $652,609 | CostOfCareReimbursedByMedcrAmt |
| Medicare Surplus Or Shortfall | -$652,609 | MedicareSurplusOrShortfallAmt |
Costing Methodology Used CostingMethodologyUsedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cost To Charge Ratio | Yes (X) | CostToChargeRatioInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Written Debt Collection Policy | Yes (1) | WrittenDebtCollectionPolicyInd |
| Financial Assistance Prvsn | Yes (1) | FinancialAssistancePrvsnInd |
| Hospital Facilities | 1 | HospitalFacilitiesCnt |
Hospital Facilities HospitalFacilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Facility | 1 | FacilityNum |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ST JUDE CHILDREN'S RESEARCH HOSPITAL | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 262 DANNY THOMAS PLACE | AddressLine1Txt |
| City | MEMPHIS | CityNm |
| State Abbreviation | TN | StateAbbreviationCd |
| ZIP | 381053678 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Website Address | WWW.STJUDE.ORG | WebsiteAddressTxt |
| State License | TN STATE LICENSE NUMBER 0000000113 | StateLicenseNum |
| Licensed Hospital | Yes (X) | LicensedHospitalInd |
| Childrens Hospital | Yes (X) | ChildrensHospitalInd |
| Teaching Hospital | Yes (X) | TeachingHospitalInd |
| Research Facility | Yes (X) | ResearchFacilityInd |
Hospital Fclty Policies Prctc HospitalFcltyPoliciesPrctcGrp
Hospital Facility Name HospitalFacilityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ST JUDE CHILDREN'S RESEARCH HOSPITAL | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Facility | 1 | FacilityNum |
| First Licensed CY Or PY | 0 | FirstLicensedCYOrPYInd |
| Tax Exempt Hospital CY Or PY | 0 | TaxExemptHospitalCYOrPYInd |
| CHNA Conducted | Yes (1) | CHNAConductedInd |
| Community Definition | Yes (X) | CommunityDefinitionInd |
| Community Demographics | Yes (X) | CommunityDemographicsInd |
| Existing Resources | Yes (X) | ExistingResourcesInd |
| How Data Obtained | Yes (X) | HowDataObtainedInd |
| Community Health Needs | Yes (X) | CommunityHealthNeedsInd |
| Other Health Issues | Yes (X) | OtherHealthIssuesInd |
| Community Hlth Needs Id Process | Yes (X) | CommunityHlthNeedsIdProcessInd |
| Consulting Process | Yes (X) | ConsultingProcessInd |
| Prior CHNA Impact | Yes (X) | PriorCHNAImpactInd |
| CHNA Conducted | 18 | CHNAConductedYr |
| Take Into Account Others Input | Yes (1) | TakeIntoAccountOthersInputInd |
| CHNA Conducted With Other Fclts | 0 | CHNAConductedWithOtherFcltsInd |
| CHNA Conducted With Non Fclts | 0 | CHNAConductedWithNonFcltsInd |
| CHNA Report Widely Available | Yes (1) | CHNAReportWidelyAvailableInd |
| Rpt Available On Own Website | Yes (X) | RptAvailableOnOwnWebsiteInd |
| Own Website URL | SEE PART V, SECTION C | OwnWebsiteURLTxt |
| Paper Copy Public Inspection | Yes (X) | PaperCopyPublicInspectionInd |
| Implementation Strategy Adopt | Yes (1) | ImplementationStrategyAdoptInd |
| Implementation Strategy Adpt | 18 | ImplementationStrategyAdptYr |
| Strategy Posted Website | Yes (1) | StrategyPostedWebsiteInd |
| Strategy Website URL | SEE PART V, SECTION C | StrategyWebsiteURLTxt |
| Organization Incur Excise Tax | 0 | OrganizationIncurExciseTaxInd |
| Elig Criteria Explained | Yes (1) | EligCriteriaExplainedInd |
| Other Criteria | Yes (X) | OtherCriteriaInd |
| Explained Basis | Yes (1) | ExplainedBasisInd |
| App Financial Asst Expln | Yes (1) | AppFinancialAsstExplnInd |
| Other Method | Yes (X) | OtherMethodInd |
| Includes Publicity Measures | Yes (1) | IncludesPublicityMeasuresInd |
| FAP Available On Website | Yes (X) | FAPAvailableOnWebsiteInd |
| FAP Available On Website URL | SEE PART V, SECTION C | FAPAvailableOnWebsiteURLTxt |
| FAP App Available On Website | Yes (X) | FAPAppAvailableOnWebsiteInd |
| FAP App Available On Website URL | SEE PART V, SECTION C | FAPAppAvailableOnWebsiteURLTxt |
| FAP Summary On Website | Yes (X) | FAPSummaryOnWebsiteInd |
| FAP Summary On Website URL | SEE PART V, SECTION C | FAPSummaryOnWebsiteURLTxt |
| FAP Avlbl On Request No Charge | Yes (X) | FAPAvlblOnRequestNoChargeInd |
| FAP App Avlbl On Request No Chrg | Yes (X) | FAPAppAvlblOnRequestNoChrgInd |
| FAP Sum Avlbl On Request No Chrg | Yes (X) | FAPSumAvlblOnRequestNoChrgInd |
| Notified FAP Copy Bill Display | Yes (X) | NotifiedFAPCopyBillDisplayInd |
| Communtity Notified FAP | Yes (X) | CommuntityNotifiedFAPInd |
| FAP Translated | Yes (X) | FAPTranslatedInd |
| FAP Actions On Nonpayment | Yes (1) | FAPActionsOnNonpaymentInd |
| Permit No Actions | Yes (X) | PermitNoActionsInd |
| Collection Activities | 0 | CollectionActivitiesInd |
| Other Actions Taken | Yes (X) | OtherActionsTakenInd |
| Nondis Emergency Care Policy | Yes (1) | NondisEmergencyCarePolicyInd |
| Prospective Medicare Medicaid | Yes (X) | ProspectiveMedicareMedicaidInd |
| Amounts Generally Billed | 0 | AmountsGenerallyBilledInd |
| Gross Charges | 0 | GrossChargesInd |
Supplemental Information SupplementalInformationGrp (13 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| ST. JUDE CHILDREN'S RESEARCH HOSPITAL | PART V, SECTION B, LINE 5: THE ST. JUDE FISCAL YEAR 2019 CHNA BUILDS UPON THE FISCAL YEAR 2013 AND 2016 CHNAS AND REFLECTS THE ACTIVITIES IDENTIFIED IN THE ST. JUDE FISCAL YEAR 2016 COMMUNITY BENEFIT IMPLEMENTATION PLAN. THE FISCAL YEAR 2019 CHNA WAS LED BY AN INTERNAL TEAM OF ST. JUDE STAFF MEMBERS. THE LEADERSHIP OF THIS TEAM ENGAGED HEALTH RESOURCES IN ACTION (HRIA), A NON-PROFIT PUBLIC HEALTH CONSULTANCY ORGANIZATION, TO CONDUCT THE CHNA. THE NEW CHNA IDENTIFIED THE IMPORTANCE OF PARTNERSHIPS AND COLLABORATION WITH OTHER ORGANIZATIONS TO MEET THE HEALTH NEED AND MEDICAL NEEDS OF CHILDREN, INCLUDING THE SHELBY COUNTY HEALTH DEPARTMENT, METHODIST LE BONHEUR HEALTHCARE, AND BAPTIST MEMORIAL HEALTH CARE AND REGIONAL ONE HEALTH. EACH INSTITUTION IS WORKING TO ALIGN ITS ASSESSMENT AND PLANNING PROCESSES, WHEN APPROPRIATE, AND TO COORDINATE ACTIVITIES RELATED TO DATA COLLECTION.TO DEVELOP A SOCIAL, ECONOMIC, AND HEALTH PORTRAIT OF THE COMMUNITY SERVED BY ST. JUDE FOR THE GREATER MEMPHIS AREA AND NATIONALLY, HRIA REVIEWED EXISTING DATA DRAWN FROM LOCAL, STATE, AND NATIONAL SOURCES. TO GAIN MORE LOCAL-LEVEL DATA, ST. JUDE WORKED WITH THE SHELBY COUNTY HEALTH DEPARTMENT TO OBTAIN DEMOGRAPHIC, ECONOMIC, AND HEALTH DATA FOR SHELBY COUNTY. HRIA CONDUCTED QUALITATIVE RESEARCH WITH INTERNAL AND EXTERNAL ST. JUDE STAKEHOLDERS AS WELL AS PATIENTS AND FAMILY MEMBERS SERVED IN ORDER TO SUPPLEMENT QUANTITATIVE FINDINGS WITH PERCEPTIONS OF COMMUNITY STRENGTHS AND ASSETS, THEIR PRIORITY HEALTH CONCERNS, AND SUGGESTIONS FOR FUTURE PROGRAMMING AND SERVICES.FOCUS GROUPS FOCUS GROUPS WERE CONDUCTED WITH CURRENT AND FORMER ST. JUDE PATIENTS, PATIENT CAREGIVERS, AND ST. JUDE CLINICAL, RESEARCH, AND ADMINISTRATIVE STAFF. DIFFERENT TOPIC AREAS WERE EXPLORED BASED ON THE UNIQUE EXPERIENCES OF EACH OF THE GROUPS. THE PATIENT AND CAREGIVER FOCUS GROUPS, CONDUCTED WITH CURRENT PATIENTS AND REPRESENTATIVES OF THE PATIENT FAMILY ADVISORY COUNCIL, EXPLORED THE EXTENT TO WHICH ST. JUDE IS MEETING THE NEEDS OF CHILDREN WITH CATASTROPHIC ILLNESSES AND OPPORTUNITIES TO BRIDGE PATIENT NEEDS IN THE FUTURE. THE CLINICAL, RESEARCH, AND ADMINISTRATIVE STAFF FOCUS GROUPS EXPLORED THESE TOPICS AS WELL AS SPECIFIC ISSUES RELATED TO THE GREATER MEMPHIS COMMUNITY. A SEMI-STRUCTURED MODERATOR'S GUIDE WAS USED ACROSS ALL DISCUSSIONS TO ENSURE CONSISTENCY IN THE TOPICS COVERED. WHILE SIMILAR, SEPARATE GUIDES WERE USED FOR THE CAREGIVER AND PATIENT FOCUS GROUPS SO THAT THEY WERE AGE AND DEVELOPMENTALLY APPROPRIATE. EACH FOCUS GROUP WAS FACILITATED BY AN EXPERIENCED HRIA STAFF MEMBER, WHILE A NOTE-TAKER TOOK DETAILED NOTES DURING THE DISCUSSION. ON AVERAGE, FOCUS GROUPS LASTED 30-90 MINUTES. BEFORE THE START OF THE GROUPS, HRIA EXPLAINED THE PURPOSE OF THE STUDY TO PARTICIPANTS AND PARTICIPANTS HAD AN OPPORTUNITY TO ASK QUESTIONS. THEY WERE ALSO NOTIFIED VERBALLY THAT GROUP DISCUSSIONS WOULD REMAIN CONFIDENTIAL, AND NO RESPONSES WOULD BE CONNECTED TO THEM PERSONALLY. PARTICIPANTS WERE RECRUITED BY ST. JUDE STAFF, WHO ARRANGED ALL LOGISTICS FOR THE ONSITE FOCUS GROUPS.MEDICAL EXECUTIVE COMMITTEE - ELIZABETH ADDERSON, MD, INFECTIOUS DISEASES - DORALINA ANGHELESCU, MD, ANESTHESIOLOGY - MICHAEL BISHOP, MD, ONCOLOGY, SOLID TUMOR - ROBIN DIAZ, JD, CHIEF LEGAL COUNSEL - SARA FEDERICO, MD, ONCOLOGY, SOLID TUMOR - WILLIAM GREENE, PHARMD, VICE PRESIDENT, PHARMACEUTICAL SERVICES - RAY MORRISON, MD, ICU, CRITICAL CARE-PULMONARY MEDICINE - ROBIN MUTZ, RN, SVP, CHIEF NURSING EXECUTIVE - TRACY PARKS, DIRECTOR, QUALITY MANAGEMENT - RICHARD ROCHESTER, MANAGER BMT/CT CLINIC - JOHN SANDLUND, MD, ONCOLOGY, LEUKEMIA/LYMPHOMA - BRANDON TRIPLETT, MD, BONE MARROW TRANSPLANT AND CELL THERAPY - JOSHUA WOLF, MD, INFECTIOUS DISEASES NURSING - MIKE BURGESS, PEDIATRIC ONCOLOGY NURSE III WKD, INPATIENT, BONE MARROW TRANSPLANT - LORI CHRISTION, INPATIENT UNIT MANAGER - JASMIN ELIZARRARAS, PEDIATRIC ONCOLOGY NURSE I, INPATIENT - CAMILLE FILOROMO, BSN, MED, PHD, RN, NEA-BC, SENIOR DIRECTOR OF CLINICAL EXPERIENCE - ANGEL PARKER, INPATIENT UNIT COORDINATOR - BOB SCHROEDER, INTERIM UNIT MANAGER, ICU - NICOLE WRIGHT, NURSING PROFESSIONAL DEVELOPMENT EDUCATOR I ST. JUDE PATIENT FAMILY ADVISORY COUNCIL - TEN MEMBERS OF THE COUNCIL PARTICIPATED ADOLESCENT ST. JUDE PATIENTS - FIVE PATIENTS PARTICIPATED KEY INFORMANT INTERVIEWS HRIA CONDUCTED 26 INTERVIEWS; 11 WERE INTERNAL REPRESENTATIVES OF ST. JUDE HOSPITAL AND 15 WERE EXTERNAL REPRESENTATIVES. INTERVIEWEES REPRESENT A RANGE OF SECTORS, INCLUDING LEADERS IN HEALTH CARE AND HEALTH RESEARCH, GOVERNMENT, AND SOCIAL SERVICE ORGANIZATIONS FOCUSING ON VULNERABLE POPULATIONS. A SEMI-STRUCTURED INTERVIEW GUIDE WAS USED ACROSS ALL DISCUSSIONS TO ENSURE CONSISTENCY IN THE TOPICS COVERED. INTERVIEWS WERE APPROXIMATELY 30 MINUTES IN LENGTH. INTERNAL KEY INFORMANT INTERVIEWS - ROBERT CLARK, MS, FACHE, CHIEF GOVERNMENT AFFAIRS OFFICER - JANICE ENGLISH, DIRECTOR, PATIENT AND FAMILY EXPERIENCE OFFICE - COLETTE HENDRICKS, VP-CLINICAL OPERATIONS - MELISSA M. HUDSON, MD, DIRECTOR, CANCER SURVIVORSHIP DIVISION - MELISSA JONES, DIRECTOR, CANCER CENTER OPERATION - PAT KEEL, SVP/CFO - ELLIS NEUFELD, MD, PHD, EVP/CLINICAL DIRECTOR - CAROLYN RUSSO, MD, ASSOCIATE MEMBER/MEDICAL DIRECTOR AFFILIATE PROGRAM- VICTOR SANTANA, MD, MEMBER/SVP CLINICAL TRIALS - DANA WALLACE, DIRECTOR, CANCER CENTER ADMINISTRATION - SHEILA ANDERSON, RN, TRANSITION NURSE CASE MANAGER, HEMATOLOGY EXTERNAL KEY INFORMANT INTERVIEWS - CARLA BAKER, RN, PROJECT DIRECTOR, MEMPHIS BREAST CANCER EQUITY CONSORTIUM, COMMON TABLE HEALTH ALLIANCE - AMY DANIELS, SENIOR VICE PRESIDENT OF INVESTOR RELATIONS, MEMPHIS CHAMBER OF COMMERCE - JOAN HAN, MD, DIRECTOR, PEDIATRIC OBESITY PROGRAM, LE BONHEUR CHILDREN'S HOSPITAL - ALISA HAUSHALTER, DNP, RN, PHNA-BC, DIRECTOR, SHELBY COUNTY HEALTH DEPARTMENT - MICHELLE HEIL, SENIOR MANAGER, HOSPITAL SYSTEMS, AMERICAN CANCER SOCIETY, NORTH CENTRAL REGION - ANITA LARKIN, MSN, RN, CLINICAL DIRECTOR, METHODIST LE BONHEUR - MARIAN LEVY, DRPH, RD, FAND, ASSOCIATE DEAN, UNIVERSITY OF MEMPHIS SCHOOL OF PUBLIC HEALTH - VALERIE NAGOSHINER, CHIEF OF STAFF, TENNESSEE DEPARTMENT OF HEALTH - GARY SHORB, EXECUTIVE DIRECTOR, THE URBAN CHILD INSTITUTE - ANDREANA SMITH, DIRECTOR OF CLINICAL ADMINISTRATION, CHURCH HEALTH CENTER - WEBB A. SMITH, PHD, CLINICAL EXERCISE PHYSIOLOGIST, HEALTHY LIFESTYLES CLINIC, LE BONHEUR CHILDREN'S HOSPITAL - JAMILA SMITH-YOUNG, DNP, MPH, CPNP-AC, NURSE PRACTITIONER, UT LE BONHEUR PEDIATRIC SPECIALISTS DIVISION OF PEDIATRIC ENDOCRINOLOGY - CHARLES SNYDER, PHD, MPH, DIRECTOR, HEALTH DISPARITIES EDUCATION AND COMMUNITY ENGAGEMENT, UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER - KATY SPURLOCK, DEPUTY DIRECTOR, THE URBAN CHILD INSTITUTE - ROBIN WOMEODU, MD, FACP, CHIEF MEDICAL OFFICER, METHODIST UNIVERSITY HOSPITAL |
| ST. JUDE CHILDREN'S RESEARCH HOSPITAL | PART V, SECTION B, LINE 13H: SEE NARRATIVE FOR PART I, LINE 3C REGARDING THE ORGANIZATION'S FINANCIAL ASSISTANCE POLICY. |
| ST. JUDE CHILDREN'S RESEARCH HOSPITAL | PART V, SECTION B, LINE 15E: SEE NARRATIVE FOR PART I, LINE 3C REGARDING THE ORGANIZATION'S FINANCIAL ASSISTANCE POLICY. |
| ST. JUDE CHILDREN'S RESEARCH HOSPITAL | PART V, SECTION B, LINE 20E: ST. JUDE DOES NOT TAKE ANY OF THE COLLECTION ACTIONS DESCRIBED IN PART V, SECTION B, LINE 19 BECAUSE ST. JUDE COVERS ALL TREATMENTS, COPAYS, DEDUCTIBLES, COINSURANCE AND ANY OTHER COST SHARING OBLIGATIONS THAT ARE NOT COVERED BY INSURANCE. ST. JUDE TAKES NO ACTION TO COLLECT FROM PATIENTS OR THEIR FAMILIES AND DOES NOT REPORT TO CREDIT AGENCIES. |
| ST. JUDE CHILDREN'S RESEARCH HOSPITAL: | PART V, SECTION B, LINE 11: ST. JUDE CHILDREN'S RESEARCH HOSPITALCOMMUNITY HEALTH NEEDS ASSESSMENT (CHNA) IMPLEMENTATION PLAN UPDATE (06/30/21)ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. CONDUCTED AND ADOPTED ITS THIRD COMMUNITY HEALTH NEEDS ASSESSMENT (CHNA) DURING FISCAL YEAR 2019 AND INTENDS TO ADDRESS THE FOLLOWING SIGNIFICANT HEALTH NEEDS, LISTED IN ORDER OF PRIORITY:IMPROVING ACCESS TO CARE:- PALLIATIVE CARE- SERVICES AND RESOURCES FOR CAREGIVERSIMPROVING COORDINATION OF CARE:- TRANSITION OF PATIENTS FROM PEDIATRIC TO ADULT HEALTHCARE- OUTPATIENT CARE EXPERIENCE - TRANSITION OF CARE FROM SPECIALTY TO PRIMARY CARE PROVIDERS- OUTPATIENT CARE EXPERIENCE - PHYSICIAN COORDINATION OF CAREIMPROVING CHILD HEALTH STATUS:- COMMUNITY HEALTH EDUCATION- PREVENTING VIRUS-ASSOCIATED CANCERS THROUGH INCREASED HPV VACCINATION- HIV COLLABORATION WITH COMMUNITY COALITION- CHILD KNOWLEDGE OF CANCER PREVENTION, NUTRITION, OBESITY AND PHYSICAL ACTIVITYTHE THIRD CHNA WAS CONDUCTED AND ADOPTED AT THE END OF FISCAL YEAR 2019; THEREFORE, THESE HEALTH NEEDS WILL BE ADDRESSED OVER TAX YEARS 2019 THROUGH 2021.HEALTH NEEDS NOT BEING ADDRESSEDIN ORDER TO EECTIVELY ADDRESS THE NEEDS IDENTIFIED, ST. JUDE IS FOCUSING ON THE NEEDS OUTLINED ABOVE. THE COMMUNITY HEALTH NEEDS ASSESSMENT IDENTIFIED THE IMPORTANCE OF PARTNERSHIPS AND COLLABORATIONS TO BUILD TO MEET THE HEALTH AND MEDICAL NEEDS OF CHILDREN, INCLUDING BUT NOT LIMITED TO COMMUNITY PARTNERS METHODIST LE BONHEUR HEALTHCARE AND CHURCH HEALTH CENTER. ST. JUDE DOES NOT HAVE THE CAPACITY OR RESOURCES TO MEET ALL NEEDS OF ALL CHILDREN AND THEIR FAMILIES, GIVEN ITS FOCUSED MISSION AND MODEL OF PROVIDING SPECIALIZED SERVICES TO CHILDREN IN CRISIS. STRATEGIC PARTNERSHIPS WITH OTHER HEALTHCARE PROVIDERS, SUCH AS METHODIST LE BONHEUR HEALTHCARE, ALONG WITH PARTNERSHIPS WITH SCHOOLS AND COMMUNITY-BASED ORGANIZATIONS ALLOW ST. JUDE TO CREATE A NETWORK OF RESOURCES THAT THEY CAN LEVERAGE TO MEET THE HEALTH AND SOCIAL NEEDS OF A WIDER COMMUNITY OF PATIENTS AND THEIR FAMILIES.ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. DID TAKE THE FOLLOWING ACTIONS DURING FISCAL YEAR 2021 WITH RESPECT TO ITS MOST RECENT CHNA IN FISCAL YEAR 2019:ST. JUDE: PATIENT POPULATION AND CLINICAL FOCUSTHE COMMUNITY SERVED BY ST. JUDE CAN BEST BE DEFINED BY UNDERSTANDING THE ST. JUDE PATIENT POPULATION AND SCOPE OF CLINICAL SERVICES. ST. JUDE IS THE ONLY CHILDREN'S RESEARCH HOSPITAL AND TREATS CHILDREN WITH CANCER AND OTHER CATASTROPHIC CHILDHOOD DISEASES SUCH AS BLOOD DISORDERS AND HIV. IT SERVES AS A NATIONAL REFERRAL CENTER FOR CHILDREN WITH CANCER AS WELL AS A LOCAL REFERRAL CENTER FOR CHILDREN WITH CANCER, BLOOD DISORDERS, AND HIV/AIDS. ST. JUDE TREATS CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED OR SUSPECTED PEDIATRIC CANCER, HIV INFECTIONS OR CERTAIN HEMATOLOGIC OR GENETIC DISEASES. WE ACCEPT MOST PATIENTS OUTSIDE OUR PRIMARY MARKET BASED ON A REFERRAL FROM ONE OF OUR EIGHT AFFILIATES OR A PHYSICIAN, THEIR AGE, AND THEIR ABILITY TO ENROLL IN AN OPEN CLINICAL TRIAL. IN ADDITION TO BEING TREATED AT ST. JUDE, PATIENTS MAY HAVE THE OPTION TO RECEIVE CARE AT ONE OF OUR EIGHT REGIONAL AFFILIATE CLINICS.ST. JUDE'S PRIMARY CLINICAL EFFORT CENTERS ON PROVIDING GROUND-BREAKING, RESEARCH-DRIVEN CURES AND TREATMENTS FOR CHILDHOOD CANCERS AND OTHER CATASTROPHIC DISEASES IN CHILDREN. MORE SPECIFICALLY, APPROXIMATELY 8,000 PATIENTS ARE SEEN AT ST. JUDE ANNUALLY FOR ACTIVE THERAPY, TREATMENT COMPLETION MONITORING, SURVIVORSHIP SUPPORT OR PARTICIPATION IN RESEARCH PROGRAMS. THE HOSPITAL IS LICENSED FOR 80 INPATIENT BEDS AND CURRENTLY STAFFS 73 BEDS FOR PATIENTS REQUIRING HOSPITALIZATION DURING TREATMENT. IT SHOULD BE NOTED THAT ST. JUDE HAS DEVELOPED UNIQUE RESOURCES THAT ALLOW A SIGNIFICANT PORTION OF PATIENTS TO BE TREATED AS OUTPATIENTS WHO MAY HAVE BEEN ADMITTED AS IN-PATIENTS AT MOST HOSPITALS. THIS IS ACCOMPLISHED THROUGH PATIENT HOUSING DEDICATED SOLELY TO ST. JUDE PATIENT FAMILIES DESIGNED WITH INFECTION CONTROL MEASURES SUCH AS HEPA AIR FILTRATION, INFECTION-RESISTANT SURFACES AND OTHER MEDICAL SAFEGUARDS THAT ARE NOT AVAILABLE IN HOTELS OR PATIENTS' HOMES.THE ST. JUDE AFFILIATE PROGRAM MAKES TREATMENTS AND CLINICAL TRIALS DEVELOPED AT ST. JUDE CHILDREN'S RESEARCH HOSPITAL AVAILABLE TO MORE CHILDREN BY OFFERING MUCH OF THE CARE CLOSE TO HOME. THE ST. JUDE AFFILIATE PROGRAM IS A NETWORK OF PEDIATRIC HEMATOLOGY-ONCOLOGY CLINICS, HOSPITALS, AND IN SOME CASES, UNIVERSITIES UNITED TO EXTEND THE MISSION OF ST. JUDE. THE PHYSICIANS AND STAFF AT THESE SITES WORK IN COLLABORATION WITH THE STAFF OF ST. JUDE TO DELIVER STATE-OF-THE-ART CARE AND INNOVATIVE CLINICAL TRIALS TO CHILDREN WITH CANCER AND BLOOD DISORDERS. ST. JUDE ALSO OPERATES ST. JUDE GLOBAL. ITS MISSION IS TO IMPROVE THE SURVIVAL RATES OF CHILDREN WITH CANCER AND OTHER CATASTROPHIC DISEASES WORLDWIDE THROUGH THE SHARING OF KNOWLEDGE, TECHNOLOGY, AND ORGANIZATIONAL SKILLS. THERE ARE 3 OVERRIDING GOALS:- TO TRAIN THE CLINICAL WORKFORCE THAT WILL BE REQUIRED TO MEET OUR MISSION- TO DEVELOP AND STRENGTHEN HEALTH SYSTEMS AND PATIENT-CENTERED INITIATIVES THAT ENCOMPASS THE ENTIRE CONTINUUM OF CARE REQUIRED FOR CHILDREN WITH CANCER AND NON-MALIGNANT HEMATOLOGICAL DISEASES- TO ADVANCE KNOWLEDGE IN GLOBAL PEDIATRIC ONCOLOGY AND HEMATOLOGY THROUGH RESEARCH TO SUSTAIN A CONTINUOUS IMPROVEMENT IN THE LEVEL AND QUALITY OF CARE DELIVERED AROUND THE GLOBEST. JUDE IS A RESEARCH ORGANIZATION, AND THERE ARE TIMES WHEN BASIC RESEARCH DISCOVERIES PERTAIN TO DISEASES THAT ARE BEYOND THE SCOPE OF DISEASES TREATED AS A PRIMARY DIAGNOSIS AT ST. JUDE. FOR THE PURPOSES OF THE FISCAL YEAR 2019 CHNA AND THIS IMPLEMENTATION PLAN, THE FOCUS IS SOLELY ON THOSE DISEASES FOR WHICH CHILDREN ARE ADMITTED TO ST. JUDE FOR TREATMENT.CONSISTENT WITH ST. JUDE'S PREVIOUS CHNA, THE FINDINGS IN 2019 HIGHLIGHTED THE ISSUES OF ACCESS TO CARE; CHILDHOOD CANCER; SICKLE CELL DISEASE AND HEMATOLOGY PATIENTS; LIVING WITH HIV AND AIDS; NEEDS OF THE PATIENTS' FAMILIES AND CAREGIVERS; POST TREATMENT AND CARE TRANSITION; HEALTH STATUS OF THE MEMPHIS COMMUNITY AND ADDITIONAL GAPS FOR THE GENERAL PEDIATRIC POPULATION. ST. JUDE HAS CHOSEN TO ADDRESS THESE NEEDS IN THREE GENERAL AIMS: IMPROVING ACCESS TO CARE, IMPROVING COORDINATION OF CARE, AND IMPROVING CHILD HEALTH STATUS. THESE AIMS OFTEN ADDRESS MULTIPLE ISSUES IDENTIFIED IN THE CHNA. GIVEN THE SUCCESS OF THE CURRENT ST. JUDE COMMUNITY BENEFIT ACTIVITIES WITH ITS PATIENT POPULATION - CHILDREN WITH CATASTROPHIC DISEASE - ST. JUDE WILL CONTINUE TO ADDRESS THESE THREE AIMS WITH THE CORRESPONDING INITIATIVES BELOW: AIM #1 IMPROVING ACCESS TO CAREPEDIATRIC HEALTH NEED:PALLIATIVE CAREHEALTH FACILITIES INVOLVED:ST. JUDE CHILDREN'S RESEARCH HOSPITAL, DEPARTMENT OF ONCOLOGY, DIVISION OF QUALITY OF LIFE AND PALLIATIVE CAREANTICIPATED OUTCOME: - CONTINUE TO TRAIN CLINICIANS IN PALLIATIVE CARE MEDICINE (PCM) AND OFFER EDUCATIONAL OPPORTUNITIES FOR PCM. |
| ACTION ITEMS TO MEET IDENTIFIED HEALTH NEED: | 1. RECRUIT AND TRAIN FIVE PHYSICIAN FELLOWS IN THE PALLIATIVE CARE TRAINING PROGRAM, 2 PEDIATRIC FELLOWS, 3 ADULT/MED-PEDS FELLOWS. 2. PROVIDE TRAINING IN PALLIATIVE CARE FOR HEALTHCARE PERSONNEL THROUGH TARGETED CONFERENCES AND OTHER EDUCATIONAL OPPORTUNITIES INCLUDING END-OF-LIFE NURSING EDUCATION CONSORTIUM (ELNEC) CONFERENCE, A REGIONAL ELNEC OFFERING FOR OUR REGIONAL HOSPICE AND PALLIATIVE CARE NURSES, AN INSTITUTION-DEVELOPED QUALITY OF LIFE SEMINAR (QOLA), AND A 1-DAY REGIONAL PEDIATRIC ONCOLOGY PALLIATIVE CARE CONFERENCE.3. EDUCATE COMMUNITY PROVIDERS ABOUT PCM THROUGH COMMUNITY-BASED BRIDGING PROGRAMS FOR HOME HEALTH AND HOSPICE CARE THROUGH THE QUALITY OF LIFE FOR ALL KIDS PROGRAM VIA A THREE-HOUR DIDACTIC CURRICULUM.4. ENHANCE TRAINING OPPORTUNITIES WITH ST. JUDE AFFILIATES.SELECTED ACCOMPLISHMENTS:- COMPLETED SUCCESSFUL TRAINING OF 2 PEDIATRIC HOSPICE AND PALLIATIVE MEDICINE FELLOWS AS WELL AS 3 ADULT/MED-PEDS HOSPICE AND PALLIATIVE MEDICINE FELLOWS. - CREATED AND BEGAN RECRUITMENT TO THE TENNESSEE PEDIATRIC PALLIATIVE CARE COLLABORATIVE.- THE COVID 19 PANDEMIC CAUSED A CESSATION OF OUR ELNEC AND QOL SEMINARS.- THE PEDIATRIC PALLIATIVE ONCOLOGY SYMPOSIUM HAS >2,500 REGISTRANTS TO THIS YEAR'S EVENT.- COMMUNITY PROVIDER EDUCATION HAPPENS TWICE A MONTH THROUGH ST. JUDE'S COMBINED FELLOWSHIP PROGRAM BOARD REVIEW SERIES. EACH SESSION AVERAGES 10 ATTENDEES RANGING FROM GRADUATE STUDENTS TO MEDICAL STUDENTS TO ADVANCED CLINICIANS. THESE EVENTS HAVE CONTINUED VIRTUALLY.PEDIATRIC HEALTH NEED:SERVICES AND RESOURCES FOR CAREGIVERSHEALTH FACILITIES INVOLVED: ST. JUDE CHILDREN'S RESEARCH HOSPITAL, MEMPHIS; IHOPE NETWORK, MASSACHUSETTS ANTICIPATED OUTCOME:- REDUCE TIME FROM REFERRAL TO FIRST APPOINTMENT FOR PRIMARY CAREGIVERS WHO HAVE NO ACCESS TO MENTAL HEALTH SERVICES.- INCREASE NUMBER OF PRIMARY CAREGIVERS WITH ACCESS TO MENTAL HEALTH SERVICES THROUGH TELE-MENTAL HEALTH.- TO PROVIDE SERVICES IN A LOCATION CONVENIENT TO THE PRIMARY CAREGIVER WITHOUT REQUIRING TRAVEL OR EXTENDED TIME AWAY FROM THE PATIENT.- TO FOSTER A BETTER ABILITY OF PARENTS AND CAREGIVERS TO ASSIST IN THE CARE OF THEIR CHILD BY PROVIDING ACCESS TO MENTAL HEALTH CARE.ACTION ITEMS TO MEET IDENTIFIED HEALTH NEED:1. DEVELOP AN INSTITUTIONAL PARENT MENTAL HEALTH TASK FORCE WITH REPRESENTATION FROM RELEVANT SERVICES.2. INTRODUCE NINA ANTONIOTTI, DIRECTOR OF INTEROPERABILITY AND PATIENT ENGAGEMENT, TO THE TELEHEALTH SUBCOMMITTEE OF THE PARENT MENTAL HEALTH TASK FORCE.3. DEVELOP CRITERIA FOR TELE-MENTAL HEALTH AND OUTCOMES OF THE PROGRAM.4. WRITE AN RFP, INCLUDING FEEDBACK FROM DEPARTMENT OF PSYCHOLOGY AND SOCIAL WORK.5. SEND OUT REQUEST FOR PROPOSALS, TO BE RETURNED BY MAY 28, 2019.6. SELECTION OF COMPANIES FOR ONSITE DEMONSTRATIONS WITH SUBCOMMITTEE.7. SELECTION OF FINAL TELE-MENTAL HEALTH COMPANY.8. REVIEW OF ARCADIAN TELEPSYCHIATRY SERVICE AGREEMENT BY ST. JUDE LEGAL SERVICES.9. BEGIN WORKFLOW DOCUMENTATION FOR REFERRALS, INCLUDING PROCESS FOR CAREGIVERS HAVING PRESCRIPTIONS FILLED AT THE ST. JUDE PHARMACY.SELECTED ACCOMPLISHMENTS:- TRANSITIONED TO NEW TELEPSYCHIATRY PROVIDER.- INCREASED THE NUMBER OF CAREGIVER'S REFERRED AND SCHEDULED TO ABOVE THE NATIONAL AVERAGE (56% FOR ST. JUDE VS. 20% NATIONAL AVERAGE).- HELD WEEKLY THEN BI-WEEKLY MEETINGS WITH TELEPSYCHIATRY PROVIDER TO ENSURE REFERRALS WERE MANAGED APPROPRIATELY AND INTAKES WERE COMPLETED.- REVIEWED YEAR ONE STATISTICS AND SHARED WITH PSYCHOSOCIAL SERVICES AT DEPARTMENT-WIDE MEETING.AIM #2 IMPROVING COORDINATION OF CAREPEDIATRIC HEALTH NEED:TRANSITION OF PATIENTS FROM PEDIATRIC TO ADULT HEALTHCARE - SICKLE CELLHEALTH FACILITIES INVOLVED:ST. JUDE CHILDREN'S RESEARCH HOSPITAL, DEPARTMENT OF HEMATOLOGY, CLINICAL HEMATOLOGY DIVISION, DIGGS-KRAUS SICKLE CELL CENTER AT REGIONAL ONE HEALTH, METHODIST HEALTHCARE COMPREHENSIVE SICKLE CELL CENTER (MCSCC)ANTICIPATED OUTCOME:- INCREASE THE NUMBER OF PATIENTS WITH SICKLE CELL DISEASE WHO ESTABLISH SUSTAINED ADULT CARE AFTER LEAVING PEDIATRIC CARE AT ST. JUDE.ACTION ITEMS TO MEET IDENTIFIED HEALTH NEED:1. CONTINUE TO WORK WITH ADULT SICKLE CELL CENTERS IN THE COMMUNITY TO ENHANCE A SEAMLESS TRANSITION FROM PEDIATRIC CARE.2. ENHANCE ADOLESCENT AND YOUNG ADULTS (AYA) TRANSITION CLINICS WITH CO-LOCATION OF PEDIATRIC AND ADULT HEMATOLOGY PROVIDERS.3. AUGMENT FORMAL PROGRAMMING AND PLANNING PROCESSES FOR ADOLESCENTS WITH HEMATOLOGIC AND ONCOLOGIC DISEASES, THROUGH DEVELOPMENT OF DISEASE EDUCATIONAL CURRICULUM, TRAINING MODULES AND WEBSITE TO FOSTER INCREASED ADOLESCENT AUTONOMY AND MEDICAL LITERACY.4. RECRUIT FOR NEW SICKLE CELL FELLOWSHIP. |
| SELECTED ACCOMPLISHMENTS: | - TWO HEMATOLOGISTS, ONE FROM EACH OF THE ADULT SICKLE CELL CENTERS, WERE RECRUITED. EACH PROVIDER ALTERNATES SPENDING A HALF DAY IN THE TEEN SICKLE CELL CLINIC.- VIRTUAL REALITY SKILLS LAB LAUNCHED. DUE TO COVID-19, WE UTILIZED THE ELECTRONIC VERSION THAT'S PRESENTED TO THE PATIENTS VIA LAPTOP COMPUTERS. TO DATE MORE THAN 20 PATIENTS HAVE PARTICIPATED AND COMPLETED VIRTUAL SKILLS LAB MODULES. DEVELOPED ELECTRONIC VERSIONS OF DISEASE SPECIFIC EDUCATIONAL SURVEYS FOR AYA.- VIRTUAL TRANSITION TOUR SUCCESSFULLY LAUNCHED AND HELD QUARTERLY FOR TEENS 17 YEARS OF AGE IN THE SICKLE CELL PROGRAM, ALONG WITH THEIR PARENTS.- RECRUITED HEMATOLOGY FELLOW (DR. MELISSA AZUL) AND A GLOBAL HEMATOLOGY FELLOW (DR. MEGHNA DUA). BOTH FELLOWS WORK IN THE ADULT SICKLE CELL CLINICS, METHODIST AND REGIONAL ONE HEALTH.- CREATED THE COMBINED PEDS/ADULT FELLOWSHIP FOR HEMATOLOGY IN WHICH DURING THE SECOND YEAR, THE FELLOW SPENDS AN ENTIRE YEAR SEEING ADULTS WITH HEMATOLOGIC DISORDERS (DR. TARUN AURORA IS THE FELLOW THIS YEAR). PEDIATRIC HEALTH NEED:TRANSITION OF PETIENTS FROM PEDIATRIC TO ADULT HEALTHCARE - CANCER SURVIVORSHEALTH FACILITIES INVOLVED:ST. JUDE CHILDREN'S RESEARCH HOSPITAL, ONCOLOGY DIVISION, CANCER SURVIVORSHIP DEPARTMENTANTICIPATED OUTCOME:- PROVIDE CANCER SURVIVORSHIP INFORMATION TO BOTH CAREGIVERS AND SURVIVORS AND THEIR HEALTH CARE PROFESSIONALS VIA AFTER COMPLETION OF THERAPY AND ST. JUDE LIFE PROGRAM SERVICES AND RESOURCES.ACTION ITEMS TO MEET IDENTIFIED HEALTH NEED:1. PROVIDE WORKSHOPS AND SPEAKERS THAT OFFER INFORMATION ABOUT AVAILABLE RESOURCES.2. GIVE SURVIVORS AND THEIR FAMILIES THE OPPORTUNITY TO LEARN FROM OTHER SURVIVORS.3. ENSURE THAT SURVIVORS UNDERSTAND HOW TO APPROACH HEALTHCARE POST-TREATMENT.4. OFFER AN ONLINE RESOURCE FOR CONTINUOUS FLOW OF SURVIVORSHIP INFORMATION (TOGETHER).5. ASSESS LATE EFFECTS OF CANCER THERAPY ON PEDIATRIC CANCER SURVIVORS.6. USE INFORMATION FROM THESE STUDIES TO DEFINE RISK GROUPS FOR VARIOUS LATE EFFECTS AND ASSESS INTERVENTION. SELECTED ACCOMPLISHMENTS:SURVIVORSHIP CLINICAL ACTIVITIES HAVE FOCUSED ON EDUCATING SURVIVORS ABOUT POTENTIAL HEALTH RISKS AND RISK MITIGATION MEASURES AND FACILITATING THEIR ACCESS TO SURVEILLANCE AND REMEDIAL INTERVENTION. BECAUSE IN PERSON EVALUATIONS CONTINUE TO BE LIMITED DUE TO COVID RESTRICTIONS, THE CLINICAL TEAM OFFERS REMOTE EDUCATION, A VARIETY OF ONLINE RESOURCES, AND CASE MANAGEMENT SERVICES TO ASSIST SURVIVORS IN ACCESSING NEEDED CARE. RETURN APPOINTMENTS FOR CAMPUS EVALUATIONS ARE PRIORITIZED BY ACUITY AND SURVIVORSHIP MILESTONE WITH THE LONG-TERM GOAL OF USING TELEHEALTH OR OTHER REMOTE ASSESSMENTS FOR SURVIVORS OF LOW ACUITY WHO ARE NOT AT A KEY TRANSITION MILESTONE (E.G., ENTRY, GRADUATION). SURVIVORS AND FAMILIES ARE COUNSELED TO ENROLL IN THE PATIENT PORTAL AND OR APP TO ENSURE THEY HAVE OPTIMAL ACCESS TO CLINICAL DATA TO SHARE WITH LOCAL HEALTH CARE PROVIDERS AND THAT THE INSTITUTION HAS ACCURATE CONTACT INFORMATION.THE SURVIVORSHIP TEAM HAS PARTICIPATED IN A VARIETY OF ONLINE/VIRTUAL FORUMS TO EDUCATION SURVIVORS/FAMILIES, GRADUATE MEDICAL TRAINEES, AND BEHAVIORAL AND MEDICAL HEALTH CARE PROVIDERS ABOUT SURVIVORSHIP CARE. EXAMPLES OF LECTURES/SEMINARS FOLLOW:LECTURES/WORKSHOPS PROVIDED BY DR. MELISSA M. HUDSON:- ST. JUDE FELLOW'S SURVIVORSHIP ON-DEMAND CURRICULUM 2020 - 2021-- CHILDHOOD CANCER SURVIVORSHIP OVERVIEW-- CHILDREN'S ONCOLOGY GROUP LONG-TERM FOLLOW-UP GUIDELINES-- SURVIVORSHIP CARE PLANS- VII CONGRESO INTERNACIONAL DE ONCOLOGIA MEDICA AMERON (VIRTUAL), "RISK-BASED SCREENING OF CHILDHOOD CANCER SURVIVORS USING THE CHILDREN'S ONCOLOGY GROUP LONG-TERM FOLLOW-UP GUIDELINES", AUGUST 8, 2020.- 1ST JOINT CONGRESS OF NATIONAL SOCIETY OF PEDIATRIC HEMATOLOGISTS AND ONCOLOGISTS (NSPHO) AND RUSSIAN SOCIETY OF PEDIATRIC ONCOLOGY (RSPO) (VIRTUAL), "LATE EFFECTS OF CHILDHOOD CANCER: THE FOUNDATION FOR RISK-STRATIFIED PEDIATRIC CANCER CARE", NOVEMBER 23, 2020.- AMERICAN INSTITUTE FOR CANCER RESEARCH LIFESTYLE AND CANCER SYMPOSIUM: EVIDENCE MATTERS, "THE INTERNATIONAL GUIDELINE HARMONIZATION GROUP PROCESS" (VIRTUAL), JANUARY 28, 2021. - 15TH ST. JUDE-VIVA FORUM (VIRTUAL), "CHILDHOOD CANCER SURVIVORSHIP OVERVIEW", MARCH 5, 2021.- INTERNATIONAL SOCIETY OF PEDIATRIC ONCOLOGY, SIOP ASIA (VIRTUAL), "CHILDHOOD CANCER SURVIVORS: BALANCING CURE AND QUALITY OF LIFE", MARCH 20, 2021. - AMERICAN SOCIETY OF PEDIATRIC HEMATOLOGY ONCOLOGY ANNUAL MEETING (VIRTUAL), "FINANCIAL TOXICITY: AN UNDER-APPRECIATED LATE EFFECT OF CHILDHOOD CANCER", APRIL 22, 2021.- 15TH EUROPEAN CONGRESS OF PEDIATRIC AND ADOLESCENT GYNECOLOGY 2021 (VIRTUAL), "LONG-TERM CONSEQUENCES OF CHILDHOOD ADOLESCENT AND YOUNG ADULT CANCER ON FEMALE REPRODUCTIVE FUNCTION", JUNE 10, 2021.- 2021 ANNUAL CONFERENCE OF TAIWAN PEDIATRIC ONCOLOGY GROUP (VIRTUAL), "DEVELOPING LONG-TERM FOLLOW-UP CLINICAL AND RESEARCH PROGRAMS FOR CHILDHOOD CANCER SURVIVORS: LESSONS LEARNED", JULY 24, 2021.LECTURES/WORKSHOPS PROVIDED BY DR. MATTHEW EHRHARDT:- ST. JUDE FELLOW'S SURVIVORSHIP ON-DEMAND CURRICULUM 2020 - 2021-- SUBSEQUENT MALIGNANT NEOPLASMS OVERVIEW-- CANCER SCREENING GUIDELINES AFTER CHILDHOOD CANCER-- SUBSEQUENT NEOPLASM PREVENTION- PEDIATRIC CANCER SURVIVORSHIP: LATE HEALTH EFFECTS, RISK-BASED SCREENING, AND OPTIMIZING CARE DELIVERY. OPTUM HEALTH TRANSPLANTATION: ESSENTIALS OF ONCOLOGY, SOLID ORGAN, AND BLOOD/MARROW TRANSPLANT MANAGEMENT FOR THE HEALTH CARE TEAM CONFERENCE, VIRTUAL (PHOENIX, AZ), DECEMBER 2020.- LATE EFFECTS EVIDENCE TABLES AND MANUSCRIPT ASSESSMENT. CHILDREN'S ONCOLOGY GROUP LONG-TERM FOLLOW-UP GUIDELINES FOR SURVIVORS OF CHILDHOOD, ADOLESCENT, AND YOUNG ADULT CANCERS TASK FORCES MONTHLY MEETING, DECEMBER 2020.- SUBSEQUENT MALIGNANT NEOPLASMS. VIVA FOUNDATION FOR CHILDREN WITH CANCER ANNUAL CONFERENCE, VIRTUAL (SINGAPORE), MARCH 2021.- TAKING PEDIATRIC CANCER SURVIVORSHIP TO HEART. PEDIATRIC CARDIO-ONCOLOGY WEBINAR SERIES. A LE BONHEUR CHILDREN'S HOSPITAL, ST. JUDE CHILDREN'S RESEARCH HOSPITAL, AND UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER COLLABORATION, VIRTUAL (MEMPHIS, TN), APRIL 2021.- LYMPHADENOPATHY AND LYMPHOMA. UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER ANNUAL RESIDENT LECTURE SERIES, LE BONHEUR CHILDREN'S HOSPITAL, MEMPHIS, TN. MAY 2021.- IMPROVING CARDIAC SCREENING FOR SURVIVORS: MOVING BEYOND EXPERT OPINION. PEDIATRIC ONCOLOGY GROUP OF ONTARIO AFTERCARE EDUCATION DAY, VIRTUAL (ONTARIO, CANADA), MAY 2021.- SUBSEQUENT MALIGNANT NEOPLASMS AFTER CHILDHOOD CANCER THERAPY. EURASIA REGIONAL PROGRAM, ST. JUDE CHILDREN'S RESEARCH HOSPITAL, MEMPHIS, TN, APRIL 2020. - CARDIOMYOPATHY SCREENING GUIDELINES AND BRIEF UPDATE ON THE ST. JUDE CARDIAC MAGNETIC RESONANCE IMAGING PROGRAM. PEDIATRIC BIOMEDICAL IMAGING INITIATIVE RESEARCH SYMPOSIUM, ST. JUDE CHILDREN'S RESEARCH HOSPITAL, MEMPHIS, TN. FEBRUARY 2021.- CARDIAC DYSFUNCTION AMONG CHILDHOOD CANCER SURVIVORS. GRAND ROUNDS, ST. JUDE CHILDREN'S RESEARCH HOSPITAL, MEMPHIS, TN. FEBRUARY 2021.- LATE EFFECTS OF CHILDHOOD CANCER: THE COST OF CURE. FELLOWS LECTURE SERIES, ST. JUDE CHILDREN'S RESEARCH HOSPITAL, MEMPHIS, TN, MARCH 2021.- PEDIATRIC CASTLEMAN'S DISEASE. HISTIOCYTIC DISEASES MONTHLY CONFERENCE, ST. JUDE CHILDREN'S RESEARCH HOSPITAL, MEMPHIS, TN, APRIL 2021.- THE ROLE OF SURVIVORSHIP CARE PLANS AND RISK-BASED SCREENING. INTEGRATING IMPLEMENTATION SCIENCE INTO CHILDHOOD CANCER SURVIVORSHIP CARE. ST. JUDE/WASHINGTON UNIVERSITY WEBINAR SERIES. VIRTUAL. MAY 2021. |
| LECTURES/WORKSHOPS PROVIDED BY DR. STEPHANIE DIXON: | - ST. JUDE FELLOW'S SURVIVORSHIP ON-DEMAND CURRICULUM 2020 - 2021-- METABOLIC LATE EFFECTS- DIXON SB. METABOLIC SYNDROME, PREDIABETES, AND DIABETES AMONG ADULT SURVIVORS OF CHILDHOOD CANCER: RESULTS FROM THE ST. JUDE LIFETIME COHORT. SYMPOSIUM ON OBESITY, METABOLISM AND SURVIVORSHIP: CHALLENGES AND OPPORTUNITIES. ST. JUDE CHILDREN'S RESEARCH HOSPITAL, MEMPHIS, TN, FEBRUARY 2020.- DIXON SB, ARMSTRONG GT. UPDATES IN LATE-ONSET CARDIAC DYSFUNCTION IN SURVIVORS OF CHILDHOOD CANCER. CTRSTC CONFERENCE AT ST. JUDE CHILDREN'S RESEARCH HOSPITAL. 24, JANUARY 2020.LECTURES/WORKSHOPS PROVIDED BY DR. DANIEL MULROONEY:- ST. JUDE FELLOW'S SURVIVORSHIP ON-DEMAND CURRICULUM 2020 - 2021-- CARDIAC TOXICITY- LESSONS FROM THE STUDY OF WILMS SURVIVORS IN THE ST. JUDE LIFETIME COHORT STUDY, CLINICAL TRANSLATIONAL RESEARCH IN SOLID TUMORS CONFERENCE, ST. JUDE CHILDREN'S RESEARCH HOSPITAL, MEMPHIS, TN, APR 2021. - AMERICAN SOCIETY OF CLINICAL ONCOLOGY, CANCER.NET PODCAST: MENTAL HEALTH NEEDS OF ADOLESCENT AND YOUNG ADULT CANCER SURVIVORS.LECTURES/WORKSHOPS PROVIDED BY DR. DANIEL GREEN:- ST. JUDE FELLOW'S SURVIVORSHIP ON-DEMAND CURRICULUM 2020 - 2021-- PULMONARY TOXICITY-- RENAL TOXICITY- JOHN DUCKETT MEMORIAL LECTURE - SOCIETY FOR PEDIATRIC UROLOGY, WASHINGTON, DC, MAY 17, 2020, EFFECTS OF CANCER TREATMENT IN CHILDREN INTO ADULTHOOD.LECTURES/WORKSHOPS PROVIDED BY DR. KARI BJORNARD:- ST. JUDE FELLOW'S SURVIVORSHIP ON-DEMAND CURRICULUM 2020 - 2021-- FERTILITY PRESERVATION-- FERTILITY LATE EFFECTS- 15TH ST. JUDE-VIVA FORUM (VIRTUAL), "REPRODUCTIVE LATE EFFECTS", MARCH 5, 2021.LECTURES/WORKSHOPS PROVIDED BY DR. WASSIM CHEMAITILLY:- ST. JUDE FELLOW'S SURVIVORSHIP ON-DEMAND CURRICULUM 2020 - 2021-- HPA AXIS DYSFUNCTION IN CHILDHOOD CANCER SURVIVORS- 15TH ST. JUDE-VIVA FORUM (VIRTUAL), "ENDOCRINE LATE EFFECTS", MARCH 5, 2021.LECTURES/WORKSHOPS PROVIDED BY DR. KEVIN KRULL:- ST. JUDE FELLOW'S SURVIVORSHIP ON-DEMAND CURRICULUM 2020 - 2021-- NEUROCOGNITIVE LATE EFFECTSPEDIATRIC HEALTH NEED:OUTPATIENT CARE EXPERIENCE - TRANSITION OF CARE FROM SPECIALTY TO PRIMARY CARE PROVIDERSHEALTH FACILITIES INVOLVED:ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TRANSITION ONCOLOGY PROGRAM (TOP), COMMUNITY PRIMARY CARE PROVIDERSANTICIPATED OUTCOME:- AT THE COMPLETION OF CANCER-DIRECTED THERAPY, PATIENTS WILL HAVE ESTABLISHED A PRIMARY CARE PROVIDER IN THEIR LOCAL COMMUNITY.- AT THE COMPLETION OF CANCER-DIRECTED THERAPY, TOP TEAM WILL SEND THE PATIENT'S ONCOLOGY TREATMENT SUMMARY TO THEIR IDENTIFIED PRIMARY CARE PROVIDER.ACTION ITEMS TO MEET IDENTIFIED HEALTH NEED:1. DEVELOP MATERIALS TO EDUCATE PATIENTS ON THE PROCESS OF FINDING A PRIMARY CARE PROVIDER IN THEIR COMMUNITY WHO ACCEPTS THEIR HEALTH INSURANCE.2. WORK WITH HIMS/CLINICAL INFORMATICS TO REVIEW STATISTICS/REPORTS RE: "FAMILY PHYSICIAN" FIELD IN EMR.3. DEVELOP PROCESS FOR CAPTURING OUTCOMES RELATED TO PRIMARY CARE PROVIDER IDENTIFICATION.4. INCREASE THE PERCENTAGE OF ONCOLOGY TREATMENT SUMMARIES SENT TO PRIMARY CARE PROVIDERS WITHIN TWO WEEKS OF THERAPY COMPLETION. SELECTED ACCOMPLISHMENTS:- TOP TEAM MEMBERS CONTINUE TO PROVIDE PATIENT EDUCATION RELATED TO THE IDENTIFICATION OF LOCAL HEALTH CARE PROVIDERS. AS OUR EARLIEST PATIENTS ENROLLED IN THE PROGRAM ARE NOW 2-2.5 YEARS OFF-THERAPY, WE ARE REACHING THE TIMEPOINT WHERE THE NEED TO TRANSITION TO LOCAL SPECIALTY PROVIDERS IS EVEN MORE RELEVANT. - WE CONTINUE TO TRACK THE PERCENTAGE OF PATIENTS (~90%) WHO HAVE IDENTIFIED A PRIMARY CARE PROVIDER BY THE END OF CANCER DIRECTED THERAPY. MOST OF THE REMAINING PATIENTS TEND TO BE IN THE PROCESS OF RELOCATING FROM ONE CITY TO ANOTHER WHILE THEY ARE COMPLETING THERAPY.- TOP TEAM MEMBERS ARE PARTICIPATING IN A WORKGROUP THAT IS EXAMINING HEALTH CARE TRANSITION PRACTICES (PEDIATRIC TO PEDIATRIC, PEDIATRIC TO ADULT, SPECIALTY TO SPECIALTY, SPECIALTY TO PRIMARY) ACROSS THE INSTITUTION. PEDIATRIC HEALTH NEED:OUTPATIENT CARE EXPERIENCE - PHYSICIAN COORDINATION OF CAREHEALTH FACILITIES INVOLVED:ST. JUDE CHILDREN'S RESEARCH HOSPITAL, ST. JUDE AFFILIATE INSTITUTIONS, ALL DOMESTIC AND INTERNATIONAL REFERRING CLINICIANS AND CENTERSANTICIPATED OUTCOME:- IMPROVE CONTINUITY OF CARE BY ENHANCING COMMUNICATION TOOLS AND EFFORTS TO PROVIDE PHYSICIANS WITH UNPARALLELED ACCESS TO PATIENT INFORMATION.ACTION ITEMS TO MEET IDENTIFIED HEALTH NEED: 1. CONTINUE TO IMPROVE THE CLINICIAN PORTAL TO PERMIT REFERRING AND AFFILIATED PHYSICIANS' CONVENIENT ACCESS TO PATIENT INFORMATION, IN ACCORDANCE WITH APPLICABLE LAW. |
| SELECTED ACCOMPLISHMENTS: | - THE AFFILIATE PROGRAM COMPLETED A JOINT QUALITY IMPROVEMENT PROJECT ENTITLED "IMPROVING DOCUMENTATION WITH ORAL CHEMOTHERAPY COMPLIANCE" IN THIS FISCAL YEAR. THIS PROJECT WAS DONE IN ASSOCIATION WITH THE ASCO QUALITY TRAINING PROGRAM WHICH PROVIDED REMOTE TRAINING FOR AFFILIATE PHYSICIANS. WE NOW HAVE QUALITY CHAMPIONS AT EACH AFFILIATE SITE. COMPLIANCE WAS IMPROVED BY STANDARDIZING ORAL CHEMOTHERAPY COMPLIANCE DOCUMENTATION, IDENTIFYING AN OWNER OF COMPLIANCE DOCUMENTATION, AND CREATING A GATEKEEPER TO REVIEW PATIENT CHARTS PRIOR TO BEING SENT TO THE RESEARCH NURSES IN MEMPHIS.- OUR NON-CLINICAL PATIENT NAVIGATOR PROGRAM CONTINUES TO HELP FAMILIES TRANSITION BACK TO THEIR HOME COMMUNITIES. THE NONCLINICAL PATIENT NAVIGATOR IMPROVED COMMUNICATION AND FOSTERED A CULTURE OF UNDERSTANDING FOR PATIENTS AND FAMILIES TRANSITIONING BETWEEN MULTIPLE HEALTH CARE FACILITIES IN OUR PEDIATRIC ONCOLOGY NETWORK. OUR WORK WAS PUBLISHED IN THIS FISCAL YEAR. AIM #3 IMPROVING CHILD HEALTH STATUSPEDIATRIC HEALTH NEED:COMMUNITY HEALTH EDUCATIONHEALTH FACILITIES INVOLVED:ST. JUDE CHILDREN'S RESEARCH HOSPITAL, COMMUNICATIONS & PUBLIC RELATIONS DEPARTMENTANTICIPATED OUTCOME:- INCREASE THE NUMBER OF RADIO EDUCATION SPOTS, ARTICLES AND SOCIAL MEDIA REGARDING HEALTH CARE RESOURCES AND HEALTH CARE CAREERS ANNUALLY.ACTION ITEMS TO MEET IDENTIFIED HEALTH NEED:1. ST. JUDE PROFESSIONALS WILL PROVIDE INFORMATION AND RESOURCES ABOUT SICKLE CELL DISEASE, HIV, CANCER, FLU, AND OTHER PEDIATRIC LIFE-THREATENING DISEASES.2. OFFER EDUCATIONAL OPPORTUNITIES AND OTHER INFORMATION ABOUT HEALTHCARE CAREERS.SELECTED ACCOMPLISHMENTS:- TOGETHER WEBSITE: THIS SITE PROVIDES RELIABLE MEDICAL EXPLANATIONS AND CLINICAL CARE INFORMATION IN EASY-TO-UNDERSTAND LANGUAGE. IT IS AVAILABLE TO PATIENTS AND THEIR FAMILIES ANYWHERE IN THE WORLD. - NEW EDUCATION CONTENT DEVELOPED FOR TOPICS INCLUDING EARLY CHILD DEVELOPMENT, COVID-19 AND VACCINES, SURVIVORSHIP, SIBLING SUPPORT, AND SIDE EFFECTS. ALSO INCLUDED IN NEW CONTENT WERE COLORING AND ACTIVITY BOOKS. CONTENT REVISIONS MADE TO EXISTING TOPICS TO MAINTAIN ACCURACY AND UNDERSTANDABILITY OF INFORMATION. - IN SEPTEMBER 2020, THE TEENS&20S MINISITE LAUNCHED FOR ADOLESCENT AND YOUNG ADULT CANCER PATIENTS AND SURVIVORS AGES 13-25 YEARS. THE MINISITE HAS SECTIONS ON SCHOOL, ADULTING, TREATMENT/SIDE EFFECTS, EMOTIONAL HEALTH, TAKING CARE OF YOURSELF, AND SHARED STORIES.- IN FEBRUARY OF 2021, TOGETHER BEGAN PUBLISHING A BLOG AND HOSTING AN ONLINE COMMUNITY. -- BLOG: PROVIDES A PLATFORM FOR A VARIETY OF VOICES IN THE CHILDHOOD AND ADOLESCENT COMMUNITY TO SHARE INFORMATION AND INSIGHTS ABOUT TIMELY TOPICS. AUTHORS INCLUDE CANCER PATIENTS AND SURVIVORS, CHILDHOOD CANCER SUBJECT MATTER EXPERTS, AND ADVOCATES. ARTICLE TOPICS INCLUDE THE IMPORTANCE OF VACCINATIONS, BACK TO SCHOOL DECISION SUPPORT, CANCER PREVENTION, INTEGRATIVE MEDICINE, WAYS TO IMPROVE SLEEP QUALITY, AND COVID-19.-- COMMUNITY: PROVIDES A SAFE SPACE FOR PARENTS, PATIENTS, SURVIVORS, AND OTHERS TO SHARE STORIES, ENCOURAGEMENT, AND HELPFUL INFORMATION. - COVER FOR THE KIDS CAMPAIGN: A MASKING EDUCATION INITIATIVE THAT DRIVES HOME PROTECTING HEALTHCARE PROVIDERS BY MASKING IN THE COMMUNITY, THEREBY SAFEGUARDING THE PATIENTS AT ST. JUDE.- COLORING AND ACTIVITY BOOKS FOR CHILDREN AND ADOLESCENTS: DEVELOPED EDUCATIONAL COLORING BOOK FOR YOUNG CHILDREN AND ACTIVITY BOOK FOR TWEENS TO HELP KIDS NORMALIZE THE VIRUS. THE COLORING BOOK IS AVAILABLE IN 17 LANGUAGES AND THE ACTIVITY BOOK IN 14 LANGUAGES.- WORLD IMMUNIZATION WEEK CAMPAIGN AND DEVELOPMENT OF VACCINES BRING US CLOSER EDUCATION TOOLKIT PROVIDED ON STJUDE.ORG FOR LOCAL COMMUNITY. TOOLKIT INCLUDES MYTH BUSTERS ABOUT THE VACCINE, EDUCATION CONTENT FOR FORMAL PRESENTATIONS, AND PROMOTIONAL ITEMS (STICKERS, CARDS, AND T-SHIRT GRAPHICS).- INFORMATION AND EDUCATION FOR LOCAL ST. JUDE FAMILIES INCLUDING WEBSITE DEVELOPMENT AND MAINTENANCE AND MEMOS SENT FROM INSTITUTION CLINICAL AND EXECUTIVE LEADERS.- PROMISE MAGAZINE, PRINT AND DIGITAL: ST. JUDE PUBLISHED 4 EDITIONS OF PROMISE THIS YEAR WITH EDUCATIONAL INFORMATION ON HIV/AIDS, GENERAL CHILDHOOD CANCER AND HEALTH RESOURCES, AND CHILDHOOD CANCER SURVIVORSHIP. - PROGRESS BLOG POSTS: ST. JUDE PUBLISHED MORE THAN 95 BLOG POSTS IN PROGRESS THIS YEAR WITH EDUCATIONAL INFORMATION ON COVID-19, FLU, HIV/AIDS, HEALTH CARE CAREERS, AND GENERAL CHILDHOOD CANCER AND HEALTH RESOURCES. - SOCIAL MEDIA ENGAGEMENT: IN FY21, ST. JUDE EDUCATED THE COMMUNITY ON TOPICS OF CHILDHOOD CANCER, SICKLE CELL DISEASE, HIV/AIDS, FLU, HPV, AND HEALTH CARE CAREERS USING FOUR SOCIAL MEDIA PLATFORMS - FACEBOOK, TWITTER, INSTAGRAM, AND LINKEDIN. ENGAGEMENT INCREASED AN AVERAGE OF 52.5% ACROSS ALL PLATFORMS. - EARNED NEWS MEDIA STORIES: BECAUSE ALL MEDIA OUTLETS HAVE AN ACCOMPANYING WEBSITE WHERE THEY ALSO SHARE THEIR NEWS (AND MANY ARE ONLINE ONLY NOW), OUR LOCAL COMMUNITY CAN ACCESS EDUCATIONAL NEWS STORIES FROM AROUND THE WORLD. IN FY21, THE ST. JUDE MEDIA RELATIONS OUTREACH (PRESS RELEASES, MEDIA ADVISORIES, PITCHING, ETC.) LED TO OVER 3,500 EARNED PLACEMENTS, INCLUDING OVER 60 TOP TIER CONSUMER MEDIA OUTLETS AND 45 TOP TIER TRADE MEDIA OUTLETS. CONTENT INCLUDED:-- THE IMPORTANCE OF VACCINATION: COVID-19, HPV, AND FLU -- COVID-19 RESOURCES, SUCH AS HOW THE VIRUS SPREADS, SIGNS AND SYMPTOMS, PROPER HANDWASHING, MASK-WEARING, SOCIAL DISTANCING, DISCUSSING THE VIRUS WITH CHILDREN, AND MORE-- SICKLE CELL DISEASE INFO AND RESOURCES -- HIV/AIDS INFO AND RESOURCES -- HEALTH CARE CAREERS-- GENERAL CHILDHOOD CANCER, CATASTROPHIC DISEASE, AND HEALTH RELATED RESOURCESPEDIATRIC HEALTH NEED:PREVENTING VIRUS-ASSOCIATED CANCERS THROUGH INCREASED HPV VACCINATIONHEALTH FACILITIES INVOLVED:ST. JUDE CHILDREN'S RESEARCH HOSPITAL, COMPREHENSIVE CANCER CENTERANTICIPATED OUTCOME:- ONBOARDING OF NEW DIRECTOR, PREVENTING VIRUS-ASSOCIATED CANCERS THROUGH INCREASED HPV VACCINATION.ACTION ITEMS TO MEET IDENTIFIED HEALTH NEED:1. LAUNCH SEARCH COMMITTEE, DEVELOP AND EVALUATE CANDIDATES, HIRE AND ONBOARD A NEW FACULTY DIRECTOR FOR THE HPV CANCER PREVENTION INITIATIVE.2. CONTINUE AND/OR STRENGTHEN PARTNERSHIPS WITH OTHERS IN THE HPV VACCINATION SPACE (E.G. NATIONAL HPV VACCINATION ROUNDTABLE, HPV CANCER FREE TENNESSEE) THROUGH ACTIVE PARTICIPATION IN COMMITTEES AND MEETINGS. |
| SELECTED ACCOMPLISHMENTS: | TO BUILD THE PROGRAM'S CAPACITY AND STRENGTHEN PARTNERSHIPS THAT IMPACT HPV VACCINATION RATES, THE FOLLOWING ACTIVITIES WERE CONDUCTED:- PROGRAM STAFF PARTICIPATED IN MULTIPLE INDIVIDUAL/SMALL/WORK GROUP MEETINGS WITH LOCAL, REGIONAL, NATIONAL, AND INTERNATIONAL PARTNERS, INCLUDING CDC, AMERICAN CANCER SOCIETY, HPV CANCER FREE TENNESSEE COALITION, PREVENT CANCER FOUNDATION, MERCK, AND IMMUNOTHERAPY FOUNDATION. MEETING OUTCOMES INCLUDE CONVENING A LOCAL HPV CANCER PREVENTION ROUNDTABLE FOR MEMPHIS AND SHELBY COUNTY, AS WELL AS, ENGAGING WITH LOCAL STAKEHOLDERS OF MISSOURI, ARKANSAS, TENNESSEE, AND MISSISSIPPI BY PARTICIPATING IN IMMUNIZATION COALITION MEETINGS, COALITION CONFERENCES. ADDITIONAL ACTIVITIES INCLUDE: -- STAFF PARTNERED WITH TENNESSEE COMPREHENSIVE CANCER COALITION (TC2) TO WORK ON BIG AND LITTLE POLICY OPPORTUNITIES TO INCREASE HPV VACCINATIONS AND SERVED ON THE EVALUATION AND STAKEHOLDER ANALYSIS COMMITTEE TO DETERMINE MEMBER PRIORITIES ACROSS TENNESSEE. -- STAFF BUILT INROADS WITH TENNESSEE NURSE PRACTITIONERS ASSOCIATION TO INCREASE HPV VACCINATIONS THROUGH MEMBER PRACTICES AND PROVIDED RESOURCES AND SUPPORTIVE MATERIALS FOR THEIR ANNUAL SUMMER ENRICHMENT CONFERENCE. -- STAFF SERVED ON THE MISSISSIPPI HPV ROUNDTABLE AND ITS WORKGROUPS - PROVIDER EDUCATION, PARENT/COMMUNITY AND SYSTEMS CHANGE.-- TO INCREASE PROGRAM AWARENESS AND BUILD COMMUNITY CAPACITY, THE HPV CANCER PREVENTION STAFF COMPLETED - 280 INTERNAL/EXTERNAL PARTNER MAILINGS AND CREATED AND DISTRIBUTED A MONTHLY EMAIL/NEWSLETTER TO - 800 PARTNERS. -- STAFF COORDINATED AND PARTICIPATED IN MULTIPLE INTERNATIONAL HPV AWARENESS DAY ACTIVITIES.-- STAFF PARTICIPATED IN HPV CANCER FREE TENNESSEE COALITION (HPVCFTN) AND DR. BRANDT SERVES AS THE CO-CHAIR OF THE WORKING GROUP. - DR. HEATHER BRANDT WAS A FEATURED PRESENTER AT THE NATIONAL HPV VACCINATION ROUNDTABLE NATIONAL MEETING AND HELPED TO COORDINATED VIDEO PRESENTATIONS WITH CIVILIAN ASTRONAUT HAYLEY ARCENEAUX, AND A ST. JUDE MOM & PATIENT FOR THE NATIONAL MEETING. - STAFF ENGAGED ST. JUDE HPV TASK GROUP TO FUNCTION AS AN INTERNAL ADVISORY BOARD AND FACILITATED 2 INTERNAL INTERVENTIONS SUBCOMMITTEE MEETINGS AND 6 HPV TASK GROUP MEETINGS AND FOCUSED EFFORTS TO EXPAND MEMBERSHIP.- THE HPV CANCER PREVENTION TEAM PARTICIPATED IN SEVERAL ACTIVITIES TO IDENTIFY OPPORTUNITIES TO IMPLEMENT NEW AND GALVANIZE EXISTING EFFORT TO INCREASE HPV VACCINE AWARENESS AND UPTAKE. THEY ARE AS FOLLOWS:-- CONDUCTED A LANDSCAPE ASSESSMENT TO IDENTIFY OPPORTUNITIES FOR INTERVENTION TO GALVANIZE EXISTING SUCCESSFUL EFFORTS AND LAUNCH NEW ONES. -- PROGRAM STAFF ORGANIZED AND FACILITATED CAPITALIZING ON OPPORTUNITIES TO PREVENT HPV CANCERS VIRTUAL SEMINAR FOR APPROXIMATELY 240 ATTENDEES. -- FACILITATED VIRTUAL ENGAGEMENT SEMINAR "MAKING ZOOM FUN" FOR APPROXIMATELY 90 INTERNAL AND EXTERNAL PARTNERS. -- PUBLISHED HPV VACCINATION POLICY ANALYSIS REPORT AND COORDINATED AND HOSTED A VIRTUAL SEMINAR, A LOOK AT STATE POLICY AND A PATH FORWARD FOR 300 PARTNERS. -- COORDINATED STATEMENT TO GET HPV VACCINATION BACK ON TRACK WITH HPV VACCINATION - ENDORSED BY ALL (71) NCI-DESIGNATED CANCER CENTERS AND SUPPORTING ORGANIZATIONS AND INITIATED THE RE-LAUNCH STATEMENT TO GET HPV VACCINATION BACK ON TRACK WITH SUPPORT FROM ASSOCIATION OF AMERICAN CANCER INSTITUTES (PREMIER ACADEMIC AND FREESTANDING CANCER CENTERS). STAFF PARTNERED WITH IMMUNIZETN, MEHARRY MEDICAL COLLEGE, AND VANDERBILT UNIVERSITY TO DRAFT AND COORDINATE A GET VACCINATIONS BACK ON TRACK STATEMENT SPECIFIC TO TENNESSEE. A TOTAL OF 17 AGENCIES ENDORSED THE LETTER. -- PROGRAM STAFF-INITIATED DEVELOPMENT OF STATE PROFILES FOR TENNESSEE, ARKANSAS, MISSOURI, AND MISSISSIPPI TO ASSESS DATA AND IDENTIFY ACTIONABLE OPPORTUNITIES AND COMPILED AND REVIEWED HPV VACCINATION AND HPV CANCERS DATA SOURCES.-- ASSESSED CURRENT UPTAKE OF HPV VACCINATION AMONG ST. JUDE EMPLOYEES INSURED THROUGH BCBSTN AND ASSESSED HPV VACCINE DOSE DISTRIBUTION FROM CENTRAL PHARMACY FOR ST. JUDE'S PATIENT POPULATION. -- AWARDED SUPPLEMENTAL AWARD - NIH, USING MULTIPLE STRATEGIES TO ADDRESS COVID VACCINE HESITANCY AMONG AFRICAN AMERICANS, A COLLABORATION WITH DR. JENNIFER ERVES, MEHARRY MEDICAL COLLEGE.-- SUBMITTED R01 APPLICATION TO NIH, HPV VACCINATION CHAMPIONS: A TECHNOLOGY-MEDIATED INTERVENTION FOR PARENTS, A COLLABORATION WITH DR. KATHLEEN CARTMELL, CLEMSON UNIVERSITY AND DR. BETH SUNDSTROM, COLLEGE OF CHARLESTON.-- PROGRAM STAFF ENGAGED IN SEVERAL IMPLEMENTATION AND EVALUATION ACTIVITIES TO SUPPORT INCREASING HPV VACCINATION AWARENESS AND UPTAKE. THIS INCLUDED COORDINATING, CONDUCTING, AND FACILITATING NUMEROUS EDUCATIONAL PRESENTATIONS FOR PARTICIPANTS REPRESENTING VARIOUS SECTORS - COMMUNITY INDIVIDUALS, SCHOOL ADMINISTRATORS, PEDIATRIC MEDICAL SOCIETIES, HEALTH COMMUNICATIONS SPECIALISTS, LEGISLATURES, AND LOCAL HEALTH DEPARTMENT STAFF. TOPICS FOCUSED ON THE FOLLOWING: HPV VACCINATION IS CANCER PREVENTION, WHAT PHYSICIANS NEED TO KNOW ABOUT HPV, AND VACCINE HESITANCY AND VACCINE CONFIDENCE AND IDENTIFYING STRATEGIES TO IMPROVE HPV VACCINATION AMONG CHILDHOOD CANCER SURVIVORS.-- THE STAFF COLLABORATED WITH LIVING WELL AND OCCUPATIONAL HEALTH, TO MAIL LETTERS TO ST. JUDE EMPLOYEES ABOUT HPV PROGRAM AND HPV VACCINATION, FACILITATE A DIRECT MAILING FROM BCBSTN AND HOST THREE EMPLOYEE HPV EDUCATION SESSIONS. -- THE TEAM COLLABORATED WITH AN EXTERNAL EVALUATOR TO ASSESS PROGRAM OFFERINGS.-- PROGRAM STAFF ENGAGED IN AND COMPLETED A STRATEGIC PLANNING PROCESS WITH ASSISTANCE FROM AN EXTERNAL CONSULTANT. -- PROGRAM STAFF CO-FACILITATED THE IMPLEMENTATION SCIENCE RESEARCH COLLABORATIVE - ST. JUDE AND WUSTL, HPV RESEARCH GROUP.-- PROGRAM STAFF ASSISTED WITH THE PLANNING WITH IMMUNIZEAR ON THE 2021 HPV SUMMIT AND DR. HEATHER BRANDT WAS A PRESENTER.-- PROGRAM STAFF ORGANIZED HPV VACCINATION NOW: SOCIAL MEDIA STRATEGIES FOR VACCINE COMMUNICATION VIRTUAL SEMINAR.-- AS PART OF THE HPV PROGRAM LAUNCH ON 3/4/2021, 11 COMMUNICATION PRODUCTS WERE INITIATED. THESE INCLUDED BLOG POSTS, NEWS ARTICLES AND INTERVIEWS, PRESS RELEASES AND SOCIAL MEDIA POSTS.PEDIATRIC HEALTH NEED:HIV COLLABORATION WITH COMMUNITY COALITIONHEALTH FACILITIES INVOLVED:ST. JUDE CHILDREN'S RESEARCH HOSPITAL, HIV CLINICAL PROGRAM - CONNECT TO PROTECT COMMUNITY COALITIONANTICIPATED OUTCOME:- REDUCE HIV/AIDS INFECTION RATES THROUGH COLLABORATION AMONG COMMUNITY LEADERS AND HEALTH RESEARCHERS. - DEVELOP STRONG HIV PREVENTION PROGRAMS, COMBINED WITH COMMUNITY ACTION, THAT REDUCE YOUTH HIV INFECTION RATES.ACTION ITEMS TO MEET IDENTIFIED HEALTH NEED: 1. FORGE ACTION-ORIENTED PARTNERSHIPS BETWEEN HEALTH RESEARCHERS AND COMMUNITY MEMBERS.2. LINK YOUTH TO CONFIDENTIAL HIV TESTING, COUNSELING SERVICES AND SPECIALIZED YOUTH CARE.3. STRENGTHEN SERVICES THAT SUPPORT YOUNG PEOPLE WITH HIV AND RELATED MEDICAL AND SOCIAL PROBLEMS.4. FOCUS PREVENTION STRATEGIES WHERE SOCIAL DETERMINANTS OF HEALTH EXISTS, AND HELP IS MOST NEEDED. |
| SELECTED ACCOMPLISHMENTS: | - STAFF COLLABORATED WITH CLINICIANS, COMMUNITY HEALTH PARTNERS AND THE LINKAGE TO CARE COORDINATORS TO REDUCE TIME GAPS TO "FIRST" MEDICAL CARE APPOINTMENT REGARDING NEWLY DIAGNOSED HIV PATIENTS WITHIN (5) DAYS IF COMING TO ST. JUDE AND 30 DAYS FOR ALL OTHER PROVIDERS.- CLINICIANS AND LINKAGE TO CARE COORDINATORS COLLABORATED WITH METHODIST LE BONHEUR COMMUNITY HIV NETWORK TO REDUCE TIME TO 1ST MEDICAL CARE APPOINTMENT TO LESS THAN 7 DAYS AFTER RECEIVING A NEW HIV DIAGNOSIS. - HIV PROGRAM STAFF CONDUCTED THIRTY-SIX COMMUNITY OUTREACH EVENTS TOTALING 104 OUTREACH HOURS AND REACHING APPROXIMATELY 8,199 INDIVIDUALS INCLUDING YOUTH, PARENTS, EDUCATORS, CLINICIANS & FAITH-BASED LEADERS. TOPICS OF FOCUS INCLUDED HIV 101, MENTAL HEALTH HYGIENE, ENDING THE HIV EPIDEMIC, EFFICACY OF THE LONG-ACTING INJECTABLE AGENT CABOTEGRAVIR (CAB LA) FOR PREP, PHYSICIANS VIRTUAL ROUNDTABLE TO INCREASE ACCESS TO PREP ESPECIALLY AMONGST ADOLESCENTS, EFFICACY STUDY OF A CANDIDATE HIV VACCINE, EFFECTIVE PRACTICES FOR YOUTH LINKAGE AND RETENTION IN HIV CARE, AND YOUTH HIV/AIDS AWARENESS.- STAFF COORDINATED AND HOSTED 4 C2P VIRTUAL MEETINGS FOR THE 25 MEMBERS OF CONNECT TO PROTECT (C2P) COMMUNITY COALITION DURING THE PANDEMIC TOTALING 30 OR MORE ATTENDEES IN FY21. ALTHOUGH THERE WAS A DECREASE IN THE NUMBER OF IN C2P MEETINGS, THIS WAS DUE IN PART TO AN UPTAKE IN THE NUMBER OF "CHALK TALKS" (11) HELD - (WHICH YIELDED 369 ATTENDEES TOTAL) AND 6 "TECHNICAL ASSISTANCE" TRAININGS THAT WERE CONDUCTED WITHIN FY21. ONE OF THE MAJOR CONTRIBUTIONS OF THE C2P COALITION WAS SERVING AS THE COORDINATING CENTER FOR ENDING THE HIV EPIDEMIC (EHE) IN MEMPHIS PLANNING. THIS RESULTED IN THE COALITION ESTABLISHING GUIDING PRINCIPLES, GOALS AND OVER 150 OBJECTIVES FOR THE EHE PLAN. - THE EHE COMMUNITY ACTION PLAN WAS COMPLETED AND SUBMITTED TO THE CDC IN DECEMBER OF 2020. THERE WERE FOUR COMMITTEES NAMELY, THE EXECUTIVE COUNCIL, POLICY COMMITTEE, PREVENT COMMITTEE AND ACCESS TO TREATMENT & CARE COMMITTEE, THAT MET ON A WEEKLY BASIS TO BRING THE EXECUTION OF THE EHE PLAN TO FRUITION. THERE WAS A TOTAL OF 30 MEETINGS THAT DROVE THE DEVELOPMENT AND COORDINATION OF THE EHE COMMUNITY ACTION PLAN DURING THE FY21 AND AT LEAST 4 ATTENDEES WERE PRESENT PER MEETING. - HIV PROGRAM STAFF CONTINUED TO PARTNER WITH UNIVERSITY OF MEMPHIS, SCHOOL OF PUBLIC HEALTH, TENNESSEE DEPARTMENT OF HEALTH AND HEADLINERS COMMUNITY ADVISORY BOARD TO IMPLEMENT WHOLE YOUNIVERSITY. AREAS OF FOCUS OF THIS EFFORT INCLUDED SEXUAL AND MENTAL HEALTH, WELLNESS, AND PRACTICING MINDFULNESS WITH A TOTAL OF 4 SESSIONS THAT HAD 70 ATTENDEES IN FY21. - ST. JUDE HIV LINKAGE TO CARE STAFF WORKED COLLABORATIVELY WITH THE SHELBY COUNTY HEALTH DEPARTMENT AND OTHER COMMUNITY AGENCIES TO CONFIDENTIALLY AND SUCCESSFULLY LINK 94 REFERRALS TO CARE. OF THE 94 REFERRALS, 76 NEWLY DIAGNOSED HIV+ YOUTH WERE LINKED TO MEDICAL CARE. TWENTY-SIX OF THOSE PATIENTS WERE LINKED TO CARE AT ST. JUDE FOR ADOLESCENT HIV SPECIALIZED CARE AND SERVICES. NINETY-TWO PERCENT OF THESE PATIENTS WERE OFFERED A MEDICAL APPOINTMENT WITHIN 5 BUSINESS DAYS AND 94% REMAIN RETAINED IN CARE. SIXTY-EIGHT REFERRALS WERE TO EXTERNAL CLINICAL PARTNERS AND WERE SUPPORTED THROUGH THE LINKAGE TO CARE PROCESS. - THE LTC COORDINATORS INCREASED LINKAGE TO CAPACITY BY CONDUCTING MORE IN-PERSON HOME VISITS, WORKING ALONGSIDE ONE ANOTHER FOR CROSS-POLLINATION OF OUTREACH OPPORTUNITIES/EVENTS, AND BY HOSTING ROOT-CAUSE ANALYSIS VIRTUAL MEETINGS WHICH IDENTIFIED KEY BARRIERS THAT DELAYED LINKAGE TO CARE. THERE WERE OVER TWO MEETINGS HELD WITHIN THIS FISCAL YEAR AND 17 PARTICIPANTS FROM 17 COMMUNITY AGENCIES. - THE HEADLINERS, YOUTH COMMUNITY ADVISORY BOARD, MET 15 TIMES (3 TIMES IN-PERSON, 12 VIRTUAL) IN FY21. THESE MEETINGS FOCUSED ON RETENTION FOR ACTIVE STUDIES AND FUNCTIONED TO GET SUPPORT AND BUY-IN AND GUIDANCE FOR UPCOMING STUDIES.- AMID THE PANDEMIC, THE HIV COMMUNITY OUTREACH TEAM LEVERAGED THEIR RELATIONSHIPS BY MAINTAINING PARTNERSHIPS WITH THE RYAN WHITE PROGRAM, H-CAP COALITION, AND OTHER COMMUNITY AGENCIES TO CREATE A VIRTUAL WORLD AIDS DAY PROGRAM. TOGETHER, WE WERE ABLE TO COLLECTIVELY HOST ACTIVITIES TO BRING AWARENESS TO NOT ONLY OUR CLINIC, BUT ALSO, HIV RESEARCH, AND EHE EFFORTS WITHIN THE LOCAL COMMUNITY.- STAFF DEVELOPED PERSONALIZED MARKETING FOR THE HIV PREVENTION TRIALS NETWORK (HPTN) YOUTH HIV PREVENTION STUDY, HPTN 083-01, (KNOWN IN OUR COMMUNITY AS THE TWINS STUDY) DURING FY21. IN ORDER TO EXPAND OUR RECRUITMENT EFFORTS DURING THE PANDEMIC CRISIS, WE INTRODUCED SOCIAL MEDIA MARKETING FOR THE TWIN STUDY BY SPONSORING ADVERTISING POSTS ON FACEBOOK AND INSTAGRAM WITH THE HELP OF THE ST. JUDE COMMUNICATIONS TEAM. WE WERE ABLE TO GARNER APPROXIMATELY 26,804 IMPRESSIONS AND CREATE TIC TOK VIDEOS WITH OUR PARTNERING STUDY SITES. WE ALSO PARTNERED WITH MIDSOUTH PRIDE, PARTNERSHIP TO END AIDS STATUS, HEADLINERS MEMPHIS, AND THE HAVEN MEMPHIS TO PARTICIPATE IN FACEBOOK LIVE VIDEOS FOR SOCIAL MEDIA. THESE EFFORTS WERE USED TO SHARE INFORMATION ABOUT THE STUDY IN VARIOUS VIRTUAL SPACES WITH ADOLESCENT PRESENCE. - FINALLY WHEN THE HIS PROGRAM WAS APPROACHED FOR ASSISTANCE FOR COVID-19 VACCINE DEVELOPMENT, THE ENTIRE TEAM INCLUDING THE OUTREACH TEAM TOOK AN ALL HANDS-ON-DECK APPROACH AND CONTRIBUTED TO SHARING INFORMATION ABOUT THE STUDIES, ADDRESSING MISINFORMATION ABOUT RESEARCH, OPTIMIZING EFFORTS TO ENROLL MINORITIES, AND MAXIMIZING STUDY PARTICIPANT RETENTION. A TOTAL OF 283 ADULTS (OVER HALF ABOVE 60 YEARS OF AGE; OVER HALF WOMEN, ABOUT A THIRD REPRESENTING A MINORITY) ENROLLED IN THE ADULT PHASE 3 COVID 19 VACCINE STUDY AND 80 CHILDREN AND COUNTING HAVE ENROLLED IN THE PEDIATRIC COVID-19 VACCINE STUDY FOR CHILDREN 6 MONTHS TO 12 YEARS OF AGE.PEDIATRIC HEALTH NEED:CHILD KNOWLEDGE OF CANCER PREVENTION, NUTRITION, OBESITY, AND PHYSICAL ACTIVITY HEALTH FACILITIES INVOLVED:ST. JUDE CHILDREN'S RESEARCH HOSPITAL, ST. JUDE COMPREHENSIVE CANCER CENTERANTICIPATED OUTCOME:- INCREASE THE NUMBER OF STUDENTS AND TEACHERS PARTICIPATING IN ST. JUDE CANCER AND HEALTHY LIVING EDUCATION PROGRAM.ACTION ITEMS TO MEET IDENTIFIED HEALTH NEED: 1. PARTNER WITH LOCAL EDUCATION AGENCIES TO DISSEMINATE CANCER AND HEALTHY LIVING EDUCATIONAL PROGRAMS. |
| SELECTED ACCOMPLISHMENTS: | - IN RESPONSE TO THE PANDEMIC, THE CANCER EDUCATION AND OUTREACH PROGRAM IN SCHOOLS TRANSITIONED THE ST. JUDE STEM IN MEDICINE AFTERSCHOOL CLUB TO A VIRTUAL FORMAT. THE CLUB IS DESIGNED TO EDUCATE 5TH GRADE STUDENTS ABOUT SIGNS AND SYMPTOMS OF CANCER WHILE ACTIVELY ENGAGING THEM IN THE SCIENCE AND ENGINEERING PRACTICES. PRELIMINARY DATA SUGGESTS THAT THE VIRTUAL FORMAT WAS JUST AS EFFECTIVE AS THE IN-PERSON VERSION AT INCREASING STUDENT CRITICAL THINKING SKILLS AND MOTIVATION TOWARDS STEM. - DURING SUMMER 2021, THE CANCER EDUCATION AND OUTREACH PROGRAM IN SCHOOLS PARTNERED WITH THE SHELBY COUNTY SCHOOLS SUMMER LEARNING ACADEMY TO DELIVER CANCER-RELATED EDUCATIONAL ACTIVITIES TO OVER 100 STUDENTS RISING INTO GRADES 2-6. - IN RESPONSE TO THE PANDEMIC, THE CANCER EDUCATION AND OUTREACH PROGRAM IN SCHOOLS TRANSITIONED OUR DNA DAY OUTREACH ACTIVITIES INTO A DNA DAY HOME KIT THAT INCLUDED HANDS-ON ACTIVITIES RELATED TO DNA AND GENOMICS AND A PAMPHLET THAT DISCUSSED TOPICS RELATED TO GENETICS, CANCER, AND CANCER PREVENTION STRATEGIES. THE KITS WERE MAILED TO OVER 300 4TH GRADE STUDENTS IN BOTH THE MEMPHIS, TN AND SPRINGFIELD, MO AREAS. - THE CANCER EDUCATION AND OUTREACH PROGRAM IN SCHOOLS LAUNCHED TWO NEW HEALTH-RELATED INITIATIVES DURING THE REPORTING PERIOD: MIDDLE SCHOOL COMMUNITY HEALTH CLUBS AND KINDERGARTEN HEALTH AND SCIENCE LEARNING MODULES. DURING SUMMER 2020, WE DEVELOPED THE MIDDLE SCHOOL COMMUNITY HEALTH CLUBS WHICH ARE AN AFTERSCHOOL CLUB FOR STUDENTS IN GRADES 6-8 RELATED TO TENNESSEE CANCER DISPARITIES AND HEALTH EQUITY. DURING THE CLUB, STUDENTS ANALYZE DATA FROM THE NCI STATE PROFILE RELATED TO A CANCER OF THEIR CHOICE AND DEVELOP AN INTERVENTION TO ADDRESS A DISPARITY THEY IDENTIFY. THIS IS CLUB WAS PILOTED IN ONE SCHOOL WITH 16 STUDENTS DURING THE 2020-2021 SCHOOL YEAR. THE TEAM ALSO WORKED WITH KINDERGARTEN TEACHERS FROM THE MEMPHIS-AREA TO DEVELOP A KINDERGARTEN LEARNING MODULE RELATED TO INFECTIOUS DISEASES. THIS CURRICULUM WAS IMPLEMENTED IN FALL 2020 BY 12 KINDERGARTEN TEACHERS ACROSS THREE SCHOOL-SITES AND 11 KINDERGARTEN TEACHERS IN THREE ADDITIONAL SCHOOLS IN SPRING 2021. - THE CANCER EDUCATION AND OUTREACH PROGRAM IN SCHOOLS LAUNCHED TWO INTERCONNECTED PROGRAMS THAT COUPLES SCIENTIST PROFESSIONAL DEVELOPMENT WITH HIGH SCHOOL OUTREACH: ST. JUDE SCIENCE AMBASSADORS CLASSROOM AND VIRTUAL SCIENCE JOURNAL CLUBS. DURING FALL 2020, FIVE SCIENTISTS PARTICIPATED IN A WORKSHOP SERIES TO ENHANCE THEIR SCIENCE COMMUNICATIONS SKILLS AND DEVELOP A PRESENTATION TO DELIVER TO HIGH SCHOOL STUDENTS DURING THE VIRTUAL SCIENCE JOURNAL CLUB. THE CLUB PARTNERED WITH THREE AP BIOLOGY TEACHERS IN MEMPHIS, TN AND TWO IN SPRINGFIELD, MO TO DELIVER THREE SCIENTISTS VISITS TO TEACH CLASSROOM. THIS PROGRAM IS THE FIRST TO ACTIVELY ENGAGE TEACHERS AND STUDENTS FROM ONE OF OUR AFFILIATE SITES IN EDUCATION AND OUTREACH. |
| ST. JUDE CHILDREN'S RESEARCH HOSPITAL: | PART V, SECTION B, LINE 7A: THE CHNA REPORT WAS MADE WIDELY AVAILABLE AT THE FOLLOWING URL: HTTPS://WWW.STJUDE.ORG/ABOUT-ST-JUDE/FINANCIALS/COMMUNITY-HEALTH-NEEDS- ASSESSMENT.HTMLST. JUDE CHILDREN'S RESEARCH HOSPITAL:PART V, SECTION B, LINE 10A: THE HOSPTIAL FACILITY'S MOST RECENTLY ADOPTED IMPLEMENTATION STRATEGY IS AVAILABLE AT THE FOLLOWING URL: HTTPS://WWW.STJUDE.ORG/ABOUT-ST-JUDE/FINANCIALS/COMMUNITY-HEALTH-NEEDS- ASSESSMENT.HTMLST. JUDE CHILDREN'S RESEARCH HOSPITAL:PART V, SECTION B, LINE 14: ST. JUDE CURRENTLY DOES NOT BILL NOR PURSUE PAYMENT FOR ANY ST. JUDE PATIENT; THEREFORE, ST. JUDE DOES NOT HAVE A BASIS FOR CALCULATING AMOUNTS CHARGED TO PATIENTS.ST. JUDE CHILDREN'S RESEARCH HOSPITAL: PART V, SECTION B, LINE 16A: THE FAP WAS MADE WIDELY AVAILABLE AT THE FOLLOWING URL: HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-POLICY.HTMLST. JUDE CHILDREN'S RESEARCH HOSPITAL:PART V, SECTION B, LINE 16B: BASED ON THE FINANCIAL ASSISTANCE STATEMENT (HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL- ASSISTANCE-STATEMENT.HTML) AND FINANCIAL ASSISTANCE POLICY (HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-POLICY.HTML), ST. JUDE DOES NOT HAVE AN APPLICATION FORM.ST. JUDE CHILDREN'S RESEARCH HOSPITAL:PART V, SECTION B, LINE 16C: A PLAIN LANGUAGE SUMMARY WAS MADE WIDELY AVAILABLE AT THE FOLLOWING URL: HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-STATEMENT.HTML |
Supplemental Information Detail SupplementalInformationDetail (18 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 3C: | NO FAMILY EVER PAYS ST. JUDE FOR TREATMENT. WE DO NOT NEED TO DETERMINE ELIGIBILITY FOR THIS ASSISTANCE. BY DEFAULT, ALL PATIENTS ARE ELIGIBLE TO RECEIVE MEDICAL CARE AND SUPPORT SERVICES AT NO COST. ALL PATIENTS ACCEPTED FOR ST. JUDE TREATMENT RECEIVE CARE WHETHER OR NOT THEY OR THEIR FAMILIES CAN PAY FOR IT. ST. JUDE DOES HAVE A BILLING SYSTEM, BUT PATIENTS DO NOT RECEIVE BILLS. IF THE PATIENT HAS INSURANCE, ST. JUDE BILLS THE INSURANCE PLAN OR OTHER ORGANIZATION THAT PAYS HEALTH COSTS. BILLING INSURANCE FOR THE COSTS THAT WOULD BE DUE AT ANY OTHER HOSPITAL ALLOWS ST. JUDE TO CONTINUE DOING SOME OF THE MOST ADVANCED RESEARCH IN THE WORLD. IT ALSO ALLOWS ST. JUDE TO PAY FOR TREATMENTS, COPAYMENTS, DEDUCTIBLES, COINSURANCE, AND ANY OTHER COSTS INSURANCE DOES NOT COVER.TO ENSURE FAMILIES ARE MAKING USE OF ALL RESOURCES FOR WHICH THEY ARE ELIGIBLE, WE HAVE PROGRAMS TO ASSIST FAMILIES IN ENROLLING IN VARIOUS PUBLIC ASSISTANCE PROGRAMS FOR WHICH THEY MAY QUALIFY, INCLUDING BUT NOT LIMITED TO TENNCARE/MEDICAID, COVERKIDS, CHIPS AND SOCIAL SECURITY. DOING SO ENSURES AN APPROPRIATE SAFETY NET SHOULD THE FAMILY SEEK TREATMENT OUTSIDE OF ST. JUDE AND IT ALLOWS US TO BE GOOD STEWARDS OF DONOR DOLLARS. WE ALSO CONTRACT WITH A VENDOR TO PROVIDE CERTIFIED APPLICATION COUNSELOR SERVICES TO ASSIST FAMILIES APPLYING FOR HEALTH INSURANCE COVERAGE THROUGH FEDERAL OR STATE FACILITATED MARKETPLACES. |
| PART I, LINE 7: | COST-TO-CHARGE RATIO DERIVED FROM WORKSHEET 2, RATIO OF PATIENT CARE COST TO CHARGES. COST-TO-CHARGE RATIO USED FOR LINE 7A FINANCIAL ASSISTANCE AT COST, LINE 7B MEDICAID, AND LINE 7C COSTS OF OTHER MEANS-TESTED GOVERNMENT PROGRAMS. SOME CHIPS VOLUME IS INCLUDED IN MEDICAID IN PART I, LINE 7B BECAUSE IN MANY STATES THE CHIPS PROGRAMS ARE MANAGED BY THE SAME THIRD PARTY ADMINISTRATORS, AND IT IS DIFFICULT TO DISTINGUISH BETWEEN CHIPS AND MEDICAID COVERAGE. |
| PART I, LINE 7G: | ST. JUDE CHILDREN'S RESEARCH HOSPITAL INCLUDED AS SUBSIDIZED HEALTH SERVICES SUPPORT FOR EIGHT AFFILIATE CLINICS TOTALING APPROXIMATELY $8.7 MILLION. |
| PART II, COMMUNITY BUILDING ACTIVITIES: | THE ST. JUDE CHILDREN'S RESEARCH HOSPITAL PRESIDENT AND CEO IS A MEMBER OF MEMPHIS TOMORROW. MEMPHIS TOMORROW IS AN ASSOCIATION OF CHIEF EXECUTIVE OFFICERS OF MEMPHIS' LARGEST ENTERPRISES. THE PURPOSE IS TO BRING TOP BUSINESS LEADERS TOGETHER WITH GOVERNMENT AND CIVIC LEADERS TO FOSTER ECONOMIC PROSPERITY FOR ALL WHO LIVE IN OUR COMMUNITY. THEIR INITIATIVES ARE FOCUSED IN THOSE AREAS WHICH DIRECTLY IMPACT ECONOMIC GROWTH AND OPPORTUNITY, INCLUDING HUMAN CAPITAL DEVELOPMENT, INDUSTRY DEVELOPMENT, AND PUBLIC SAFETY. ST. JUDE ALSO PARTICIPATES WITH MEMPHIS FAST FORWARD WHOSE STRATEGIES ARE BASED ON THE PREMISE THAT ECONOMIC GROWTH AND PROSPERITY, AND IMPROVED QUALITY OF LIFE, WILL FOLLOW ONCE MEMPHIS AND SHELBY COUNTY SUCCESSFULLY ADDRESS THE BASICS: GOOD JOBS, QUALITY EDUCATION, SAFE STREETS AND EFFICIENT GOVERNMENT. ST. JUDE IS A MEMBER OF THE ASPIRING FOR PURCHASING EXCELLENCE (APEX) ASSOCIATION OF MEMPHIS. APEX IS AN ASSOCIATION OF PURCHASING AND PROCUREMENT PROFESSIONALS FROM MEMPHIS ORGANIZATIONS WHOSE PURPOSE IS TO PROMOTE BEST PRACTICES IN SUPPLIER DIVERSITY. ADDITIONALLY, ST. JUDE IS GOLD SPONSOR FOR THE MID-SOUTH MINORITY BUSINESS COUNCIL (MMBC) ECONOMIC DEVELOPMENT FAIR. THE MMBC SERVES AS THE MID-SOUTH'S FOREMOST MINORITY BUSINESS DEVELOPMENT ORGANIZATION. THE MMBC HELPS TO DEVELOP A STRONG MINORITY AND WOMEN BUSINESS COMMUNITY IN AN EFFORT TO IMPACT ECONOMICALLY THE ENTIRE MID-SOUTH REGION. IN 2021, THE PEDIATRIC ONCOLOGY EDUCATION PROGRAM BROUGHT IN THIRTY-THREE SUMMER STUDENTS FOR INTERNSHIPS IN BASIC SCIENCE OR CLINICAL RESEARCH. THE RHODES COLLEGE SUMMER PLUS PROGRAM ACCEPTS 15 STUDENTS INTO THE HOSPITAL'S RESEARCH LABORATORIES FOR A PERIOD OF ONE SUMMER, ONE ACADEMIC YEAR, AND A SECOND SUMMER. ADDITIONALLY, EXPERIENTIAL LEARNING INTERNSHIPS ARE STRUCTURED BY AND MANAGED BY ACADEMIC PROGRAMS IN MANY AREAS FROM SCIENCE TO ACCOUNTING. THESE PROGRAMS SUPPORT INCREASING THE AWARENESS OF CAREERS IN RESEARCH SCIENCE, HEALTHCARE, OR HEALTHCARE MANAGEMENT AND CONTRIBUTE TO PREPARING STUDENTS TO ENTER THESE CAREERS. THE CLINICAL EDUCATION AND TRAINING OFFICE HOSTS FORTY TO FIFTY STUDENTS ANNUALLY AS PATIENT CARE OBSERVERS. THESE STUDENTS ARE AT DIFFERENT STAGES OF TRAINING AND ARE FROM UNDERGRADUATE COLLEGES OR PROFESSIONAL HEALTHCARE SCHOOLS INCLUDING MEDICAL SCHOOLS. THE OBSERVERS ARE DECIDING ON OR CONFIRMING A DESIRE TO PURSUE A CAREER IN HEALTHCARE. THE FAMILY, GUEST, AND VOLUNTEER SERVICES DEPARTMENT PROVIDES SUMMER PROGRAMS FOR HIGH SCHOOL STUDENTS AND YEAR-ROUND PROGRAMS FOR COLLEGE STUDENTS. BOTH OF THESE PROGRAMS DRIVE ENTRY INTO HEALTH CAREERS. THE DEPARTMENT ALSO ENGAGES TWELVE FULL-TIME INTERNS, 4 EACH SEMESTER, WHO ARE EMBEDDED ON THE TEAM AND PREPARED FOR CAREERS IN NON-PROFIT LEADERSHIP OR HEALTHCARE MANAGEMENT. HOWEVER, DUE TO THE COVID-19 PANDEMIC, WE WERE FORCED TO SUSPEND ALL SUMMER PROGRAMS AND INTERNSHIPS IN 2021. THE OFFICE OF LEGAL SERVICES (OLS) OFFERS LEGAL INTERNSHIPS TO LOCAL (UNIVERSITY OF MEMPHIS, OLE MISS) LAW STUDENTS DURING THE ACADEMIC YEAR AND TO NATIONAL LAW SCHOOLS DURING THE SUMMER. INTERNS PERFORM LEGAL RESEARCH; DRAFT MEMORANDA, LETTERS, AND OTHER DOCUMENTS; DRAFT AND REVIEW CONTRACTUAL AGREEMENTS; PREPARE PRESENTATIONS TO ST. JUDE PERSONNEL; AND ASSIST WITH DRAFTING POLICIES. INTERNS ALSO LEARN THROUGH OBSERVATION OF AND PARTICIPATION IN DAY-TO-DAY LAW PRACTICE ACTIVITIES, INCLUDING LEGAL PROCEEDINGS, NEGOTIATIONS, MEETINGS, TRAININGS, AND COUNSELING SESSIONS. WHEN POSSIBLE, INTERNS WORK WITH CLIENT DEPARTMENTS AND DEPARTMENTAL STAFF TO GATHER INFORMATION AND TO GAIN INSIGHT INTO AND UNDERSTANDING OF RESEARCH, CLINICAL, BUSINESS, AND HEALTH CARE OPERATIONS. DUE TO COVID-19, OLS HAS TRANSITIONED THE INTERNSHIP PROGRAM TO REMOTE FORMAT. IN ADDITION, MEMBERS OF THE OFFICE OF LEGAL SERVICES ENGAGED IN THE FOLLOWING ACTIVITIES WITHIN THE MEMPHIS AND LARGER TENNESSEE COMMUNITIES: - SERVED AS CHAIR OF THE HEALTH LAW & POLICY ADVISORY BOARD OF THE CECIL C. HUMPHREYS SCHOOL OF LAW, UNIVERSITY OF MEMPHIS. - PRESENTED ON "IN-HOUSE COUNSEL PANEL" AT THE TENNESSEE BAR ASSOCIATION ANNUAL HEALTH LAW FORUM ON OCTOBER 9, 2020.- PRESENTED ON "THE COVID PLAYBOOK - HOW COMPANIES ARE RESPONDING TO PANDEMIC INDUCED CHANGE" AT THE SOCIETY FOR HUMAN RESOURCE MANAGEMENT MEMPHIS, ON MARCH 8, 2021.- SERVED ON THE TENNESSEE BAR ASSOCIATION HEALTH LAW SECTION EXECUTIVE COUNCIL.- FINALLY, THE CHIEF GOVERNMENT AFFAIRS OFFICER WORKED IN COLLABORATION WITH LEGAL STAFF AND OUTSIDE ADVOCACY GROUPS TO SUPPORT EFFORTS TO CREATE A STATE PALLIATIVE CARE/QUALITY OF LIFE ADVISORY COUNCIL.THE ST. JUDE CHIEF GOVERNMENT AFFAIRS OFFICER CONTINUES TO SERVE ON THE BOARD OF DIRECTORS OF THE MEMPHIS RIVER PARKS PARTNERSHIP (MRPP). THE MRPP IS A NON-PROFIT ORGANIZATION THAT, UNDER A LONG-TERM CONTRACT WITH THE CITY OF MEMPHIS, MANAGES ALL THE PARKS ALONG A 5-MILE STRETCH OF THE MEMPHIS RIVERFRONT INCLUDING ALONG DOWNTOWN MEMPHIS AND MUD ISLAND RIVER PARK. ELEMENTS ALONG THE RIVER FOSTER HEALTHY LIFESTYLES INCLUDING RIVERFIT, A SERIES OF PHYSICAL FITNESS CHALLENGES, AND A PLAYGROUND DESIGNED SPECIFICALLY FOR CHILDREN AT BEALE ST. LANDING, THE ONLY CHILD-DESIGNATED PLAYGROUND ON THE MEMPHIS RIVERFRONT. THE MRPP IS ALSO WORKING WITH THE CITY OF MEMPHIS TO IMPLEMENT A SERIES OF IMPROVEMENTS DESIGNED TO TIE THE RIVERFRONT CLOSER TO WORKERS AND RESIDENTS OF DOWNTOWN MEMPHIS TO MAKE ACCESS TO RIVERFRONT AMENITIES EASIER FOR ALL CITIZENS OF MEMPHIS AND TOURISTS VISITING THE CITY. AS PART OF THESE ADVOCACY EFFORTS, MRPP WAS AWARDED $10M IN STATE FUNDING TO UPGRADE TOM LEE PARK ON THE MEMPHIS RIVER FRONT.THE ST. JUDE CHIEF GOVERNMENT AFFAIRS OFFICER CONTINUES TO SERVE ON THE BOARD OF COMMISSIONERS OF THE MEMPHIS AREA TRANSIT AUTHORITY (MATA). IN THIS CAPACITY, HE HELPS TO PROMOTE THE HEALTH OF THE COMMUNITY BY ADVOCATING FOR POLICIES THAT ENABLE ENHANCED MOBILITY FOR A LARGER PERCENTAGE OF THE POPULATION OF MEMPHIS AND SHELBY COUNTY.THE CHIEF LEGAL OFFICER IS A BOARD MEMBER OF THE MEMPHIS CHILD ADVOCACY CENTER, WHICH HELPS LOCAL CHILDREN FIND SAFETY AND HEALING (INCLUDING ACCESS TO A MENTAL HEALTH PROFESSIONAL) AFTER A REPORT OF SEXUAL OR OTHER SEVERE ABUSE AND OFFERS ABUSE PREVENTION TRAINING TO COMMUNITY VOLUNTEERS AND PARENTS. THE CHIEF LEGAL OFFICER, AS CHAIR OF THE ADVISORY BOARD OF THE INSTITUTE FOR HEALTH LAW & POLICY OF THE CECIL C. HUMPHREYS UNIVERSITY OF MEMPHIS SCHOOL OF LAW, ENDEAVORS TO ADDRESS UNMET HEALTH LAW NEEDS OF THE LOCAL COMMUNITY AND WORK WITH COMMUNITY LEADERS TO PROACTIVELY ADDRESS HEALTH POLICY NEEDS.THE MANAGING COUNSEL FOR HEALTH AFFAIRS SERVES ON THE BOARD OF THE MEMPHIS BAR ASSOCIATION HEALTH LAW SECTION AND AS A MEMBER FOR THE DIVERSITY MENTORSHIP PROGRAM, ADVANCELAW.COM. THE ASSOCIATE COUNSEL SERVES ON THE MEMPHIS BAR ASSOCIATION HEALTH LAW SECTION BOARD. THE ASSOCIATE COUNSEL, MANAGING COUNSEL AND CHIEF LEGAL OFFICER ALSO REGULARLY PARTICIPATE IN THE HEALTH LAW SECTION'S VOLUNTEER EVENTS, WHICH INCLUDE SPONSORING A SATURDAY LEGAL CLINIC PROVIDING UNREPRESENTED MEMBERS OF THE COMMUNITY AN OPPORTUNITY TO MEET WITH A VOLUNTEER ATTORNEY AND DISCUSS LEGAL ISSUES, INCLUDING THOSE THAT HAVE AN IMPACT ON PERSONAL HEALTH. THE CHIEF LEGAL OFFICER AND THE MANAGING COUNSEL FOR HEALTH AFFAIRS BOTH MENTOR LAW STUDENTS FROM THE UNIVERSITY OF MEMPHIS'S CECIL C. HUMPHREYS SCHOOL OF LAW. THE MANAGER OF THE CANCER EDUCATION AND OUTREACH PROGRAM IN THE ST. JUDE COMPREHENSIVE CANCER CENTER DEDICATES 80% OF HER TIME, AND THE COORDINATOR FOR CANCER EDUCATION DEDICATES 100% OF HER TIME TO CANCER EDUCATION OUTREACH, INCLUDING ACTIVITIES SUCH AS K-12 CURRICULUM DEVELOPMENT, SCHOOL VISITS FOR CANCER AND HEALTHY LIVING EDUCATION, CAREER TALKS, TEACHER TRAINING WORKSHOPS AND PUBLIC-ACCESS WEBSITE DEVELOPMENT. THE CANCER EDUCATION AND OUTREACH PROGRAM PROVIDES ACCESS TO CAREER DEVELOPMENT FOR K-12 STUDENTS FROM UNDERREPRESENTED POPULATIONS IN SCIENCE BY PARTNERING WITH LOCAL SCHOOLS TO OFFER FORMAL AND INFORMAL SCIENCE EDUCATION PROGRAMMING. EXISTING EDUCATIONAL EFFORTS OF THE SJCCC CANCER EDUCATION AND OUTREACH PROGRAM INCLUDE:THE ST. JUDE AFTERSCHOOL STEM CLUBS, A PARTNERSHIP WITH THE SHELBY COUNTY SCHOOL DISTRICT, IS DESIGNED TO PROVIDE 5TH-GRADE STUDENTS OPPORTUNITIES TO ENGAGE IN SCIENCE AND ENGINEERING CONCEPTS IN AN INFORMAL SETTING. DURING THE 2020-2021 SCHOOL YEAR, THE SJCCC CANCER EDUCATION AND OUTREACH PROGRAM FACILITATED AFTERSCHOOL STEM CLUBS IN 18 ELEMENTARY SCHOOLS TO 54 5TH-GRADE STUDENTS. |
| THE ST. JUDE COMMUNITY HEALTH CLUBS, A PARTNERSHIP WITH THE SHELBY COUNTY | SCHOOL DISTRICT, IS DESIGNED TO PROVIDE STUDENTS IN GRADES 6-8 OPPORTUNITIES TO DEVELOP INTERVENTIONS TO REDUCE CANCER HEALTH DISPARITIES IN THEIR COMMUNITY. DURING THE 2020-2021 SCHOOL YEAR, THE SJCCC CANCER EDUCATION AND OUTREACH PROGRAM PILOTED AN AFTERSCHOOL COMMUNITY HEALTH CLUB IN ONE MIDDLE SCHOOL TO 12 STUDENTS IN GRADES 6-8. THE ST. JUDE SCIENCE AMBASSADORS CLASSROOM, A FOUR-PART PROFESSIONAL DEVELOPMENT EXPERIENCE AIMED TO IMPROVE SCIENTISTS' SCIENCE COMMUNICATION SKILLS THROUGH STORYTELLING, REDUCING JARGON, SIMPLIFYING FOR UNDERSTANDING, AND PROMOTING AUDIENCE INTERACTION THROUGH A VIRTUAL PLATFORM. THROUGHOUT THE SERIES, SCIENTISTS PRODUCED A LAY SUMMARY AND PRESENTATION RELATED TO A JOURNAL ARTICLE THAT THEY EITHER AUTHORED OR WAS CLOSELY RELATED TO THEIR AREA OF RESEARCH. THE PRESENTATION IS THEN DELIVERED TO HIGH SCHOOL STUDENTS DURING THE ST. JUDE VIRTUAL SCIENCE JOURNAL CLUB (SEE BELOW). DURING FALL 2020, 5 ST. JUDE SCIENTISTS PARTICIPATED IN THE ST. JUDE SCIENCE AMBASSADORS CLASSROOM.THE ST. JUDE VIRTUAL SCIENCE JOURNAL CLUB, WHICH CONSISTS OF THREE SESSIONS IN WHICH A ST. JUDE SCIENTIST "VISITS" THE CLASSROOM VIA A VIRTUAL PLATFORM TO DISCUSS FINDINGS FROM A SCIENTIFIC JOURNAL. DURING SPRING 2021, THE ST. JUDE VIRTUAL SCIENCE JOURNAL CLUB WAS HOSTED IN 5 AP BIOLOGY CLASSROOMS AT 3 SCHOOLS IN SHELBY COUNTY AND 2 SCHOOLS IN THE SPRINGFIELD PUBLIC SCHOOL DISTRICT AT THE SPRINGFIELD, MO ST. JUDE AFFILIATE SITE, REACHING A TOTAL OF 57 STUDENTS. THE KINDERGARTEN STEM COLLABORATIVE, A TEACHER PROFESSIONAL DEVELOPMENT AND CURRICULUM WRITING COLLABORATIVE AIMED AT INCREASING THE QUALITY AND QUANTITY OF STEM EDUCATIONAL EXPERIENCE IN THE KINDERGARTEN CLASSROOM. IN THE 2020-2021 SCHOOL YEAR, THE PROGRAM ENGAGED 21 KINDERGARTEN TEACHERS ACROSS 6 SCHOOLS WHO IMPLEMENTED THE CURRICULUM TO MORE THAN 400 STUDENTS.IN ADDITION, THE CANCER EDUCATION AND OUTREACH PROGRAM OFFERS AN INTERNSHIP EXPERIENCE TO LOCAL COLLEGE STUDENTS IN THE MEMPHIS AREA MAJORING IN EITHER A SCIENCE OR SCIENCE EDUCATION. INTERNS FACILITATE AFTERSCHOOL STEM PROGRAMMING IN LOCAL K-12 LICENSED EDUCATION AGENCIES (LEAS). |
| PART III, LINE 2: | BAD DEBT EXPENSE IS EQUAL TO CHARGES ON ACCOUNTS DETERMINED TO BE UNCOLLECTIBLE. SEE NARRATIVE FOR PART I, LINE 3C REGARDING THE ORGANIZATION'S FINANCIAL ASSISTANCE POLICY.THERE WERE NO UNCOLLECTIBLE ACCOUNTS IN THE CURRENT YEAR. |
| PART III, LINE 4: | BAD DEBT EXPENSE EXPLANATION IN FINANCIAL STATEMENTS FOOTNOTES IS AS FOLLOWS:NET PATIENT SERVICE REVENUES - NET OPERATING REVENUES ARE RECORDED AT THE TRANSACTION PRICE ESTIMATED BY THE HOSPITAL TO REFLECT THE TOTAL CONSIDERATION DUE FROM THIRDPARTY PAYORS IN EXCHANGE FOR PROVIDING GOODS AND SERVICES IN PATIENT CARE. THESE SERVICES ARE CONSIDERED TO BE A SINGLE PERFORMANCE OBLIGATION AND HAVE A DURATION OF LESS THAN ONE YEAR. REVENUES ARE RECORDED AS THESE GOODS AND SERVICES ARE PROVIDED. THE TRANSACTION PRICE, WHICH INVOLVES SIGNIFICANT ESTIMATES, IS DETERMINED BASED ON THE HOSPITAL'S STANDARD CHARGES FOR THE GOODS AND SERVICES PROVIDED, WITH A REDUCTION RECORDED FOR PRICE CONCESSIONS RELATED TO THIRD PARTY CONTRACTUAL ARRANGEMENTS AS WELL AS OTHER IMPLICIT PRICE CONCESSIONS.ST. JUDE CHILDREN'S RESEARCH HOSPITAL DOES NOT CONSIDER BAD DEBT EXPENSE A COMMUNITY BENEFIT. |
| PART III, LINE 8: | ST. JUDE CHILDREN'S RESEARCH HOSPITAL DOES NOT CONSIDER THE MEDICARE SHORTFALL A COMMUNITY BENEFIT. THE COST TO CHARGE RATIO WAS USED TO DETERMINE MEDICARE ALLOWABLE COSTS OF CARE. |
| PART III, LINE 9B: | ALL PATIENTS ACCEPTED FOR ST. JUDE TREATMENT RECEIVE CARE WHETHER OR NOT THEY OR THEIR FAMILIES CAN PAY FOR IT. ST. JUDE DOES HAVE A BILLING SYSTEM, BUT PATIENTS DO NOT RECEIVE BILLS. IF THE PATIENT HAS INSURANCE, ST. JUDE BILLS THE INSURANCE PLAN OR OTHER ORGANIZATION THAT PAYS HEALTH COSTS. THIS IS SET FORTH IN OUR FINANCIAL ASSISTANCE STATEMENT (HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-STATEMENT.HTML) AND FINANCIAL ASSISTANCE POLICY (HTTPS://WWW.STJUDE.ORG/ LEGAL/FINANCIAL-ASSISTANCE-POLICY.HTML). |
| PART VI, LINE 2: | ST. JUDE'S PRIMARY CLINICAL EFFORT CENTERS ON PROVIDING GROUND-BREAKING, RESEARCH-DRIVEN TREATMENTS FOR CHILDHOOD CANCERS AND OTHER CATASTROPHIC DISEASES IN CHILDREN. CANCERPEDIATRIC CANCERS ARE RARE COMPARED TO ADULT CANCERS. ONLY 10,050 NEW CASES ARE EXPECTED TO OCCUR AMONG CHILDREN 14 YEARS OF AGE AND YOUNGER IN 2021; HOWEVER, CANCER IS THE LEADING CAUSE OF DISEASE-RELATED DEATH IN U.S. CHILDREN (FOOTNOTE 1). THE PRINCIPAL FOCUS OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL IS CANCER. SEVENTY-FIVE PERCENT OF ALL RESOURCES AT ST. JUDE ARE INVESTED IN ELUCIDATING BASIC BIOLOGICAL MECHANISMS OF PEDIATRIC CANCERS AND TRANSLATING THIS KNOWLEDGE INTO IMPROVED DIAGNOSTIC TOOLS AND CURATIVE THERAPIES, WHILE MINIMIZING LONG-TERM SIDE EFFECTS. AS THE FIRST AND ONLY NATIONAL CANCER INSTITUTE-DESIGNATED COMPREHENSIVE CANCER CENTER FOCUSED EXCLUSIVELY ON CHILDREN, ST. JUDE SERVES AS A NATIONAL RESOURCE FOR RESEARCH AND TREATMENT OF PEDIATRIC CANCERS. OUR INITIATIVES ARE DESIGNED TO IMPACT PEDIATRIC CANCER TREATMENT ON A LOCAL, REGIONAL, NATIONAL AND GLOBAL SCALE. OUR CANCER PATIENTS COME FROM ALL OVER THE UNITED STATES AND ABROAD; HOWEVER, 66% OF THE NEW CANCER PATIENTS WE REGISTER RESIDE IN THE ST. JUDE CATCHMENT AREA, WHICH INCLUDES A 180-MILE RADIUS AROUND ST. JUDE LOCATED IN MEMPHIS, TN AND A 100-MILE RADIUS AROUND EACH OF OUR EIGHT AFFILIATES. THESE EIGHT AFFILIATES ARE IN HUNTSVILLE, AL, CHARLOTTE, NC, JOHNSON CITY, TN, BATON ROUGE, LA, SHREVEPORT, LA, TULSA, OK, SPRINGFIELD, MO, AND PEORIA, IL. THE CATCHMENT POPULATION IS GENERALLY CHARACTERIZED BY A HIGHER PROPORTION OF NON-HISPANIC BLACK/AFRICAN AMERICAN RACE, LOWER PROPORTION OF HISPANIC ETHNICITY, LOWER HOUSEHOLD INCOMES AND HOME VALUES, AND LOWER PROPORTION WITH AN EDUCATION BEYOND HIGH SCHOOL. APPROXIMATELY 4.9% OF THE POPULATION LIVE IN RURAL AREAS (BY RUCA CODE 10). TAKEN TOGETHER, THIS DIVERSE POPULATION INCLUDES MANY WITH LIMITED RESOURCES WHO ARE MEDICALLY UNDERSERVED. THROUGH ST. JUDE'S FOUNDING POLICY - THAT NO PATIENT BE DENIED TREATMENT BASED ON RACE, ETHNICITY, RELIGION, OR A FAMILY'S INABILITY TO PAY - AND WITH THE PROVISION OF RESOURCES TO OFFSET THE COSTS OF TRANSPORTATION AND HOUSING DURING CLINIC VISITS AND TREATMENT, WE REMOVE BARRIERS IN ACCESS TO OUR CUTTING-EDGE CLINICAL RESEARCH TRIALS AND EXCEPTIONAL CLINICAL CARE. ALL PEDIATRIC PATIENTS IN OUR CATCHMENT AREA ARE ACCEPTED TO ST. JUDE FOR TREATMENT OF THEIR CANCER.THE DEMOGRAPHICS OF THE PEDIATRIC CANCER POPULATION TREATED AT ST. JUDE CLOSELY MATCH THOSE OF OUR CATCHMENT AREA (BASED ON 2010 DATA FROM THE US CENSUS BUREAU) AND ALIGN WITH THE ESTIMATED INCIDENCE OF PEDIATRIC CANCER IN REPRESENTED RACIAL AND ETHNIC GROUPS (BASED ON SURVEILLANCE EPIDEMIOLOGY AND END RESULTS [SEER] 2009 DATA), CONFIRMING THAT ST. JUDE IS CLOSELY ALIGNED WITH THE NEEDS OF THE POPULATION IT SERVES. DEMOGRAPHICS FROM THE ST. JUDE PEDIATRIC CANCER COHORT ARE COMPARED WITH THE DEMOGRAPHICS OF THE CATCHMENT AREA ANNUALLY TO MONITOR DEMOGRAPHIC REPRESENTATION OF OUR CANCER PATIENTS IN RELATION TO THE AREA THAT WE SERVE. THERE ARE NO KNOWN DIFFERENCES IN PEDIATRIC CANCER INCIDENCE BY GEOGRAPHIC REGION IN THE U.S. CONSEQUENTLY, IT IS NOT POSSIBLE TO CATER OUR CLINICAL TRIALS TO TARGET PEDIATRIC CANCERS SPECIFICALLY PREVALENT IN OUR CATCHMENT AREA. WHILE NUMEROUS ADULT CANCERS HAVE BEEN SHOWN TO HAVE HIGH VARIATION IN INCIDENCE RATES ACROSS RACES AND ETHNICITIES, THE SITUATION IS LESS CLEAR IN PEDIATRIC CANCER, WHERE FEWER DISCREPANCIES HAVE BEEN IDENTIFIED. ALTHOUGH OUR CATCHMENT AREA HAS A HIGHER PROPORTION OF AFRICAN-AMERICAN PATIENTS THAN THE GENERAL U.S. POPULATION, THERE ARE VERY FEW EXAMPLES OF PEDIATRIC CANCERS IN WHICH THE INCIDENCE IS HIGHER IN RACIAL AND/OR ETHNIC MINORITIES (FOOTNOTES 2 AND 3). CONSEQUENTLY OUR RESEARCH AND CLINICAL TRIALS ADDRESS THE MOST PRESSING PROBLEMS IN PEDIATRIC CANCER. ST. JUDE OFFERS THERAPEUTIC TRIALS FOR THE TOP PEDIATRIC CANCERS (FOOTNOTE 1) INCLUDING ACUTE LYMPHOBLASTIC LEUKEMIA, MEDULLOBLASTOMA, NEUROBLASTOMA, HODGKIN LYMPHOMA, RETINOBLASTOMA, RHABDOMYOSARCOMA AND OTHERS. MANY OF THESE TRIALS ARE INSTITUTIONALLY SPONSORED; HOWEVER, ST. JUDE ALSO PARTICIPATES IN SEVERAL CLINICAL TRIALS CONSORTIA PROVIDING OUR CANCER PATIENTS ACCESS TO A VARIETY OF THERAPEUTIC STUDIES. PEDIATRIC CANCER PATIENTS MAY EXPERIENCE TREATMENT-RELATED SIDE EFFECTS MANY YEARS AFTER DIAGNOSIS. THE CHILDHOOD CANCER SURVIVOR STUDY AND ST. JUDE LIFE ARE TWO STUDIES, ACTIVE AT ST. JUDE, ASSESSING LATE EFFECTS OF CANCER THERAPY ON PEDIATRIC CANCER SURVIVORS. INFORMATION FROM THESE STUDIES WILL BE USED TO DEFINE RISK GROUPS FOR VARIOUS LATE EFFECTS AND ASSESS INTERVENTIONS.COMMUNITY OUTREACH AND ENGAGEMENT (COE) AT THE ST. JUDE COMPREHENSIVE CANCER CENTER (SJCCC) PROMOTES A COORDINATED APPROACH TO ENSURING THAT CHILDREN WHO HAVE CANCER, CHILDREN WHO HAVE SURVIVED CANCER, AND HEALTHY CHILDREN ALL BENEFIT FROM CUTTING-EDGE SCIENCE, CLINICAL CARE, AND PREVENTION EFFORTS PROVIDED BY THE SJCCC. THESE COE ACTIVITIES SPAN LOCAL, NATIONAL, AND GLOBAL GEOGRAPHIC AREAS THROUGH THE COLLECTIVE IMPACT OF THE ST. JUDE GLOBAL PEDIATRIC MEDICINE PROGRAM, CANCER EDUCATION AND OUTREACH PROGRAM IN SCHOOLS, TOGETHER WEBSITE AND COMMUNITY, ST. JUDE AFFILIATE NETWORK, AND THE ST. JUDE HPV CANCER PREVENTION PROGRAM. THE ST. JUDE PATIENT FAMILY ADVISORY COUNCIL (PFAC) PROVIDES THE OPPORTUNITY FOR COE TO ENGAGE PATIENTS AND FAMILIES. A MEMBER OF THE COE LEADERSHIP TEAM JOINED THE PFAC AS A STAFF CHAMPION, ATTENDS MONTHLY MEETINGS, AND FACILITATES CONNECTIONS, AND SUPPORTS COMMUNICATION BETWEEN THE PFAC AND THE COE.A KEY AREA THAT ST. JUDE IS PROMOTING IN OUR CATCHMENT AREA AND BEYOND IS PREVENTION OF HPV-RELATED CANCERS. THE AMERICAN CANCER SOCIETY AND OTHER NATIONAL ORGANIZATIONS HAVE PUT FORTH THE GOAL TO ERADICATE HPV-RELATED CANCERS THROUGH HPV VACCINATION AND TIMELY EARLY DETECTION EFFORTS. NEARLY 80 MILLION INDIVIDUALS IN THE U.S. - 1 OUT OF EVERY 4 PEOPLE - ARE INFECTED WITH HUMAN PAPILLOMAVIRUS (HPV). APPROXIMATELY 36,000 CANCERS ARE ATTRIBUTABLE TO HPV OCCUR EACH YEAR (FOOTNOTE 4). U.S. VACCINATION RATES REMAIN SIGNIFICANTLY LOWER FOR HPV THAN FOR OTHER RECOMMENDED ADOLESCENT VACCINES. ACCORDING TO 2020 DATA FROM THE CDC, 90% OF 13 - 17 YEAR OLDS HAVE BEEN VACCINATED WITH TDAP AND 89% HAVE HAD AT LEAST ONE DOSE OF MENINGOCOCCAL CONJUGATE COMPARED TO ONLY 59% UP-TO-DATE WITH HPV VACCINATION (HAVE RECEIVED ALL DOSES IN THE SERIES). BY SEX, 61% OF GIRLS AND APPROXIMATELY 56% OF BOYS AGED 13-17 ARE UP-TO-DATE ON THE HPV VACCINE (FOOTNOTE 5). IN 2020, TENNESSEE'S COMBINED HPV VACCINATION COVERAGE (UP-TO-DATE) FOR MALES AND FEMALES AGED 13-17 IS ONLY 53%, WHICH RANKS NEAR THE BOTTOM IN THE NATION. SIMILAR TRENDS IN LOW HPV VACCINATION UPTAKE ARE OBSERVED IN OTHER STATES INCLUDED IN THE ST. JUDE CATCHMENT AREA OF THE MID-SOUTH AND SOUTHEAST RANGING FROM THE HIGHEST UP-TO-DATE RATES OF HPV VACCINATION IN LOUISIANA (60%) TO THE LOWEST IN MISSISSIPPI (31%). RESIDENTS OF TENNESSEE AND THE MID-SOUTH AND SOUTHEASTERN U.S. HAVE AMONG THE HIGHEST INCIDENCE OF HPV-RELATED CANCERS IN THE COUNTRY (FOOTNOTE 4). AS THE ONLY NCI-DESIGNATED CANCER CENTER DEVOTED SOLELY TO CHILDREN, ST. JUDE IS COMMITTED TO TAKING ON A NEW LEADERSHIP ROLE IN PROTECTING YOUNG PEOPLE FROM PREVENTABLE HPV-ASSOCIATED CANCERS LATER IN LIFE. COINCIDING WITH INTERNATIONAL HPV AWARENESS DAY (03/04/21), ST. JUDE'S HPV CANCER PREVENTION PROGRAM (HPV CPP) OFFICIALLY LAUNCHED, CONDUCTING SEVERAL PRESENTATIONS, INTERNAL AND EXTERNAL COMMUNICATIONS CAMPAIGNS, AND PARTNER MAILINGS TO APPROXIMATELY 800 INDIVIDUALS. THROUGHOUT THE FIRST YEAR OF THE PROGRAM, TEAM MEMBERS ESTABLISHED INFRASTRUCTURE FOCUSED ON GALVANIZING EXISTING SUCCESSFUL EFFORTS AND STRATEGIZED ON WAYS TO CONTRIBUTE TO EMERGENT EFFORTS. TO SHARE THE LATEST INFORMATION ON HOW TO INCREASE UPTAKE OF HPV VACCINATION, APPROXIMATELY 300 COMMUNITY PARTNERS ATTENDED A VIRTUAL SEMINAR ENTITLED CAPITALIZING ON OPPORTUNITIES TO PREVENT HPV CANCERS WE ORGANIZED. CONTENT EXPERTS DISCUSSED THE GROWING BODY OF EVIDENCE SHOWING THE EFFECTIVENESS OF HPV VACCINATION IN PREVENTING CANCER, TRENDS IN HPV VACCINATION COVERAGE, AND EMERGING DATA ON THE EFFECTS OF THE COVID-19 PANDEMIC ON HPV VACCINATION. PROGRAM STAFF FORGED RELATIONSHIPS BY PARTICIPATING IN REGIONAL AND STATE-LEVEL PUBLIC HEALTH, CANCER CONTROL, AND IMMUNIZATION WORKGROUPS ACROSS FOUR STATES (TN, MS, AR, MO) AND CONDUCTED A LANDSCAPE ASSESSMENT TO IDENTIFY OPPORTUNITIES FOR INTERVENTIONS. THE HPV PROGRAM CONDUCTED A POLICY ANALYSIS OF STATE (TENNESSEE) AND REGIONAL (MID-SOUTH AND SOUTHEASTERN U.S.) POLICIES PROMOTING OR HINDERING HPV VACCINATION AND FACILITATED A VIRTUAL SEMINAR, A LOOK AT STATE POLICY AND A PATH FORWARD. (NOTE: THIS NARRATIVE FOR PART VI, LINE 2 IS CONTINUED BELOW) - SEE PAGE 115/151 |
| PART VI, LINE 3: | AS NOTED IN PART I, LINE 3C, NO FAMILY EVER PAYS ST. JUDE FOR TREATMENT. IN ADDITION, ST. JUDE PROVIDES AN UNPARALLELED LEVEL OF SUPPORT SERVICES AT NO COST TO FAMILIES. WE ALSO HAVE PROGRAMS TO ASSIST FAMILIES IN ENROLLING IN VARIOUS PUBLIC ASSISTANCE PROGRAMS FOR WHICH THEY MAY QUALIFY, INCLUDING BUT NOT LIMITED TO TENNCARE/MEDICAID, COVERKIDS, CHIPS AND SOCIAL SECURITY. FAMILIES ALSO HAVE ACCESS TO AN ONLINE EDUCATIONAL RESOURCE TITLED "YOU AND THE AFFORDABLE CARE ACT" (HTTPS://WWW.STJUDE.ORG/TREATMENT/PATIENT-RESOURCES/CAREGIVER-RESOURCES/PATIENT-FAMILY-EDUCATION-SHEETS/LEGAL-FINANCIAL/YOU-AND-THE-AFFORDABLE-CARE-ACT.HTML). THIS ENSURES AN APPROPRIATE SAFETY NET SHOULD THE FAMILY SEEK TREATMENT OUTSIDE OF ST. JUDE AND IT ALLOWS US TO BE GOOD STEWARDS OF DONOR DOLLARS. WE UTILIZE AN OUTSIDE CONTRACTOR TO PROVIDE APPLICATION ASSISTANCE. THE HOSPITAL'S FINANCIAL ASSISTANCE STATEMENT (HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-STATEMENT.HTML) AND FINANCIAL ASSISTANCE POLICY (HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-POLICY.HTML) ARE POSTED ON THE HOSPITAL'S WEBSITE AND AVAILABLE AT REGISTRATION. THE DOCUMENTS ARE AVAILABLE IN ENGLISH AND SPANISH. FOR FAMILIES SPEAKING OTHER LANGUAGES, WE UTILIZE ONSITE INTERPRETER SERVICES AND/OR PROFESSIONAL CONTRACTED INTERPRETATION AND TRANSLATION SERVICES. |
| PART VI, LINE 4: | ST. JUDE CHILDREN'S RESEARCH HOSPITAL IN MEMPHIS, TENNESSEE, IS A SPECIALTY HOSPITAL THAT TREATS PEDIATRIC CATASTROPHIC DISEASES WITH A FOCUS ON CANCER, INFECTIOUS DISEASES, BLOOD DISORDERS AND NEUROLOGICAL DISEASES. MOST PATIENTS AT ST. JUDE ARE REFERRED BY A PHYSICIAN, DIAGNOSED WITH A DISEASE CURRENTLY UNDER STUDY, AND ELIGIBLE FOR A RESEARCH PROTOCOL. ST. JUDE IS THE ONLY PEDIATRIC RESEARCH CENTER FOR CHILDREN WITH CATASTROPHIC DISEASES, INCLUDING CANCER AND BLOOD DISORDERS, WHERE FAMILIES NEVER PAY FOR TREATMENT NOT COVERED BY INSURANCE. IN FACT, NO FAMILY RECEIVES A BILL FROM ST. JUDE FOR TRANSPORTATION, HOUSING OR FOOD. NO CHILD IS EVER DENIED TREATMENT DUE TO RACE, SEX, NATIONALITY, ETHNICITY, RELIGION, OR THE FAMILY'S ABILITY TO PAY. THE COMMUNITY SERVED BY ST. JUDE CAN BEST BE DEFINED BY UNDERSTANDING THE PATIENT POPULATION AND SCOPE OF CLINICAL SERVICES AT ST. JUDE. THE INSTITUTION SERVES AS A NATIONAL REFERRAL CENTER FOR CHILDREN WITH CATASTROPHIC DISEASES, SUCH AS CANCER BLOOD DISORDERS, NEUROLOGICAL DISEASES AND HIV/AIDS. IT DOES NOT ADMIT CHILDREN FOR ANY DIAGNOSTIC GROUPS OUTSIDE OF THESE SERVICES AND DOES NOT OFFER MEDICAL SERVICES BEYOND THOSE NECESSARY TO CARE FOR CHILDREN WITH THESE DISEASES. ST. JUDE DOES NOT HAVE AN EMERGENCY ROOM (ER). MOST PATIENTS ARE REFERRED BY A MEDICAL PROFESSIONAL EXTERNAL TO ST. JUDE, TYPICALLY THE CHILD'S PEDIATRICIAN OR A PEDIATRIC SUBSPECIALIST, PRIOR TO RECEIVING TREATMENT ST. JUDE. ST. JUDE'S PRIMARY CLINICAL EFFORTS CENTER ON PROVIDING GROUNDBREAKING, RESEARCH-DRIVEN TREATMENTS. SPECIFICALLY, ABOUT 8,600 PATIENTS ARE SEEN AT ST. JUDE YEARLY, MOST OF WHOM ARE ENROLLED ON CLINICAL TRIALS FOR NEW TREATMENTS DEVELOPED BY ST. JUDE, AND WHO ARE TREATED ON A CONTINUOUS OUTPATIENT BASIS. THE HOSPITAL HAS 77 OPERATIONAL BEDS FOR PATIENTS REQUIRING HOSPITALIZATION DURING TREATMENT, WITH A LICENSE TO GO UP TO 80 BEDS. IT SHOULD BE NOTED THAT ST. JUDE CARES FOR A SIGNIFICANT PORTION OF PATIENTS ON AN OUTPATIENT BASIS, RATHER THAN RESTRICTING TREATMENT TO AN INPATIENT UNIT. THIS IS ACCOMPLISHED THROUGH PATIENT HOUSING DEDICATED SOLELY TO ST. JUDE PATIENTS AND FAMILIES DESIGNED WITH INFECTION CONTROL MEASURES SUCH AS HEPA FILTRATION, INFECTION-RESISTANT SURFACES AND OTHER MEDICAL SAFEGUARDS NOT AVAILABLE IN HOTELS OR PATIENTS' HOMES. ST. JUDE HAS A NETWORK OF EIGHT AFFILIATED PEDIATRIC HEMATOLOGY/ONCOLOGY CLINICS IN THE U.S., ALLOWING ST. JUDE TO EXTEND CARE AND BENEFITS TO MORE CHILDREN AND INCREASE THE NUMBER OF CHILDREN TREATED ON ST. JUDE CLINICAL TRIALS.ST. JUDE ALSO OPERATES THE ST. JUDE GLOBAL INITIATIVE THROUGH GLOBAL PEDIATRIC MEDICINE (GPM), AIMED AT IMPROVING SURVIVAL RATES OF CHILDREN WITH CANCER AND OTHER CATASTROPHIC DISEASES WORLDWIDE. ST. JUDE ACCOMPLISHES THIS BY SHARING KNOWLEDGE, TECHNOLOGY AND ORGANIZATIONAL SKILLS, IMPLEMENTING NEW APPROACHES TO TREAT PEDIATRIC CANCER GLOBALLY, AND GENERATING INTERNATIONAL NETWORKS COMMITTED TO ERADICATING CANCER IN CHILDREN. IT IS ESTIMATED THAT MORE THAN 400,000 CHILDREN WORLDWIDE DEVELOP CANCER EACH YEAR NEARLY HALF OF WHOM ARE NEVER DIAGNOSED. APPROXIMATELY, 90% OF THESE CHILDREN WITH CANCER LIVE IN LOW- AND MIDDLE-INCOME COUNTRIES. CANCER IS EMERGING AS A MAJOR CAUSE OF CHILDHOOD DEATH IN ALL DEVELOPING COUNTRIES, REPLACING OTHER CAUSES OF CHILDHOOD MORTALITY (E.G., HIV, MALNUTRITION, INFECTIONS). DESPITE VAST IMPROVEMENTS IN THERAPY AND SURVIVAL IN HIGH-INCOME COUNTRIES OVER THE PAST 30 YEARS, AN ESTIMATED 60% DO NOT HAVE ACCESS TO ADEQUATE DIAGNOSIS AND MODERN CARE. ST. JUDE STRIVES TO ADDRESS THE NEEDS OF THOSE CHILDREN IN COUNTRIES THAT LACK SUFFICIENT RESOURCES AND HELP THEM MANAGE THEIR OWN BURDEN OF CASES EFFECTIVELY.WHILE SICK CHILDREN FROM AROUND THE WORLD HAVE TRAVELED TO OUR HOSPITAL IN MEMPHIS, RECEIVING TREATMENT IN THEIR OWN COUNTRIES IS MORE EFFICIENT AND LESS DISRUPTIVE FOR THEM AND THEIR FAMILIES. AS A RESULT OF OUR INTERNATIONAL EFFORTS, WE ARE ABLE TO REACH FAR MORE CHILDREN THAN WOULD EVER BE ABLE TO COME TO MEMPHIS. A BASIC HEALTHCARE INFRASTRUCTURE IS NEEDED TO SUPPORT PEDIATRIC ONCOLOGY PROGRAMS, WHICH IN TURN FURTHER IMPROVES THE DEVELOPMENT OF BASIC HEALTHCARE. AT THE LOCAL LEVEL, ST. JUDE GLOBAL DEVELOPS PARTNERSHIPS WITH MEDICAL INSTITUTIONS AND FUND-RAISING ORGANIZATIONS AND FACILITATES THE INVOLVEMENT OF GOVERNMENT AND OTHER ORGANIZATIONS TO SUPPORT KEY PROGRAMS AND THE EDUCATION OF LOCAL PERSONNEL. AT THE REGIONAL LEVEL, ST. JUDE GLOBAL DEVELOPS PROGRAMS THROUGH THE USE OF TECHNOLOGY AND FOSTERS REGIONAL AND INTERNATIONAL COLLABORATIONS WITH OTHER PEDIATRIC MEDICAL INSTITUTIONS THROUGH THE ST. JUDE GLOBAL ALLIANCE. THE PRIMARY GOAL IS TO DEVELOP LOCAL AND REGIONAL SELF-SUFFICIENCY. THIS MODEL RESULTS IN SIGNIFICANT OVERALL IMPROVEMENT IN HEALTHCARE FACILITIES, THE LEVEL OF PRACTICE, THE CONFIDENCE OF HEALTHCARE PROVIDERS, AND LOCAL COMMUNITY INVOLVEMENT. ST. JUDE EMPHASIZES THE BUILDING OF REGIONAL EXPERTISE AND DIAGNOSTIC CAPABILITIES, WHICH PROVIDE A CRITICAL MASS OF PROFESSIONALS WHO CONTINUALLY LEARN FROM AND ASSIST EACH OTHER. COST EFFICIENCY IS ALSO REALIZED BECAUSE OF SHARED RESOURCES.THE ST. JUDE GLOBAL ALLIANCE IS A GLOBAL NETWORK ESTABLISHED TO PURSUE THE SHARED VISION OF IMPROVING THE QUALITY OF HEALTH CARE DELIVERY AND INCREASING SURVIVAL RATES OF CHILDREN WITH CANCER AND BLOOD DISORDERS WORLDWIDE. CURRENTLY, THE ALLIANCE HAS RECEIVED APPLICATIONS FROM 153 MEDICAL INSTITUTIONS IN 57 COUNTRIES WITH ESTABLISHED PARTNERSHIPS WITH 121 OF THE MEDICAL INSTITUTIONS IN 57 COUNTRIES. MEMBERS OF THE ALLIANCE ARE A PART OF A GLOBAL COMMUNITY DEDICATED TO TRANSFORMING GLOBAL CHILD HEALTH. THEY WILL HAVE THE OPPORTUNITY TO DEVELOP GLOBAL PROJECTS AND STUDIES, CONNECT WITH COMMITTEES AND WORKING GROUPS AT THE REGIONAL AND GLOBAL LEVEL, AND ENGAGE WITH ST. JUDE FACULTY AND STAFF FOR TRAINING AND DEVELOPMENT. ALLIANCE MEMBER INSTITUTIONS IN THE FOLLOWING COUNTRIES RECEIVE ADDITIONAL SUPPORT FROM ST. JUDE FOR PROJECT IMPLEMENTATION - BRAZIL, CHILE, CHINA, DOMINICAN REPUBLIC, ECUADOR, EL SALVADOR, GUATEMALA, HAITI, HONDURAS, JORDAN, LEBANON, MEXICO, MOZAMBIQUE, NICARAGUA, PERU, PHILIPPINES, SOUTH AFRICA, URUGUAY, VENEZUELA, ZAMBIA AND ZIMBABWE. ST. JUDE WORKS WITH ITS PARTNERS TO DEVELOP EVIDENCED-BASED TREATMENT PROTOCOLS TAILORED TO REGIONAL NEEDS AND RESOURCES. ADDITIONALLY, ST. JUDE'S PHYSICIANS AND NURSES SERVE AS MENTORS TO CLINICAL PERSONNEL AT PARTNER SITES, PROVIDE LOCAL AND ONLINE TRAINING FOR ONCOLOGY CARE, DIAGNOSIS, AND SUPPORTIVE CARE, AND PARTICIPATE IN ONLINE MEETINGS TO DISCUSS CLINICAL CARE BEST PRACTICES. THE MAJORITY OF ONLINE MEETINGS AND TRAINING ARE PROVIDED VIA ST. JUDE'S WEB-BASED PLATFORM, ST. JUDE CURE4KIDSTM (C4K), A FREE RESOURCE FOR PEDIATRIC ONCOLOGY PROFESSIONALS, SCIENTISTS AND RESEARCHERS, REGARDLESS OF THEIR AFFILIATION WITH ST. JUDE OR ITS PARTNERS. IN ADDITION TO CONTENT THAT INCLUDES MORE THAN 880 ONLINE SEMINARS, 16 SELF-PACED COURSES, AND 50 INSTRUCTOR-LED COURSES, C4K PROVIDES ONLINE MEETING AND CONFERENCE SPACE. IN FY20, C4K HAD 29,472 CONTENT VIEWS WITH 7,074 UNIQUE REGISTERED USERS AND HOSTED 1,017 MEETINGS WITH 1,059 UNIQUE PARTICIPANTS FROM 147 DIFFERENT COUNTRIES; THERE ARE 65 NCI CENTERS THAT PARTICIPATE IN C4K. FINALLY, ST. JUDE PARTNERS WITH LOCAL FUNDRAISING ORGANIZATIONS THAT SUPPORT THE MEDICAL PROGRAMS. THIS MODEL HAS PROVEN TO BE HIGHLY EFFECTIVE IN PROVIDING POOR CHILDREN IN DEVELOPING COUNTRIES ACCESS TO MODERN TREATMENT AND CARE.ST. JUDE IS ALSO A RESEARCH ORGANIZATION, WITH RESEARCH COVERING A BROADER SCOPE OF HEALTH ISSUES THAN THE DISEASES TREATED AS A PRIMARY DIAGNOSIS. THE HOSPITAL'S OUTREACH INCLUDES THE LOCAL MARKET, AFFILIATE INSTITUTIONS, OTHER AREAS OF THE UNITED STATES/U.S. TERRITORIES, AND THE INTERNATIONAL COMMUNITY. THE LOCAL MARKET ENCOMPASSES MEMPHIS, TENNESSEE AND THE SURROUNDING GEOGRAPHIC AREA WITH APPROXIMATELY 27% OF NEW ONCOLOGY PATIENTS RESIDING WITHIN THIS AREA.FY21 NEW CANCER PATIENTSPATIENT ORIGIN % OF TOTALMEMPHIS, TN AND SURROUNDING AREA 27%AFFILIATE REFERRAL 42%NATIONAL REFERRAL (OTHER AREAS OF U.S.) 27%INTERNATIONAL REFERRAL 4%GRAND TOTAL 100%(NOTE: THIS NARRATIVE FOR PART VI, LINE 4 IS CONTINUED BELOW.) - SEE PAGE 123/151 |
| PART VI, LINE 5: | ST. JUDE CHILDREN'S RESEARCH HOSPITAL WAS OPENED IN 1962. OUR MISSION IS TO ADVANCE CURES, AND MEANS OF PREVENTION, FOR PEDIATRIC CATASTROPHIC DISEASES THROUGH RESEARCH AND TREATMENT. CONSISTENT WITH THE VISION OF OUR FOUNDER, DANNY THOMAS, NO CHILD IS DENIED TREATMENT BASED ON RACE, RELIGION OR A FAMILY'S INABILITY TO PAY. OUR VISION IS TO BE THE WORLD LEADER IN ADVANCING THE TREATMENT AND PREVENTION OF CATASTROPHIC DISEASES IN CHILDREN. THIS VISION IS PURSUED BY PROVIDING OUTSTANDING PATIENT CARE; BY CONDUCTING BASIC, TRANSLATIONAL AND CLINICAL RESEARCH DESIGNED TO ELUCIDATE BIOLOGICAL MECHANISMS, UNDERSTAND DISEASE PATHOGENESIS, IMPROVE DIAGNOSIS, ENHANCE TREATMENT OUTCOME, PREVENT DISEASES AND MINIMIZE ADVERSE CONSEQUENCES OF TREATMENT; AND BY EDUCATING HEALTH CARE AND SCIENTIFIC RESEARCH PROFESSIONALS. THROUGH THESE EFFORTS, WE SEEK TO CURE AND ENHANCE THE QUALITY OF LIFE FOR AN INCREASING NUMBER OF CHILDREN WHO COME TO US FOR TREATMENT BY EXPANDING AND SHARING KNOWLEDGE TO ADVANCE TREATMENT OF CHILDREN WITH CATASTROPHIC DISEASES WORLDWIDE, WHILE DEVELOPING STRATEGIES TO PREVENT CATASTROPHIC DISEASES IN CHILDREN.ST. JUDE COMBINES LABORATORY AND CLINICAL RESEARCH TO ADVANCE THE CARE OF CHILDREN WITH CANCER AND OTHER CATASTROPHIC DISEASES. THE FOCUS IS ON PROVIDING OUTSTANDING PATIENT CARE RESULTS AND ON RESEARCH FINDINGS THAT TRANSLATE INTO IMPROVED PATIENT OUTCOMES. ST. JUDE HAS AN ACADEMIC FACULTY ENGAGED IN A BROAD SPECTRUM OF RESEARCH, INCLUDING THERAPEUTIC TRIALS, INVESTIGATION OF DISEASE PATHOGENESIS AND DISCOVERY-ORIENTED BASIC RESEARCH.HOSPITAL OPERATIONS ARE OVERSEEN BY A BOARD OF GOVERNORS, MOST OF WHICH ARE NEITHER EMPLOYEES, INDEPENDENT CONTRACTORS, OR THEIR FAMILY MEMBERS. RESEARCH ACTIVITIES ARE REVIEWED ANNUALLY BY A SCIENTIFIC ADVISORY BOARD COMPOSED OF INTERNATIONALLY PROMINENT PHYSICIANS AND SCIENTISTS.ST. JUDE CONTRIBUTED TO THE BUILDING OF A STATE-OF-THE ART NEUROSURGICAL FACILITY FOR TREATING LOCAL PEDIATRIC PATIENTS AND ST. JUDE BRAIN TUMOR PATIENTS. THE FACILITY IS EQUIPPED WITH INTRA-OPERATIVE IMAGING EQUIPMENT (IMRI). WHEN PURCHASED, ONLY TWO NEUROSURGICAL FACILITIES IN THE UNITED STATES PROVIDED PATIENTS WITH THIS LEVEL OF TREATMENT, WHICH ALLOWS IMAGING TO TAKE PLACE DURING SURGICAL PROCEDURES. IMRI EQUIPMENT ALLOWS SURGEONS TO MAKE INFORMED DECISIONS DURING THE SURGERY. LIVE WEB CASTS ALLOW OTHERS TO VIEW PROCEDURES. OUR ASSISTANCE WITH THIS FACILITY HELPS ASSURE THAT CHILDREN IN THE AREA HAVE ACCESS TO THE BEST NEUROSURGICAL TREATMENT AVAILABLE.ST. JUDE COMPLETED THE FIRST PHASE OF THE PEDIATRIC CANCER GENOME PROJECT (PCGP) IN JANUARY 2013 - A COLLABORATION WITH WASHINGTON UNIVERSITY TO FIND CLUES TO THE CAUSES OF CHILDHOOD CANCER AND POTENTIAL NEW TREATMENTS AND CURES. THE PROJECT HAS RESULTED IN GROUNDBREAKING DISCOVERIES IN A NUMBER OF CHILDHOOD CANCERS INCLUDING RETINOBLASTOMA, MEDULLOBLASTOMA, NEUROBLASTOMA, DIFFUSE INTRINSIC PONTINE GLIOMA, TWO AGGRESSIVE FORMS OF LEUKEMIA AND LOW-GRADE GLIOMAS. IN DECEMBER 2012, THE PCGP WAS RECOGNIZED AS ONE OF TIME MAGAZINE'S TOP 10 MEDICAL BREAKTHROUGHS AND, IN 2013, AS ONE OF TIME MAGAZINE'S TOP 100 NEW SCIENTIFIC DISCOVERIES. THE SECOND PHASE OF PCGP EXAMINED THE CANCER SAMPLES FROM 300 CHILDREN AND FOCUSED ON DEFINING MUTATIONS THAT CONTRIBUTE TO TUMOR FORMATION, CHARACTERIZING THE STATE OF THE CANCER CELL'S EPIGENOME AND DESCRIBING HOW IT DIFFERED FROM WHAT IS SEEN IN THE NORMAL CELLS. THE SECOND PHASE ALSO INCLUDED A CLINICAL GENOMICS PROJECT CALLED GENOMES FOR KIDS THAT INVOLVED NEXT-GENERATION SEQUENCING FOR CHILDREN WITH CANCER. WHEN PHASE 2 IS COMPLETE, ST. JUDE HOPES TO HAVE A MODEL FOR HOW TO EXTEND GENOME SEQUENCING TO EVERY CHILDHOOD CANCER PATIENT IN THE UNITED STATES. FROM ITS BEGINNINGS IN 2010, THE PCGP IS THE LARGEST, BROADEST, PRIVATELY FUNDED SEQUENCING PROJECT FOR CHILDREN WITH CANCER AND HAS SEQUENCED MORE THAN 800 MATCHED PAIRS OF TUMOR AND HEALTHY GENOMES FROM YOUNG PATIENTS. THE PCGP HAS PROVIDED NEW DETAILS ABOUT THE MUTATIONS THAT UNDERLIE THE DEVELOPMENT AND GROWTH OF A RANGE OF CHILDHOOD CANCERS, AND HAS LAID THE FOUNDATION FOR IMPROVED DIAGNOSTIC TESTING AND THE NEXT GENERATION OF MORE EFFECTIVE, LESS-TOXIC THERAPIES. THE PROJECT HAS LED TO NEW DIRECTIONS IN RESEARCH INVOLVING HIGH-RISK LEUKEMIA, BRAIN AND SOLID TUMORS AS WELL AS NEW COMPUTATIONAL METHODS THAT HAVE BEEN SHARED FOR FREE WITH THE GLOBAL SCIENTIFIC COMMUNITY.THE CYCLOTRON (PARTICLE ACCELERATOR) AT ST. JUDE ENABLES RESEARCHERS TO TRACK THE GROWTH OF CANCER CELLS, PINPOINT THE PRODUCTION OF NEW DNA BY TUMOR CELLS AND STUDY THE HEARTS OF ADULT CHILDHOOD CANCER SURVIVORS RETURNING TO ST. JUDE FOR LIFETIME FOLLOW-UP. THE CYCLOTRON HELPS RESEARCHERS BETTER UNDERSTAND CHILDHOOD CANCER BY ENABLING THEM TO PRODUCE NEW, VERY SHORT-ACTING TRACERS.ST. JUDE USES THE SERVICES OF CHILDREN'S GMP, LLC (OF WHICH ST. JUDE IS THE SOLE MEMBER). CHILDREN'S GMP, LLC, MANAGES AND OPERATES A GOOD MANUFACTURING PRACTICE (GMP) FACILITY THAT ENGAGES IN THE PRODUCTION OF BIOLOGICS AND DRUGS FOR RESEARCH. THE GMP OFFERS RESOURCES TO STUDY RARE DISEASES OVERLOOKED BY PHARMACEUTICAL COMPANIES BECAUSE THERE IS LITTLE PROFIT IN MANUFACTURING DRUGS FOR LESSER-KNOWN DISEASES. THE FACILITY, OPERATING ACCORDING TO APPROVED FDA STANDARDS, ALLOWS DOCTORS TO TAILOR TREATMENTS SPECIFICALLY FOR AN INDIVIDUAL CHILD.THE CELL AND TISSUE IMAGING CENTER INCLUDES ELECTRON MICROSCOPY AND LIGHT MICROSCOPY. THE FACILITY PROVIDES INVESTIGATORS ACCESS TO TRANSMISSION ELECTRON MICROSCOPY, CONFOCAL LASER SCANNING MICROSCOPY, MULTIPHOTON MICROSCOPY, IMAGE ANALYSIS, CELL MICROINJECTION AND LIVE CELL IMAGING. THE FEI TECNAI 20 200KV FEG ELECTRON MICROSCOPE, WHICH CAN MAGNIFY AN OBJECT 700,000 TIMES, IS AT THE HEART OF THIS PROGRAM. THIS TECHNOLOGY ALLOWS RESEARCHERS TO GET A CLOSER LOOK AT CANCER TO BETTER UNDERSTAND HOW IT GROWS AND SPREADS AND RESPONDS TO THERAPY. USING THE ELECTRON MICROSCOPE, RESEARCHERS LEARN HOW CANCER CELLS BREAK AWAY FROM THE TUMOR AND SPREAD THROUGHOUT THE BODY.ST. JUDE IS HOME TO THE ONLY PROTON BEAM RADIATION THERAPY CENTER DEVOTED SOLELY TO TREATING CHILDREN WITH BRAIN TUMORS AND SEVERAL OTHER CHILDHOOD CANCERS. PROTON THERAPY IS LESS DAMAGING TO SURROUNDING HEALTHY TISSUE THAN OTHER CURRENT RADIATION THERAPIES. THIS EQUIPMENT ENABLES ST. JUDE TO PROVIDE THIS THERAPY IN A MORE INTEGRATED MANNER TO OUTPATIENTS AND ALLOW OUR RADIATION ONCOLOGISTS TO LEAD THE DEVELOPMENT OF NEW TREATMENTS WITH PROTONS. TO FURTHER PALLIATIVE SERVICES IN THE COMMUNITY, ST. JUDE PARTICIPATED WITH LE BONHEUR CHILDREN'S HOSPITAL IN DEVELOPING THE QUALITY OF LIFE FOR ALL KIDS PALLIATIVE PROGRAM FOR SERIOUSLY ILL CHILDREN. HOSPICE STAFF, BOTH IN THE HOME AND IN THE HOSPICE RESIDENCE, PROVIDES INTERDISCIPLINARY CARE TO CHILDREN THROUGHOUT THE ILLNESS TRAJECTORY AND CONCURRENT THERAPIES.ST. JUDE ADMINISTRATIVE LEADERS AND FACULTY MEMBERS OF THE DEPARTMENT OF PHARMACEUTICAL SCIENCES HAVE BEEN AT THE FOREFRONT OF BRINGING NATIONAL ATTENTION TO THE PEDIATRIC CANCER DRUG SHORTAGE TOPIC, ACTIVELY ENGAGING REGULATORY AND LEGISLATIVE BODIES TO UNDERSTAND THE IMPACT THESE DRUG SHORTAGES HAVE ON PEDIATRIC CARE AND RESEARCH. PRESENTATIONS OR WRITTEN TESTIMONY HAVE BEEN PROVIDED TO THE FDA CENTER FOR DRUG EVALUATION AND RESEARCH WORKSHOP, TWO SENATE HEARINGS, AND HEALTH SUBCOMMITTEE OF THE HOUSE COMMITTEE ON ENERGY AND COMMERCE. ST. JUDE FOCUSES ON EDUCATING AND TRAINING THE NEXT GENERATION OF DOCTORS, NURSES, RESEARCHERS AND ACADEMIC LEADERS. FROM PROGRAMS FOR HIGH SCHOOL STUDENTS TO THE POSTDOCTORAL LEVEL, THE HOSPITAL PLAYS A MAJOR ROLE IN PREPARING FUTURE LEADERS OF SCIENCE AND MEDICINE THROUGH OUR K-12 EDUCATION OUTREACH, PEDIATRIC ONCOLOGY EDUCATION PROGRAM, AND ST. JUDE GRADUATE SCHOOL. FURTHERMORE, ST. JUDE GLOBAL PROVIDES AN EDUCATION AND COLLABORATION WEB SITE, CURE4KIDSTM (WWW.CURE4KIDS.ORG). VIA THE CONNECT2PROTECT PROGRAM, ST. JUDE COLLABORATES WITH CHURCHES, OTHER HEALTH CARE ORGANIZATIONS AND CIVIC GROUPS TO RAISE AWARENESS ABOUT PREVENTING THE SPREAD OF HIV/AIDS. THE PRIMARY TARGET IS THE AFRICAN-AMERICAN COMMUNITY, ALTHOUGH OTHER ETHNIC GROUPS ARE ALSO SERVED INCLUDING ASIAN, CAUCASIAN AND HISPANIC.THE FUNDRAISING SOURCE FOR ST. JUDE IS ALSAC (AMERICAN LEBANESE AND SYRIAN ASSOCIATED CHARITIES, INC.), WHICH RAISES FUNDS SOLELY FOR THE HOSPITAL. BECAUSE OF THE HOSPITAL'S MISSION, PEOPLE NATIONWIDE CONTRIBUTE VIA TENS OF THOUSANDS OF FUNDRAISING EFFORTS. ALSAC CONTRIBUTED $997 MILLION IN FY21 TO SUPPORT ST. JUDE.VOLUNTEERS ENHANCE THE QUALITY OF PATIENT CARE BY PARTNERING WITH CLINICAL STAFF TO PROVIDE AN ADDITIONAL PERSONAL TOUCH. VOLUNTEERS ALSO HELP ENSURE A SAFE ENVIRONMENT. THEY LEND ASSISTANCE AND PROVIDE COMPASSIONATE CONCERN BY OFFERING A LISTENING EAR TO FAMILIES AT A TIME WHEN THEY NEED IT MOST. THEY ARE VITAL AMBASSADORS FOR THE HOSPITAL AND COMMUNITY.(NOTE: THIS NARRATIVE FOR PART VI, LINE 5 IS CONTINUED BELOW.) - SEE PAGE 125/151 |
| PART VI, LINE 2 (CONTINUATION FROM 104/151) | ADDITIONALLY, ST. JUDE'S HPV CPP HELPED TO SECURE A CONSENSUS STATEMENT FROM ALL 71 NCI DESIGNATED CANCER CENTERS TO HELP GET VACCINATION BACK ON TRACK AND SUBSEQUENTLY PARTNERED WITH VANDERBILT INGRAM CANCER CENTER, IMMUNIZETN AND MEHARRY MEDICAL COLLEGE TO COMPLETE A CONSENSUS STATEMENT FOR THE STATE OF TENNESSEE. IN AN EFFORT TO EXPLORE DATA AND IDENTIFY OPPORTUNITIES FOR COLLECTIVE ACTION, THE TEAM COLLABORATED WITH LOCAL ONCOLOGY SPECIALISTS TO COORDINATE AND LAUNCH THE MEMPHIS AND SHELBY COUNTY HPV CANCER PREVENTION ROUNDTABLE. WE ANTICIPATE APPROXIMATELY 200 COMMUNITY-, CLINICAL- AND POLICY- LEVEL STAKEHOLDERS WILL ATTEND AND JOIN THIS ROUNDTABLE.HEMATOLOGYTHE GEOGRAPHIC CATCHMENT AREA FOR ST. JUDE ENCOMPASSES 21 COUNTIES IN WESTERN TENNESSEE INCLUDING MEMPHIS, AND AREAS IN EAST ARKANSAS, NORTH MISSISSIPPI, AND A FEW COUNTIES IN MISSOURI. MORE THAN 100,000 PEOPLE IN THE UNITED STATES HAVE SICKLE CELL DISEASE (SCD), AND IT IS ESTIMATED THAT MORE THAN 1 MILLION PEOPLE WORLDWIDE SUFFER FROM THE DISEASE. IT IS THE MOST FREQUENT GENETIC BLOOD DISORDER IN THE WORLD. ST. JUDE HAS ONE OF THE LARGEST PEDIATRIC SCD PROGRAMS IN THE COUNTRY AND PROVIDES COMPREHENSIVE TREATMENT AND EDUCATION TO ABOUT 900 CHILDREN WITH SCD IN THE GEOGRAPHIC CATCHMENT AREA. SCD IS DIAGNOSED BY STATE-WIDE NEWBORN SCREENING IN ALL 50 STATES. ST. JUDE HAS A PARTNERSHIP WITH NEWBORN SCREENING PROGRAMS IN TN AND MS THAT ENSURES A STABLE RELATIONSHIP AMONG PARENTS, PATIENTS, PRIMARY CARE PROVIDERS. ABOUT 50 NEWBORNS WITH SCD ARE IDENTIFIED EACH YEAR IN OUR GEOGRAPHIC CATCHMENT AREA. OUR SCD INFANT TODDLER PROGRAM CONTACTS AND ACCEPTS ALL CHILDREN DIAGNOSED WITH THE DISEASE IN OUR CATCHMENT AREA TO ITS COMPREHENSIVE CARE SERVICE. ADDITIONALLY, ST. JUDE PROVIDES TRAIT COUNSELING SERVICE TO INFANTS BORN WITH SICKLE CELL TRAIT TO 21 COUNTIES IN WESTERN TN. ST. JUDE PROVIDES CONFIRMATORY TESTING, EDUCATION AND COMPREHENSIVE CARE AND FOLLOW-UP THROUGHOUT CHILDHOOD FOR CHILDREN WITH SCD DISEASE. FROM BIRTH TO AGE 18 YEARS, PATIENTS ARE CLINICALLY EVALUATED AT LEAST EVERY 6 MONTHS, RECEIVE EDUCATION AND MULTI-DISCIPLINARY SERVICES ACCORDING TO STANDARDIZED TREATMENT AND EDUCATION GUIDELINES. SERVICES ALSO INCLUDE COMMUNITY OUTREACH AND EDUCATION OF THE LOCAL COMMUNITY. ST. JUDE HAS ESTABLISHED A FORMAL TRANSITION PROGRAM TO ADULT CARE FOR PATIENTS WITH SCD AND PROVIDES SUPPORT TO PATIENTS AND FAMILIES THROUGHOUT THE TRANSITION PROCESS BY WORKING CLOSELY WITH THE ADULT SCD PROGRAMS AT METHODIST UNIVERSITY HOSPITAL AND REGIONAL ONE HOSPITAL. IN THE PAST, THE SCD PROGRAM AT ST. JUDE HAS COLLABORATED WITH SEVERAL FEDERALLY QUALIFIED HEALTH CARE CENTERS, WITH COMMUNITY PRIMARY CARE PHYSICIANS, LATINO MEMPHIS (THE LARGEST HISPANIC SOCIAL AGENCY IN TENNESSEE), WITH THE SICKLE CELL FOUNDATION OF TENNESSEE (A COMMUNITY-BASED SCD ORGANIZATION), AND WITH REGIONAL SCD PROVIDERS TO ENSURE A MEDICAL HOME AND ADEQUATE SOCIAL SUPPORT FOR ALL SCD PATIENTS IN THE AREA. ST. JUDE ASSESSES PATIENT NEEDS THROUGH PARENT AND PATIENT SURVEYS, INTERACTIVE EDUCATION, MATERIALS REVIEW, AND GROUP DISCUSSIONS WITH PARENTS AND PATIENTS. ST. JUDE HAS AN ANNUAL SICKLE CELL EDUCATION DAY FOR PATIENTS WITH SICKLE CELL DISEASE AND THEIR FAMILIES/CAREGIVERS. MORE THAN 250 ATTEND THIS EVENT EVERY YEAR. ADDITIONALLY, ST. JUDE COLLABORATES WITH NATIONAL ORGANIZATIONS TO PROVIDE EDUCATION TO HEALTHCARE PROVIDERS AND PEOPLE WITH SICKLE CELL DISEASE TO INCREASE SICKLE CELL AWARENESS. ST. JUDE PROVIDES FREE EDUCATIONAL BOOKLETS AND BROCHURES (HARD COPY REQUEST OR DOWNLOAD) ON THE HEMATOLOGY WEBSITE AS WELL AS INTERACTIVE EDUCATIONAL VIDEOS. PEOPLE FROM THROUGHOUT THE US AND OTHER COUNTRIES UTILIZE THE EDUCATIONAL WEBSITE. ST. JUDE PARTICIPATES IN NUMEROUS HEALTH FAIRS, SCHOOL PROGRAMS, AND OTHER COMMUNITY EVENTS TO INCREASE KNOWLEDGE AND AWARENESS OF HEMATOLOGICAL DISORDERS AND THEIR IMPACT ON THE PATIENTS AND THE COMMUNITY. ST. JUDE ALSO PROVIDES CLINICAL SERVICES FOR APPROXIMATELY 800 CHILDREN PER YEAR WITH OTHER NON-MALIGNANT HEMATOLOGICAL DISORDERS THROUGH A STRONG RELATIONSHIP WITH LOCAL COMMUNITY PHYSICIANS. CHILDREN FROM THE GEOGRAPHIC CATCHMENT AREA OF ST. JUDE (AS OUTLINED ABOVE) WITH ILLNESSES SUCH AS HEMOPHILIA, APLASTIC ANEMIA, THROMBOSIS, THALASSEMIA, SPHEROCYTOSIS, AND IMMUNE THROMBOCYTOPENIC PURPURA AND OTHER NON-MALIGNANT HEMATOLOGIC DISORDERS ARE REFERRED TO AND RECEIVE STATE-OF THE-ART CARE FROM ST. JUDE PHYSICIANS AND MEDICAL STAFF. ST. JUDE IS ONE OF A SELECT GROUP OF FEDERALLY RECOGNIZED PEDIATRIC HEMOPHILIA TREATMENT CENTERS AND PROVIDES STATE-OF-THE-ART COMPREHENSIVE CARE TO APPROXIMATELY 300 CHILDREN WITH BLEEDING AND THROMBOSIS DISORDERS.IN ADDITION TO PROVIDING AND CONTINUOUSLY IMPROVING STANDARDIZED CARE TO THESE PATIENT POPULATIONS, ST. JUDE HEMATOLOGY DEDICATES A SIGNIFICANT AMOUNT OF RESOURCES TO CLINICAL, TRANSLATIONAL, AND BASIC RESEARCH TO IMPROVE SURVIVAL AND DECREASE MORBIDITY OF CHILDREN WITH NON-MALIGNANT CHRONIC BLOOD DISEASES. MOST PATIENTS PARTICIPATE IN RESEARCH STUDIES, WHICH HAVE RESULTED IN MAJOR IMPROVEMENTS IN CLINICAL CARE. FOR EXAMPLE, RECENT RESULTS FROM THE BABY HUG TRIAL SHOWED THAT DAILY ORAL HYDROXYUREA IS SAFE AND EFFECTIVE FOR INFANTS AND YOUNG CHILDREN WITH SCD, WHICH LED TO THE RECOMMENDATION OF ITS GENERAL USE IN THIS SUBPOPULATION. ALSO, IN A FIRST-IN-MAN TRIAL, ST. JUDE HEMATOLOGY SHOWED THE SAFETY AND EFFICACY OF A NOVEL GENE TRANSFER AGENT CARRYING THE FACTOR IX GENE FOR TREATMENT OF HEMOPHILIA B; ALL FOURTEEN ADULT PARTICIPANTS WITH SEVERE HEMOPHILIA B HAD NO SERIOUS UNEXPECTED SIDE EFFECTS AND ALL PARTICIPANTS SHOWED AN INCREASE IN FACTOR IX LEVELS LEADING TO A SUBSTANTIAL REDUCTION IN THEIR BLEEDING TENDENCY. ADDITIONALLY, ST. JUDE HAS DEVELOPED A VECTOR FOR GENE TRANSFER TO TREAT CHILDREN WITH X LINKED SEVERE COMBINED IMMUNODEFICIENCY (X LINKED SCID) DISEASE WHICH HAS SHOWN PROMISE AS A CURE FOR THE DISEASE. ST. JUDE IS PARTNERING WITH SEVERAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO PROVIDE ACCESS TO FIRST-IN-HUMAN GENETIC THERAPIES FOR SCD. ST. JUDE IS ALSO DEVELOPING SEVERAL NOVEL GENETIC THERAPIES TO CURE SCD. IN ADDITION, AN ONGOING CLINICAL TRIAL IS EVALUATING A NEW METHOD OF BONE MARROW TRANSPLANTATION FOR PATIENTS WITH SICKLE CELL DISEASE.HIVTHE CONNECT TO PROTECT (C2P) COMMUNITY COALITION LED BY MEMBERS OF THE HOSPITAL'S COMPREHENSIVE HIV PREVENTION AND TREATMENT PROGRAM FOR CHILDREN AND YOUTH, HAS SIGNIFICANTLY CONTRIBUTED TO THE STRONG COMMUNITY TIES THAT ST. JUDE HAS ESTABLISHED AND STRENGTHENED. LAUNCHED IN 2008, C2P IS MADE UP OF 25 PARTNER AGENCIES REPRESENTING A DIVERSE MIX OF STAKEHOLDERS FROM VARIOUS SECTORS IN MEMPHIS. THIS INCLUDES THE HEALTH DEPARTMENT, FAITH-AND COMMUNITY-BASED ORGANIZATIONS, SCHOOLS, BUSINESSES, YOUTH AND HEALTH CARE ORGANIZATIONS; ALL ALIGNED WITH THE COMMON GOAL OF OPTIMIZING HIV PREVENTION AND TREATMENT. THE STRENGTH OF THIS COALITION HAS BEEN TO PROVIDE A NON-THREATENING, COLLABORATIVE ENVIRONMENT WHERE INDIVIDUALS AND AGENCIES WITH DIFFERENT BACKGROUNDS AND PRIORITIES HAVE BEEN ABLE TO COLLABORATIVELY IMPLEMENT OVER 70 NEW POLICIES, PRACTICES AND PROGRAMS THAT IMPACT HIV PREVENTION AND TREATMENT IN YOUTH. IN THIS COALITION WE HAVE LEARNED AND SHARED BEST PRACTICES, AND TOGETHER, IDENTIFIED AND DEVELOPED NEW STRUCTURAL CHANGE OBJECTIVES TO ADDRESS IMPEDIMENTS THAT PREVENT YOUTH FROM MOVING ALONG THE HIV PREVENTION AND TREATMENT CARE CONTINUUM. WITHIN THIS 2021 FISCAL YEAR AND IN THE MIDST OF THE PANDEMIC, STAFF PIVOTED FROM AN IN PERSON TO A VIRTUAL MEETING PLATFORM AND COORDINATED AND HOSTED 4 C2P VIRTUAL MEETINGS FOR THE 25 MEMBER ORGANIZATIONS OF THE CONNECT TO PROTECT (C2P) COMMUNITY COALITION. |
| HAVING ACCESS TO, AND COMMITMENT FROM, SUCH A DIVERSE GROUP OF PEOPLE | AND ORGANIZATIONS HAS ALLOWED FOR SHARED RESPONSIBILITY IN TRANSFORMING THE HEALTH TRAJECTORY OF THE CITY. THE COALITION DESIGNED A STRATEGIC PLAN THAT SPECIFICALLY ADDRESSES YOUTH BARRIERS TO TESTING, TRANSITIONING TO ADULT CARE, PRE-EXPOSURE PROPHYLAXIS AND LINKAGE OF NEWLY DIAGNOSED HIV+ YOUTH TO MEDICAL CARE. AS BARRIERS ARE IDENTIFIED, MEMBERS ENGAGE IN DIALOGUE AND DISCUSSIONS WITH KEY STAKEHOLDERS, AND STRATEGIZE FOR POLICY AND PRACTICE CHANGES RELATED TO COMMONLY IDENTIFIED OBSTACLES SUCH AS DISCLOSURE, TIMELINES OF CONFIRMATORY TEST, MEDICATION/APPOINTMENT, SOCIAL DETERMINANTS, AND ADHERENCE. SINCE IMPLEMENTING THE STRATEGIC MULTISITE INITIATIVE FOR LINKAGE AND ENGAGEMENT (SMILE) TO CARE PROGRAM IN 2010-2021, WE HAVE BEEN ABLE TO ASSIST APPROXIMATELY 2,118 YOUTH AND YOUNG ADULTS WITH GETTING INTO MEDICAL CARE. THIS FISCAL YEAR, OF THE 94 REFERRED FOR HIV CARE, 94% HAVE BEEN RETAINED IN CARE AND EXPECTED TO ACHIEVE VIRAL SUPPRESSION. THE SUCCESS OF THE PROGRAM GARNERED NATIONAL ATTENTION AND HAS BEEN RECOGNIZED BY THE CENTERS FOR DISEASE CONTROL AS A BEST PRACTICE MODEL. AS A RESULT, WE HAVE BEEN WORKING COLLABORATIVELY WITH THE SHELBY COUNTY HEALTH DEPARTMENT AND LE BONHEUR COMMUNITY HIV NETWORK TO REPLICATE AND EXPAND OUR MODEL OF LINKAGE TO CARE AND TREATMENT BY APPLYING FOR GRANT SUPPORT TO HIRE ADDITIONAL STAFF. THIS HAS ALLOWED OUR PROGRAM TO ASSIST OTHER AGENCIES WITH HELPING TO LINK NEWLY DIAGNOSED YOUTH AND YOUNG ADULTS INTO CARE AND ALSO CONTRIBUTE TO REDUCING THE HIV COMMUNITY VIRAL LOAD. IN ADDITION, FOR OVER TWO YEARS, C2P MEMBERS ALONGSIDE THE ST. JUDE COORDINATING CENTER STAFF, HAVE BEEN SYSTEMATICALLY WORKING ON AN ENDING THE HIV EPIDEMIC IN MEMPHIS IMPLEMENTATION PLAN. THIS COLLABORATIVE EFFORT WAS RECENTLY FUNDED (SEPTEMBER 2019) BY THE CENTERS FOR DISEASE CONTROL TO ACCELERATE STATE AND LOCAL PLANNING EFFORTS TO ACHIEVE ZERO NEW HIV INFECTIONS BY THE YEAR 2030. THIS HAS LED TO MORE INTENTIONAL ENGAGEMENT OF NEW STAKEHOLDERS, GRASS ROOTS ORGANIZATIONS, AND OTHER GATEKEEPERS TO HELP FORTIFY AND BUILD OUT THE ENGAGEMENT PROCESSES. SINCE SEPTEMBER OF 2019, C2P HAS MANAGED TO HOST AND PARTICIPATE IN OVER 35 STAKEHOLDER MEETINGS AND GET BUY-IN AND SUPPORT FROM 20 NEW PARTNER REPRESENTATIVES FROM 13 DIFFERENT ORGANIZATIONS TO CONTINUE TO ENRICH THE EHE MEMPHIS PLANNING COALITION. WITHIN THIS 2021 FISCAL YEAR, THERE WERE (11) VIRTUAL CHALK TALKS THAT WERE CREATED AND HELD THAT GARNERED OVER 350 ATTENDEES. THE WEEKLY SERIES AS A WAY TO KEEP COMMUNITY PARTNER ENGAGEMENT STRONG AND VIABLE. THIS VIRTUAL PLATFORM HAS ALLOWED US TO HIGHLIGHT THE ACCOMPLISHMENTS AND SWIFT ADJUSTMENTS THAT MANY OF OUR COMMUNITY PARTNERS HAVE HAD TO ADOPT, AS WELL AS, CONTINUE TO ENCOURAGE PARTNERS TO COMPLETE ENDING THE HIV EPIDEMIC MEMPHIS PLANS. THE EHE COMMUNITY ACTION PLAN WAS COMPLETED AND SUBMITTED TO THE CDC IN DECEMBER OF 2020. THERE WERE FOUR COMMITTEES NAMELY - THE EXECUTIVE COUNCIL, POLICY COMMITTEE, PREVENT COMMITTEE AND ACCESS TO TREATMENT & CARE COMMITTEE, THAT MET ON A WEEKLY BASIS TO BRING THE EXECUTION OF THE EHE PLAN TO FRUITION. THERE WAS A TOTAL OF 30 MEETINGS THAT DROVE THE DEVELOPMENT AND COORDINATION OF THE EHE COMMUNITY ACTION PLAN DURING THE FY21 AND AT LEAST 4 ATTENDEES WERE PRESENT PER MEETING. THIS RESULTED IN THE COALITION ESTABLISHING GUIDING PRINCIPLES, GOALS AND OVER 150 OBJECTIVES FOR THE EHE PLAN. LASTLY, MEMBERS OF THE HIV PREVENTION PROGRAM HAVE CO-FACILITATED AND/OR PARTICIPATED IN APPROXIMATELY 36 COMMUNITY BASED EDUCATIONAL AND TESTING EVENTS (FACE TO FACE/VIRTUAL), CONFERENCES AND INTERVIEWS THAT HAVE IMPACTED APPROXIMATELY 8,199 INDIVIDUALS INCLUDING YOUTH, PARENTS, EDUCATORS, CLINICIANS & FAITH-BASED LEADERS IN MEMPHIS AND SURROUNDING AREAS. WE RECOGNIZE THE STRENGTH AND VALUE OF OUR COMMUNITY ENGAGEMENT INFRASTRUCTURE AND THAT MEMBERS ARE COMMITTED TO CONTINUE CROSS-AGENCY COLLABORATION. OUR GOALS ARE TO SUCCESSFULLY ACHIEVE MILESTONES AND IMPLEMENT NEW POLICIES AND PRACTICES THAT SUFFICIENTLY ADDRESS COMMUNITY NEEDS. HOWEVER, OUR COMMUNITY ENGAGEMENT INFRASTRUCTURE HAS BEEN CHALLENGED SINCE COVID-19 HAS CAUSED IN-PERSON MOBILIZATION ACTIVITIES (CONFERENCES, SUBCOMMITTEE MEETINGS, PANEL DISCUSSIONS, EDUCATIONAL SEMINARS, ETC.) TO CEASE AS A RESULT OF SHELTERING IN PLACE. WE HAVE IMPLEMENTED AS MANY CARE AND TREATMENT MODALITIES AS WE CAN USING THE TELEPHONE, EMAIL AND TEXT MESSAGING. STILL, SOME INDIVIDUALS ARE NOT ABLE TO BE REACHED AS THIS CRISIS HAS UNCOVERED A DIGITAL DIVIDE. AS COVID-19 CASES CONTINUE TO RISE IN OUR COMMUNITY, WE WILL IMPLEMENT THE USE OF MORE VIRTUAL PLATFORMS AS A MEANS OF CREATING COMMUNITY TOUCH POINTS. WE WILL SCALE UP THE USE OF PHONE AND EMAIL TO ENSURE PATIENT LINKAGE AND ENGAGEMENT IN CARE AND HOPE TO GARNER ASSISTANCE FROM RESOURCE COMMODITY CENTERS TO PARTNER TO REACH THOSE INDIVIDUALS THAT HAVE LIMITED ACCESS TO DIGITAL PLATFORMS. OUR HIV PREVENTION AND TREATMENT PROGRAM HAS REALLY VALUED THE STRONG AND BI-DIRECTIONAL COLLABORATION WITH COLLEAGUES IN THE COMMUNITY. WITH A SHARED FOCUS, WHAT WE HAVE BEEN ABLE TO ACHIEVE WITH OUR LINKAGE TO CARE, RETENTION IN CARE AND PREP EFFORTS, WOULD NOT HAVE BEEN FEASIBLE WITHOUT COMMUNITY AGENCY BUY-IN AND SUPPORT. 1. AMERICAN CANCER SOCIETY. CANCER FACTS & FIGURES 2021. ATLANTA: AMERICAN CANCER SOCIETY; 2021.2. LIU ET AL. J CLIN ONCOL 34(14):1634-43, 2016.3. BHATIA ET AL. CANCER 122(15):2426-2439, 2016.4. SENKOMAGO V, HENLEY SJ, THOMAS CC, MIX JM, MARKOWITZ LE, SARAIYA M. HUMAN PAPILLOMAVIRUS - ATTRIBUTABLE CANCERS - UNITED STATES, 2012-2016. MMWR MORB MORTAL WKLY REP 2019;68:724-728. DOI: HTTP://DX.DOI.ORG/10.15585/MMWR.MM6833A35. ELAM-EVANS LD, YANKEY D, SINGLETON JA, ET AL. NATIONAL, REGIONAL, STATE, AND SELECTED LOCAL AREA VACCINATION COVERAGE AMONG ADOLESCENTS AGED 13-17 YEARS - UNITED STATES, 2019. MMWR MORB MORTAL WKLY REP 2020;69:1109-1116. DOI: HTTP://DX.DOI.ORG/10.15585/MMWR.MM6933A1 |
| PART VI, LINE 4 (CONTINUATION FROM PAGE 110/151) | THE ST. JUDE AFFILIATE PROGRAM (AP) IS A NETWORK OF EIGHT AFFILIATED PEDIATRIC HEMATOLOGY/ONCOLOGY CLINICS IN THE U.S., ALLOWS ST. JUDE PATIENTS TO BE TREATED CLOSER TO HOME AND TO INCREASE ENROLLMENT ON ST. JUDE CLINICAL TRIALS. THE PHYSICIANS AND STAFF AT THESE SITES WORK IN COLLABORATION WITH THE STAFF AT ST. JUDE TO DELIVER PROTOCOL RELATED CARE OR EVIDENCE-BASED TREATMENT WHEN NOT PARTICIPATING IN A TRIAL TO PEDIATRIC HEMATOLOGY-ONCOLOGY PATIENTS, SO THAT PATIENTS CAN RECEIVE CARE CLOSER TO HOME. AFFILIATES ARE CURRENTLY LOCATED IN BATON ROUGE, LA, CHARLOTTE, NC, HUNTSVILLE, AL, JOHNSON CITY, TN, PEORIA, IL, SHREVEPORT, LA, SPRINGFIELD, MO, AND TULSA, OK. THE AFFILIATES' ENROLLMENT OF PATIENTS ON ST. JUDE CLINICAL TRIALS HELPS ST. JUDE FIND CURES FASTER AND SAVE MORE CHILDREN. ST. JUDE PROVIDES FINANCIAL SUPPORT FOR CLINICAL OPERATIONS TO ENSURE EXCELLENT QUALITY OF CARE THAT MEETS ST. JUDE PROTOCOL GUIDELINES AND TO PROVIDE PATIENT ASSISTANCE. THE AP AND OTHER STAFF ASSIST THE AFFILIATES IN THE DEVELOPMENT OF NEW PEDIATRIC HEMATOLOGY-ONCOLOGY PROGRAMS; PROVIDE MONITORING AND CONSULTATION TO IMPROVE PATIENT CARE AND CLINICAL PROCESSES FOR THE AFFILIATE CLINIC AND CHILDREN'S HOSPITAL; AND PROVIDE NUMEROUS EDUCATIONAL OFFERINGS AND MENTORING FOR AFFILIATE STAFF. IN ADDITION, ST. JUDE HAS MANY PROCESSES TO ENSURE GOOD CONTINUITY OF CARE BETWEEN THE AFFILIATES AND ST. JUDE. THE AFFILIATES' CLINICAL RECORDS FOR SHARED PATIENTS ARE AVAILABLE IN ST. JUDE MEDICAL RECORDS AND EVERY AFFILIATE HAS ACCESS TO ST. JUDE ELECTRONIC MEDICAL RECORDS OF SHARED PATIENTS. THE AFFILIATES ALSO HAVE ACCESS TO ALL ELECTRONIC RESOURCES, E.G. PATIENT EDUCATION MATERIALS, RESEARCH PROTOCOLS, CLINICAL GUIDELINES AND RESOURCES; EVERYTHING ON THE ST. JUDE INTRANET. IN ADDITION TO ASSISTING THE AFFILIATES, ST. JUDE PROVIDES CONSULTATION SERVICES FOR MORE THAN 2,700 NATIONAL AND OVER 1,000 INTERNATIONAL REQUESTS. FOR FY21 PATIENT CONSULTATIONS BY CONTINENT TOTALED 3,772 AS FOLLOWS:CONTINENT NUMBER OF PATIENT CONSULTATIONS NORTH AMERICA (INCL. CENTRAL AMERICA AND CARIBBEAN) 2,897SOUTH AMERICA 122EUROPE 134AFRICA 25ASIA 518AUSTRALIA 53UNKNOWN LOCATION 23 TOTAL 3,772 |
| PART VI, LINE 5 (CONTINUATION FROM PAGE 115/151) | IN SEPTEMBER 2018, ST. JUDE LAUNCHED THE TOGETHER WEBSITE, A PATIENT EDUCATION RESOURCE FOR FAMILIES FACING PEDIATRIC CANCER NO MATTER WHERE THEY ARE BEING TREATED. IT IS NOW AVAILABLE IN 8 LANGUAGES: ARABIC, BURMESE, CHINESE (SIMPLIFIED), FRENCH, HINDI, RUSSIAN, AND SPANISH. IN SEPTEMBER 2020, THE TOGETHER TEENS&20S MINISITE LAUNCHED FOR ADOLESCENT AND YOUNG ADULT CANCER PATIENTS AND SURVIVORS AGES 13-25 YEARS. IN FEBRUARY OF 2021, TOGETHER BEGAN HOSTING AN ONLINE COMMUNITY THAT PROVIDES A SAFE SPACE FOR PARENTS, PATIENTS, SURVIVORS, AND OTHERS TO SHARE STORIES, ENCOURAGEMENT, AND HELPFUL INFORMATION. IN OCTOBER 2019, ST. JUDE INVESTIGATORS PUBLISHED A PAPER IN THE JOURNAL OF CLINICAL ONCOLOGY DETAILING HOW THEY REDUCED RELAPSE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS BY ADDING DOSES OF CHEMOTHERAPY IN THE CEREBROSPINAL FLUID EARLIER IN TREATMENT. THE RESEARCHERS REPORTED THAT THE APPROACH IMPROVED CNS CONTROL WITHOUT ADDING TOXICITY.ALSO IN 2019, THE ST. JUDE PEDIATRIC TRANSLATIONAL NEUROSCIENCE INITIATIVE STARTED TO TAKE SHAPE. THIS INSTITUTION-WIDE EFFORT AIMS TO TRANSFORM UNDERSTANDING AND TREATMENT OF DEVASTING CHILDHOOD NEUROLOGICAL DISORDERS. DR. RICHARD S. FINKEL JOINED ST. JUDE TO HEAD THE CLINICAL CENTERPIECE, THE CENTER FOR EXPERIMENTAL NEUROTHERAPEUTICS. ON THE RESEARCH SIDE, DR. PETER MCKINNON IS LEADING THE NEW CENTER FOR PEDIATRIC NEUROLOGICAL DISEASE RESEARCH. THIS MARKS AN EXPANSION OF THE INSTITUTION'S FOCUS TO ENCOMPASS PEDIATRIC NEUROLOGICAL DISEASES AND A NEW PROGRAM TO HELP CHILDREN AFFECTED BY THEM.ST. JUDE CONTINUED ITS GENE THERAPY TREATMENT CLINICAL TRIAL THAT HAS CURED BABIES WITH X-LINKED SEVERE COMBINED IMMUNODEFICIENCY (SCID-X1). SCIENTISTS HOPE THE NOVEL COMBINATION THERAPY WILL LEAD TO CURES FOR SICKLE CELL DISEASE AND OTHER BLOOD DISORDERS. SCID-X1 IS SOMETIMES CALLED "BUBBLE BOY" DISEASE BECAUSE PATIENTS ARE USUALLY BOYS. THEY ARE BORN WITHOUT GOOD DISEASE-FIGHTING IMMUNE SYSTEMS AND NEED PROTECTION FROM THE WORLD. A MUTATION IN A SINGLE GENE STOPS PEOPLE WITH SCID-X1 FROM MAKING IMMUNE CELLS THAT WORK. A TEAM LED BY THE LATE BRIAN SORRENTINO, MD, OF ST. JUDE DESIGNED A VECTOR TO CARRY A CORRECT COPY OF THE GENE INTO BLOOD-PRODUCING CELLS. THE VECTOR INCLUDED SAFETY FEATURES THAT PROTECT AGAINST TREATMENT-RELATED SIDE EFFECTS, INCLUDING LEUKEMIA. THE FIRST EIGHT SCID-X1 BABIES TREATED WITH THE ST. JUDE GENE THERAPY ARE ALL GROWING NORMALLY. THEY ARE NOW MAKING COMPLETE SETS OF IMMUNE CELLS FOR THE FIRST TIME. NONE HAVE DEVELOPED SERIOUS INFECTIONS.OTHER PROGRAMS BEGUN DURING 2019 INCLUDE: A NEW ACUTE CARE CLINIC FOR ESTABLISHED PATIENTS, A PILOT FOR HOME HEALTH SERVICES DURING THE PANDEMIC, TRAINING MORE THAN 160 PROVIDERS ON TELEMEDICINE, AND INCREASING TELEMEDICINE OPTIONS FOR PATIENTS. WITH THE EMERGENCE OF THE COVID-19 PANDEMIC IN MARCH 2020, ST. JUDE CHILDREN'S RESEARCH HOSPITAL MOVED QUICKLY TO PROTECT THE HEALTH AND SAFETY OF OUR EMPLOYEES, FAMILIES, AND THE MOST VULNERABLE MEMBERS OF OUR COMMUNITY - OUR PATIENTS. ST. JUDE FACULTY AND STAFF WORKED TOGETHER TO CREATE A SAFE HARBOR AGAINST COVID-19. PROTECTION MEASURES INCLUDE A FIRST-OF-ITS-KIND COVID-19 TESTING PROGRAM FOR EMPLOYEES AS WELL AS PATIENTS AND THEIR FAMILIES; CAMPUS ZONING; REDUCED PERSONNEL AND VISITOR ACCESS; AND HEIGHTENED INFECTION-CONTROL PROCEDURES. BEFORE MANY AREAS IN THE COUNTRY WERE ABLE TO TEST FOR COVID-19, ST. JUDE CREATED ITS OWN CLINICAL TESTING PROGRAM FOR PATIENTS, FAMILIES AND STAFF. EACH DAY, HUNDREDS OF EMPLOYEES RANDOMLY SELECTED FOR SCREENING ENTER THE MARLO THOMAS CENTER AUDITORIUM, SIT DOWN AT TESTING STATIONS AND HAVE THEIR NOSES SWABBED FOR EVIDENCE OF THE NOVEL CORONAVIRUS. MEANWHILE, PATIENTS AND THEIR FAMILIES UNDERGO TESTING IN ANOTHER PART OF THE HOSPITAL. NURSES PLACE THE SWABS INTO VIALS WITH TRANSPORT MEDIA THAT HAS BEEN PRODUCED AND PACKAGED AT THE CHILDREN'S GMP, LLC, A FACILITY LOCATED ON THE ST. JUDE CAMPUS. THE VIALS ARE THEN TRANSPORTED TO THE HOSPITAL'S CLINICAL COVID-19 TESTING LAB, WHERE PATHOLOGISTS TEST BETWEEN 5,000 AND 6,000 SAMPLES PER WEEK. ACROSS THE HOSPITAL, WORKERS EMPLOY MANY TACTICS TO CREATE A SAFE ENVIRONMENT, INCLUDING USING UV LIGHT TO STERILIZE AND KILL MICROBIOLOGICAL CONTAMINANTS. CANCER NEVER SLEEPS, SO RESEARCHERS AT ST. JUDE CONTINUE THEIR WORK WHILE ADHERING TO NEW GUIDELINES FOR PHYSICAL DISTANCING, DISINFECTION AND THE USE OF PERSONAL PROTECTIVE EQUIPMENT. THE CAMPUS HAS BEEN ZONED SO THAT ADMINISTRATIVE AND RESEARCH EMPLOYEES DO NOT COME INTO CONTACT WITH PATIENTS, FAMILIES AND CLINICAL EMPLOYEES. THIS IS ONE MORE LAYER OF PROTECTION FOR THE CHILDREN IN OUR CARE.ST. JUDE IS A HUB OF NATIONAL AND INTERNATIONAL EFFORTS TO ADVANCE UNDERSTANDING AND TREATMENT OF COVID-19 IN CHILDREN AND YOUNG PEOPLE, ESPECIALLY THOSE WITH CANCER DIAGNOSES. NATIONALLY, WE ARE HOSTING A REGISTRY TO COLLECT DATA ON CHILDREN WITH COVID-19. THE GOAL IS TO LEARN MORE ABOUT THE INCIDENCE, DISTRIBUTION, CLINICAL PRESENTATION, MANAGEMENT AND OUTCOMES OF THE INFECTION IN CHILDREN. ST. JUDE GLOBAL HAS ALSO CREATED A WEBSITE DEDICATED TO THE EFFECT OF THE PANDEMIC ON CHILDREN WITH CANCER AROUND THE WORLD. THE GLOBAL COVID-19 OBSERVATORY AND RESOURCE CENTER FOR CHILDHOOD CANCER (HTTPS://GLOBAL.STJUDE.ORG/EN-US/GLOBAL-COVID-19-OBSERVATORY-AND-RESOURCE-CENTER-FOR-CHILDHOOD-CANCER/REGISTRY.HTML) ALLOWS CLINICIANS WORLDWIDE TO COLLABORATE, CONNECT AND FIND THE LATEST INFORMATION ON COVID-19 AS IT RELATES TO PEDIATRIC CANCER.ST. JUDE PRODUCED EDUCATIONAL RESOURCES ON COVID-19 FOR OUR COMMUNITY, MAKING THEM PUBLICLY AVAILABLE ON STJUDE.ORG AND OUR @STJUDERESEARCH SOCIAL MEDIA CHANNELS, AS WELL AS PROVIDING EXPERTS FOR NEWS MEDIA STORIES ON COVID-19. COMMUNITY EDUCATION ALSO INCLUDED THE FOLLOWING: TOGETHER WEBSITE: TOGETHER PROVIDES COVID-19 VIRUS AND VACCINE EDUCATION, INCLUDING INFORMATION ON HOW TO TALK TO YOUR CHILD ABOUT COVID-19 AND VACCINES, HOW TO PREVENT THE SPREAD OF CORONAVIRUS, HOW TO TALK TO FRIENDS AND FAMILY ABOUT VACCINE HESITANCY, AND WHAT COVID-19 MEANS FOR CHILDREN WITH WEAKENED IMMUNE SYSTEMS AND FOR CHILDHOOD CANCER SURVIVORS. TOGETHER DEVELOPED COLORING AND ACTIVITY BOOKS FOR CHILDREN AND TWEENS TO HELP NORMALIZE THE VIRUS. THE COLORING BOOK IS AVAILABLE IN 17 LANGUAGES AND THE ACTIVITY BOOK IN 14 LANGUAGES. PROMISE MAGAZINE, PRINT AND DIGITAL: ST. JUDE PUBLISHED 4 QUARTERLY MAGAZINES THIS YEAR WITH EDUCATIONAL INFORMATION ON HIV/AIDS, COVID-19, GENERAL CHILDHOOD CANCER AND HEALTH RESOURCES, AND CHILDHOOD CANCER SURVIVORSHIP. PROGRESS BLOG POSTS: ST. JUDE PUBLISHED MORE THAN 95 ARTICLES IN PROGRESS THIS YEAR WITH EDUCATIONAL INFORMATION ON COVID-19, SICKLE CELL DISEASE, FLU, HIV/AIDS, HEALTH CARE CAREERS, GENERAL CHILDHOOD CANCER AND HEALTH RESOURCES, AND CHILDHOOD CANCER SURVIVORSHIP.COVER FOR THE KIDS CAMPAIGN: ST. JUDE DEVELOPED A MASKING EDUCATION INITIATIVE THAT DRIVES HOME PROTECTING HEALTHCARE PROVIDERS BY MASKING IN THE COMMUNITY, THEREBY SAFEGUARDING THE PATIENTS AT ST. JUDE (HTTPS://WWW.STJUDE.ORG/MEDIA-RESOURCES/SPECIAL-ANNOUNCEMENTS/COVER-FOR-THE-KIDS.HTML).WORLD IMMUNIZATION WEEK CAMPAIGN: ST JUDE DEVELOPED VACCINES BRING US CLOSER EDUCATION TOOLKIT FOR LOCAL COMMUNITY (HTTPS://WWW.STJUDE.ORG/ GET-VACCINATED.HTML). TOOLKIT INCLUDES MYTH BUSTERS ABOUT THE VACCINE, EDUCATION CONTENT FOR FORMAL PRESENTATIONS, AND PROMOTIONAL ITEMS (STICKERS, CARDS, AND T-SHIRT GRAPHICS).IN THE MIDST OF A PANDEMIC, THE DEDICATED SCIENTISTS AT ST. JUDE CONTINUE TO TRAVEL THEIR PATH OF INNOVATION, MAKING DISCOVERIES AND SHARING THEIR FINDINGS WITH THE WORLD. OUR RESEARCHERS DEVELOPED SOFTWARE TO IDENTIFY CANCER-CAUSING MUTATIONS LURKING IN VAST REGIONS OF THE HUMAN GENOME. THEY PREMIERED A DATA PORTAL THAT WILL SPEED DISCOVERIES AND NOVEL THERAPIES FOR THE TREATMENT OF CHILDHOOD SOLID TUMORS. AND THEY HAVE CREATED AN INNOVATIVE RESOURCE THAT ALLOWS RESEARCHERS WORLDWIDE TO TEST NOVEL THERAPIES FOR CHILDHOOD BRAIN TUMORS. |
| THIS YEAR, OUR SCIENTISTS REPORTED DECREASED RISK OF CENTRAL NERVOUS SYSTEM | RELAPSE WITHOUT INCREASED TOXICITY FOR PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA. ST. JUDE PHYSICIAN-SCIENTISTS REPORTED NEW FINDINGS TO EXPAND OUR UNDERSTANDING OF BRAIN TUMORS, INCLUDING MINIMIZING TREATMENT RELATED TOXICITY FOR PINEOBLASTOMA PATIENTS AND REDUCING OTOTOXICITY AND HEARING LOSS IN CHILDREN TREATED FOR MEDULLOBLASTOMA. ST. JUDE IMMUNOLOGISTS ADVANCED OUR UNDERSTANDING OF HOW THE IMMUNE SYSTEM RESPONDS TO INFECTION AND FURTHER REPORTED NEW DISCOVERIES USING ADAPTIVE CELL THERAPY TO SPECIFICALLY TARGET TUMORS. A TEAM OF COMPUTATIONAL BIOLOGISTS, PATHOLOGISTS AND ONCOLOGISTS COMPLETED GENOMIC ANALYSES OF MELANOMA TUMORS TO ENHANCE EFFORTS TO FIND NEW TREATMENTS.STRUCTURAL BIOLOGISTS AT ST. JUDE ARE USING ADVANCED TECHNOLOGY IN MOLECULAR ANALYSIS TO BETTER UNDERSTAND STRUCTURE AND MECHANISMS OF PROTEINS TO IDENTIFY NEW TARGETS FOR CANCER THERAPY, LEADING TO NUMEROUS PUBLISHED ARTICLES HELPING SCIENTISTS ACROSS THE WORLD. FINDING CURES AND SAVING CHILDREN REMAINS AT THE FOREFRONT OF ALL WE DO. OUR FACULTY AND STAFF KNOW ALL TOO WELL THAT CANCER AND OTHER DEADLY ILLNESSES DON'T STOP, EVEN IN THE MIDST OF A PANDEMIC. AS A RESULT, WE CONTINUE TO CARE FOR THOUSANDS OF CHILDREN WITH CANCER AND OTHER LIFE-THREATENING DISEASES. WE ARE FOCUSED ON ENSURING PATIENTS GET THE TREATMENT THEY NEED AND UNDERSTANDING THE SCIENTIFIC FOUNDATION THROUGH BASIC AND TRANSLATIONAL RESEARCH, CLINICAL TRIALS, AND POPULATION SCIENCE FOCUSED ON CATASTROPHIC CHILDHOOD DISEASES AND SURVIVORSHIP. |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | 0 | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (4 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|
| OUR LADY OF THE LAKE REGIONAL MEDICAL CENTER | |||||||
| 5000 HENNESSY BLVD | BATON ROUGE | LA | 70808 | 720423651 | 501(C)(3) | $1,000,000 | FINANCIAL SUPPORT |
| SAINT FRANCIS MEDICAL CENTER | |||||||
| 530 NE GLEN OAK AVE | PEORIA | IL | 61637 | 370662569 | 501(C)(1) | $490,909 | OPERATION OF ST. JUDE CLINIC |
| CHURCH HEALTH | |||||||
| 1350 CONCOURSE AVE STE 142 | MEMPHIS | TN | 38104 | 581716113 | 501(C)(3) | $100,750 | FINANCIAL SUPPORT |
| UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER | |||||||
| 62 S DUNLAP AVE STE 500 | MEMPHIS | TN | 38163 | 626001636 | GOVERNMENT ENTITY | $17,200 | SPONSORSHIP |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 3 | Total501c3OrgCnt |
| Total Other Org | 1 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | ST. JUDE CHILDREN'S RESEARCH HOSPITAL IS ACTIVELY INVOLVED WITH THE DONEE. THROUGH THIS ACTIVE INVOLVEMENT, THE ORGANIZATIONS ARE MONITORED TO ENSURE THE SUPPORT IS USED APPROPRIATELY. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| First Class Or Charter Travel | Yes (X) | FirstClassOrCharterTravelInd |
| Idemnification Gross Up Pmts | Yes (X) | IdemnificationGrossUpPmtsInd |
| Written Policy Ref T And E Expnss | Yes (1) | WrittenPolicyRefTAndEExpnssInd |
| Substantiation Required | Yes (1) | SubstantiationRequiredInd |
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Written Employment Contract | Yes (X) | WrittenEmploymentContractInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (1) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | Yes (1) | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (13 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CHARLES M ROBERTS | ||||||||||||||
| EVP/DIRECTOR CANCER CENTER | $879,767 | $0 | $150 | $0 | $530,428 | $0 | $72,888 | $0 | $13,228 | $0 | $1,496,461 | $0 | $300,000 | $0 |
| JAMES R DOWNING | ||||||||||||||
| PRESIDENT/CEO | $1,194,386 | $0 | $100,150 | $0 | $8,931 | $0 | $230,350 | $0 | $25,166 | $0 | $1,558,983 | $0 | $0 | $0 |
| MATTHEW J KRASIN | ||||||||||||||
| FACULTY | $635,863 | $0 | $17,650 | $0 | $553,656 | $0 | $31,350 | $0 | $34,947 | $0 | $1,273,466 | $0 | $0 | $0 |
| RICHARD C SHADYAC JR | ||||||||||||||
| EX-OFFICIO DIRECTOR | $0 | $877,077 | $0 | $0 | $0 | $68,687 | $0 | $103,459 | $0 | $19,605 | $0 | $1,068,828 | $0 | $64,529 |
| THOMAS E MERCHANT | ||||||||||||||
| CHAIR | $851,216 | $0 | $17,650 | $0 | $78,015 | $0 | $31,350 | $0 | $34,947 | $0 | $1,013,178 | $0 | $0 | $0 |
| ELLIS NEUFELD | ||||||||||||||
| EVP/CLINICAL DIRECTOR | $832,321 | $0 | $150 | $0 | $5,079 | $0 | $145,720 | $0 | $23,254 | $0 | $1,006,524 | $0 | $0 | $0 |
| ANDREW DAVIDOFF | ||||||||||||||
| CHAIR | $836,053 | $0 | $17,650 | $0 | $75,151 | $0 | $31,350 | $0 | $32,387 | $0 | $992,591 | $0 | $0 | $0 |
| DOUGLAS R GREEN | ||||||||||||||
| CHAIR | $551,235 | $0 | $27,650 | $0 | $289,540 | $0 | $31,350 | $0 | $26,794 | $0 | $926,569 | $0 | $0 | $0 |
| CHING-HON PUI | ||||||||||||||
| CHAIR | $793,944 | $0 | $27,650 | $0 | $8,790 | $0 | $31,350 | $0 | $7,659 | $0 | $869,393 | $0 | $0 | $0 |
| JAMES I MORGAN | ||||||||||||||
| EVP/SCIENTIFIC DIRECTOR | $639,229 | $0 | $150,150 | $0 | $13,831 | $0 | $31,350 | $0 | $27,725 | $0 | $862,285 | $0 | $0 | $0 |
| PATRICIA A KEEL | ||||||||||||||
| EVP, CAO & CFO | $766,773 | $0 | $150 | $0 | $5,074 | $0 | $66,350 | $0 | $14,191 | $0 | $852,538 | $0 | $0 | $0 |
| CARLOS RODRIGUEZ-GALINDO | ||||||||||||||
| EVP/CHAIR | $728,541 | $0 | $150 | $0 | $3,673 | $0 | $65,748 | $0 | $11,691 | $0 | $809,803 | $0 | $0 | $0 |
| MARY ANNA QUINN | ||||||||||||||
| FORMER EVP/CAO | $196,417 | $0 | $0 | $0 | $20,528 | $0 | $0 | $0 | $5,717 | $0 | $222,662 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (4 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 1A | CHARTER TRAVEL: ONE OFFICER TRAVELED ONCE ON HOSPITAL BUSINESS BY CHARTER. CHARTER FLIGHT WAS NECESSITATED BY COVID, AND PRE-APPROVED BY THE BOARD CHAIR. TRAVEL EXPENSES ARE REIMBURSED UNDER AN ACCOUNTABLE PLAN AND ARE NOT RECORDED AS COMPENSATION. TAX INDEMNIFICATION AND GROSS-UP PAYMENTS: A PAYMENT WAS ISSUED FOR DEPENDENT TUITION FOR ONE OFFICER. THE APPLICABLE EXPENSE WAS GROSSED-UP AND INCLUDED IN THE EMPLOYEE'S W-2 AS ADDITIONAL TAXABLE COMPENSATION. |
| PART I, LINE 4A: | UNDER A VOLUNTARY SEPARATION AGREEMENT ENTERED INTO BY THE EMPLOYEE AND THE ORGANIZATION, THE EMPLOYEE IS ENTITLED TO SEVERANCE PAY. THE TERMS AND CONDITIONS TO RECEIVE SEVERANCE PAYMENTS ARE CONFIDENTIAL. ALL SEVERANCE AGREEMENTS, WHEN LEGALLY PERMITTED, INCLUDE A RELEASE OF CLAIMS. SEVERANCE PAYMENTS WERE MADE DURING THE YEAR TO THE FOLLOWING LISTED PERSON IN PART VII: MARY ANNA QUINN $197,400 |
| PART I, LINE 4B: | THE ORGANIZATION ESTABLISHED A NON-QUALIFIED DEFERRED COMPENSATION PLAN PURSUANT TO CODE SECTION 457(F) OF THE INTERNAL REVENUE CODE. THE PLAN AMOUNTS ARE SUBJECT TO SUBSTANTIAL FUTURE SERVICE REQUIREMENTS TO THE ORGANIZATION AND ARE SUBJECT TO SUBSTANTIAL RISK OF FORFEITURE. NO NONQUALIFIED PLAN PAYMENTS WERE MADE DURING THE YEAR TO TWO PERSONS IN PART VII. |
| SCHEDULE J, PART II: | RICHARD C. SHADYAC, JR. SERVES AS AN EX-OFFICIO VOTING DIRECTOR OF THE BOARD OF ST. JUDE. MR. SHADYAC IS EMPLOYED AS AN OFFICER OF ALSAC, A RELATED ORGANIZATION TO ST. JUDE. THE COMPENSATION SHOWN IN COLUMNS (B), (C), (D) AND (E) WAS PAID TO MR. SHADYAC BY ALSAC FOR HIS DUTIES AS CEO OF ALSAC. |
Schedule L IRS990ScheduleL
Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp (6 entries)
| Relationship DescriptionRelationshipDescriptionTxt | TransactionTransactionAmt | TransactionTransactionDesc | Sharing Of RevenuesSharingOfRevenuesInd |
|---|---|---|---|
| LINDA H ATWOOD | |||
| SEE PART V | $10,478 | EMPLOYMENT | 0 |
| SUSANNA DOWNING | |||
| SEE PART V | $75,838 | EMPLOYMENT | 0 |
| JEREMY P QUINN | |||
| SEE PART V | $93,234 | EMPLOYMENT | 0 |
| DIANE ROBERTS | |||
| SEE PART V | $243,342 | EMPLOYMENT | 0 |
| CHRISTOPHER ROBERTS | |||
| SEE PART V | $26,327 | EMPLOYMENT | 0 |
| LYNN RODRIGUEZ | |||
| SEE PART V | $170,985 | EMPLOYMENT | 0 |
Supplemental Information Detail SupplementalInformationDetail (6 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: | (A) NAME OF INTERESTED PERSON: LINDA H. ATWOOD(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF OFFICER, ELLIS NEUFELD.(C) AMOUNT OF TRANSACTION: $10,478(D) DESCRIPTION OF TRANSACTION: EMPLOYMENT(E) SHARING OF ORGANIZATION REVENUES? = NO |
| SCHEDULE L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: | (A) NAME OF INTERESTED PERSON: SUSANNA DOWNING(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF PRESIDENT AND CEO, JAMES R. DOWNING.(C) AMOUNT OF TRANSACTION: $75,838(D) DESCRIPTION OF TRANSACTION: EMPLOYMENT(E) SHARING OF ORGANIZATION REVENUES? = NO |
| SCHEDULE L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: | (A) NAME OF INTERESTED PERSON: JEREMY QUINN(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF FORMER OFFICER, MARY ANNA QUINN.(C) AMOUNT OF TRANSACTION: $93,234(D) DESCRIPTION OF TRANSACTION: EMPLOYMENT(E) SHARING OF ORGANIZATION REVENUES? = NO |
| SCHEDULE L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: | (A) NAME OF INTERESTED PERSON: DIANE ROBERTS(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF OFFICER, CHARLES M. ROBERTS.(C) AMOUNT OF TRANSACTION: $243,342(D) DESCRIPTION OF TRANSACTION: EMPLOYMENT(E) SHARING OF ORGANIZATION REVENUES? = NO |
| SCHEDULE L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: | (A) NAME OF INTERESTED PERSON: CHRISTOPHER ROBERTS(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF OFFICER, CHARLES M. ROBERTS.(C) AMOUNT OF TRANSACTION: $26,327(D) DESCRIPTION OF TRANSACTION: EMPLOYMENT(E) SHARING OF ORGANIZATION REVENUES? = NO |
| SCHEDULE L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: | (A) NAME OF INTERESTED PERSON: LYNN RODRIGUEZ(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF OFFICER, CARLOS RODRIGUEZ-GALINDO.(C) AMOUNT OF TRANSACTION: $170,985(D) DESCRIPTION OF TRANSACTION: EMPLOYMENT(E) SHARING OF ORGANIZATION REVENUES? = NO |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (8 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART VI, SECTION A, LINE 2 | FAMILY RELATIONSHIP AMONG DIRECTORS: JOSEPH S. AYOUB, JR., ESQ. AND PAUL J. AYOUB, ESQ.; ROBERT A. BREIT, MD AND JOSEPH G. SHAKER; JOSEPH C. SHAKER AND JOSEPH G. SHAKER. |
| FORM 990, PART VI, SECTION A, LINE 3 | MANAGEMENT COMPANY, WITT KEIFER, WAS RETAINED TO PROVIDE TEMPORARY STAFFING FOR THE POSITION OF SENIOR VICE PRESIDENT OF CAMPUS OPERATIONS, WHO HAD MANAGEMENT DUTIES CUSTOMARILY PERFORMED UNDER THE DIRECT SUPERVISION OF THE CFO & CAO. |
| FORM 990, PART VI, SECTION A, LINE 5 | THE ORGANIZATION WAS TARGETED THROUGH A SOCIAL ENGINEERING FRAUD WHICH RESULTED IN A TRANSFER OF $2,171,740 TO A FRAUDULENT ACCOUNT. THE ATTACKERS IMPERSONATED A REPRESENTATIVE OF AN ESTABLISHED CONSTRUCTION CONTRACTOR OF WHOM THE ORGANIZATION OWED FEES FOR SERVICES RENDERED AND REQUESTED AN UPDATE TO THE BANK ACCOUNT USED TO COLLECT PAYMENTS. SUBSEQUENT TO UPDATING THE PROVIDED BANKING INFORMATION, FUNDS FOR ACTUAL SERVICES RENDERED WERE TRANSFERRED TO THE NEW BANK ACCOUNT. UPON BECOMING AWARE OF THE LOSS, THE FBI WAS NOTIFIED BY TELEPHONE AND A COMPLAINT REFERRAL FORM WAS FILED WITH THE FBI'S INTERNET CRIME COMPLAINT CENTER. A DETAILED FORENSICS INVESTIGATION WAS CONDUCTED INTERNALLY, AND DETAILS WERE SHARED WITH THE FBI. FOLLOWING IDENTIFICATION OF THE LOSS, AN EXTERNAL AUDIT FIRM WAS ENGAGED TO PERFORM AN INTERNAL CONTROL ASSESSMENT OF BUSINESS CYCLES MOST SUSCEPTIBLE TO CASH FRAUD SCHEMES. THE ORGANIZATION PERFORMED A COMPREHENSIVE REVIEW OF EXISTING PROCESSES AND POLICIES, AND WHERE WARRANTED, UPDATES WERE MADE TO CONTROLS TO STRENGTHEN THE CONTROL ENVIRONMENT. THE ORGANIZATION IMPLEMENTED A BANK ACCOUNT AUTHENTICATION PLATFORM TO FACILITATE NEWLY IMPLEMENTED CONTROLS AND ENHANCED EXISTING CONTROLS TO ENSURE APPROPRIATE RISK COVERAGE ACROSS THE ENTIRE PROCESS. ADDITIONAL TARGETED PHISHING TESTS/TRAINING HAVE BEEN IMPLEMENTED TO RAISE CYBERCRIME AWARENESS. THE INTERNAL CYBERSECURITY TEAM PARTNERS WITH SUBJECT MATTER SPECIALISTS TO SELECT PHISHING SCENARIOS REPRESENTING REAL THREATS. FOR EACH PHISHING SCENARIO, USERS RECEIVE INSTANT FEEDBACK. KEY METRICS RELATED TO PHISHING TEST CAMPAIGNS ARE REPORTED TO THE LEADERSHIP AS WELL AS TO THE BOARD ON A REGULAR BASIS. SUCH TESTING HELPS EMPLOYEES RECOGNIZE CYBER THREATS, INCLUDING SOCIAL ENGINEERING TACTICS USED TO GAIN SENSITIVE INFORMATION. CLAIMS WERE SUBMITTED TO THE ORGANIZATION'S CRIME AND CYBER INSURANCE CARRIERS. $250,000 WAS RECEIVED FROM THE CRIME CARRIER. IN ADDITION, $16,625 WAS RECOVERED FROM THE BANK WHERE THE FRAUDULENT WIRE PAYMENT WAS DEPOSITED. |
| FORM 990, PART VI, SECTION B, LINE 11B | IN THE THIRD QUARTER OF THE FISCAL YEAR, THE AUDIT & COMPLIANCE COMMITTEE ARE PROVIDED WITH A DRAFT COPY OF THE FORM 990 AND ALL REQUIRED SCHEDULES. THE AUDIT & COMPLIANCE COMMITTEE MEETS WITH ITS TAX PREPARER TO REVIEW THE DRAFT FORM 990 BEFORE IT IS FILED WITH THE IRS. ADDITIONALLY THE COMPENSATION COMMITTEE OF THE BOARD IS PROVIDED WITH A DRAFT COPY OF THE COMPENSATION SECTIONS OF THE FORM 990, AND THE CONFLICT OF INTEREST COMMITTEE OF THE BOARD IS PROVIDED WITH A DRAFT COPY OF THE CONFLICT-OF-INTEREST SECTIONS OF THE FORM 990 FOR REVIEW BEFORE THE FINALIZED DOCUMENT IS FILED WITH THE IRS. EACH VOTING MEMBER OF THE BOARD IS PROVIDED WITH A FINAL COPY OF THE FORM 990 AND ALL REQUIRED SCHEDULES BEFORE IT IS FILED WITH THE IRS. |
| FORM 990, PART VI, SECTION B, LINE 12C | NEW BOARD MEMBERS ARE GIVEN A COPY OF THE BOARD OF GOVERNOR'S CONFLICT OF INTEREST POLICY AND COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM. IN ADDITION, ALL BOARD MEMBERS COMPLETE A CONFLICT OF INTEREST DISCLOSURE UPDATE AT LEAST ANNUALLY. THERE IS A CONFLICT OF INTEREST COMMITTEE OF THE BOARD THAT REVIEWS THE ANNUAL CONFLICT OF INTEREST DISCLOSURE STATEMENTS THAT ARE COMPLETED BY EACH BOARD MEMBER AND DISCUSSES AND RESOLVES CONFLICTS OF INTEREST, WITH OPPORTUNITY FOR APPEAL TO THE FULL BOARD. IN ADDITION, THE ORGANIZATION HAS A CHIEF COMPLIANCE OFFICER AND COMPLIANCE DEPARTMENT, WHICH ADMINISTER THE CONFLICT OF INTEREST DISCLOSURE PROCESS FOR ALL EMPLOYEES IN CLINICAL, RESEARCH, AND SELECT ADMINISTRATIVE DEPARTMENTS, AS WELL AS EMPLOYEES IDENTIFIED AS SUPERVISORS OR WHO HAVE PURCHASING AUTHORITY. ALL SUCH EMPLOYEES COMPLETE CONFLICT OF INTEREST TRAINING AND A CONFLICT OF INTEREST DISCLOSURE ANNUALLY. THE COMPLIANCE OFFICER ENSURES EMPLOYEES MEET THESE REQUIREMENTS AND REVIEWS SUBMITTED DISCLOSURES. DISCLOSURES IDENTIFIED AS AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST ARE ADDRESSED BY THE COMPLIANCE OFFICE WITH INVOLVEMENT OF THE INSTITUTIONAL CONFLICT OF INTEREST COMMITTEE AS APPROPRIATE. DEPENDING ON THE FACTS AND CIRCUMSTANCES, THE ACTIVITY MAY BE MANAGED PURSUANT TO A MANAGEMENT PLAN, OR PROHIBITED. |
| FORM 990, PART VI, SECTION B, LINE 15 | AN INDEPENDENT COMPENSATION COMMITTEE OF THE BOARD, ADVISED BY AN INDEPENDENT OUTSIDE EXPERT, ANNUALLY REVIEWS THE REASONABLENESS OF THE TOTAL REMUNERATION PAID TO THE CEO, OTHER OFFICERS, AND CERTAIN OTHER EMPLOYEES. THE LAST REVIEW WAS COMPLETED IN DECEMBER 2021. THE BOARD'S EXECUTIVE TOTAL COMPENSATION PHILOSOPHY IS INTENDED TO SUPPORT THE ORGANIZATION'S OVERALL STRATEGY AND OBJECTIVES, ATTRACT AND RETAIN EMPLOYEES, LINK COMPENSATION TO PERFORMANCE AND THE ATTAINMENT OF THE ORGANIZATION'S OBJECTIVES, AND PROVIDE COMPENSATION AT A REASONABLE COST WHILE FULFILLING THE CHARITABLE MISSION OF THE ORGANIZATION. THE BOARD TARGETS TOTAL REMUNERATION BETWEEN THE 50TH AND 75TH PERCENTILES OF THE DEFINED COMPARATOR MARKET, WHILE GIVING DUE CONSIDERATION TO THE MISSION AND THE CHARITABLE NATURE OF THE ORGANIZATION. NO REVIEWED EMPLOYEE'S TOTAL REMUNERATION WAS OVER THE 75TH PERCENTILE FOR THE REPORTING YEAR. |
| FORM 990, PART VI, SECTION C, LINE 19 | FINANCIAL STATEMENTS ARE AVAILABLE FROM THE HOSPITAL'S WEBSITE. GOVERNING DOCUMENTS AND THE CONFLICT OF INTEREST POLICY ARE MADE AVAILABLE ONLY AS REQUIRED BY APPLICABLE STATE LAW. |
| FORM 990, PART XI, LINE 9: | CHANGE IN INTEREST IN NET ASSETS OF ALSAC WITHOUT DONOR RESTRICTIONS 2,016,275,384. CHANGE IN INTEREST IN NET ASSETS OF ALSAC WITH DONOR RESTRICTIONS 286,779,348. |
Schedule R IRS990ScheduleR
Id Disregarded Entities IdDisregardedEntitiesGrp (5 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Total IncomeTotalIncomeAmt | End Of Year AssetsEndOfYearAssetsAmt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt |
|---|---|---|---|---|---|---|---|---|---|
| CHILDREN'S GMP LLC | |||||||||
| 262 DANNY THOMAS PLACE | MEMPHIS | TN | 381053678 | 474475625 | VACCINE MANUFACTURER | TN | $267,627 | $3,963,184 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC |
| THANKS & GIVING LLC | |||||||||
| 262 DANNY THOMAS PLACE | MEMPHIS | TN | 381053678 | 201310435 | ROYALTY INCOME FROM RECORD SALES | TN | $0 | $10,632 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC |
| THE RIGHT WORDS LLC | |||||||||
| 262 DANNY THOMAS PLACE | MEMPHIS | TN | 381053678 | 954878579 | ROYALTY INCOME FROM BOOK SALES | NY | $0 | $0 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC |
| ST JUDE CHILDREN'S RESEARCH HOSPITAL GRADUATE SCHOOL OF BIOMEDICAL SCIENCES | |||||||||
| 262 DANNY THOMAS PLACE | MEMPHIS | TN | 381053678 | 813240987 | HIGHER EDUCATION | TN | $133,032 | $1,725,421 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC |
| ST JUDE CHILDREN'S RESEARCH HOSPITAL HOME CARE LLC | |||||||||
| 262 DANNY THOMAS PLACE | MEMPHIS | TN | 381053678 | 852379541 | HOME HEALTH SERVICE PROVIDER | TN | $0 | $300,000 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC |
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp
Disregarded Entity Name DisregardedEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AMERICAN LEBANESE SYRIAN ASSOCIATED CHARITIES INC | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 501 ST JUDE PLACE | AddressLine1Txt |
| City | MEMPHIS | CityNm |
| State Abbreviation | TN | StateAbbreviationCd |
| ZIP | 381053678 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 351044585 | EIN |
| Primary Activities | SOLICIT SUPPORT FOR OPERATION OF ST. JUDE | PrimaryActivitiesTxt |
| Legal Domicile State | IL | LegalDomicileStateCd |
| Exempt Code Section | 501(C)(3) | ExemptCodeSectionTxt |
| Public Charity Status | 7 | PublicCharityStatusTxt |
| Direct Controlling NA | N/A | DirectControllingNACd |
| Controlled Organization | 0 | ControlledOrganizationInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | 0 | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | 0 | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (1) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | 0 | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | 0 | DivRelatedOrganizationInd |
| Asset Sale To Other Org | 0 | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | 0 | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | 0 | AssetExchangeInd |
| Rental Of Facilities To Oth Org | 0 | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | Yes (1) | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | 0 | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | Yes (1) | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | Yes (1) | SharingOfFacilitiesInd |
| Paid Employees Sharing | 0 | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | Yes (1) | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | Yes (1) | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | 0 | TransferToOtherOrgInd |
| Transfer From Other Org | 0 | TransferFromOtherOrgInd |